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13 |  CHAPTER 1
History of high intensity focused ultrasound
 High intensity focused ultrasound (HIFU) is a rapid growing noninvasive focal treatment modality 
with a large range of applications. An ultrasound (US) source, also known as the transducer, is po-
sitioned outside the body and generates high frequency (0.8-5 MHz) US beams into a small focal 
volume inside the targeted tissue, without the requirements for transcutaneous insertion of probes 
or needles (Fig. 1.1) (1). Absorption of the ultrasonic energy within the focal volume induces tem-
perature rise above 56 °C within the focus, generating coagulative necrosis and keeping surround-
ing tissue intact (2). An area of interest can be destructed by positioning multiple interconnected 
focal volumes.
 The idea of focused ultrasound was first introduced in 1942 (3), and the first clinical application 
of HIFU, in the 50s, was the destruction of selective regions in the brain for better understanding 
of neurobehavior and later on the treatment of Parkinson’s (4-6). However due to poor imaging 
methods for treatment targeting and evaluation, HIFU did not became clinically accepted until the 
90s when US and magnetic resonance imaging (MRI) techniques were introduced (7). These mo-
dalities led to good anatomical and functional information for treatment targeting and treatment 
evaluation. Since then major technical improvements have been made. Nowadays, a wide range of 
systems are in development for the treatment of tumors with HIFU in different organs, including 
prostate (8), liver (9), breast or bone (10,11).
 Thermal ablation of the tissue is clinically the most used method of HIFU treatment. However, 
beside thermal effects, US waves also introduce mechanical effects due to the radiation forces or 
the creation of cavitation effects. These mechanical effects can be used to fragmentized the tissue 
(cavitation cloud histotripsy or boiling histotripsy (12)), temporarily opening of the blood brain 
barrier (13-15), or an increase of the vascular permeability (13). The histopathological and physio-
logical effect strongly depends on the acoustic settings used for HIFU treatment as well as the tissue 
characteristics. The aim of this thesis is to develop an in vivo set-up to create pure mechanical HIFU 
ablation using a method called boiling histotripsy (BH) in mice tumor models. This set-up is further 
used to evaluate the pathological and physiological effects and evaluation of the treatment with MR 
imaging. Thermal HIFU (T-HIFU) ablation is used as an comparison.
 This chapter describes the basic principles of HIFU and describes some major effects of both 
thermal and mechanical HIFU ablation methods. Furthermore, the most common MRI methods for 
HIFU treatment guidance and evaluation will be discussed. Finally the aim and outline of the thesis 
is described.
Figure 1.1  Schematic overview of HIFU ablation.
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Figure 1.2  Left: Axial pressure profile of the HIFU system used for studies described within this thesis (unit 
MPa). Right: longitudinal (sagittal) pressure profile of HIFU system. The full width halve maxi-
mum of the focal spot, used for the studies in this thesis, is 0.5 x 0.5 x 2 mm.
Basic principles of HIFU
 Ultrasound waves are generated by a transducer outside the body. The US wave propagates as 
a sinusoidal pressure wave through the different layers of tissue after which it is bundled in a small 
focus at the targeted region. The acoustic energy of the ultrasound waves are fused within the 
small focal volume (Fig. 1.2). The size of this focal volume depends on the wavelength λ (i.e. central 
frequency) and geometry constant (K) of the transducer. Generally an estimation of the focal 
volume can be determined by 1 λ x 1 λ  x K λ  (16).
 The US beam propagates through the tissue as a pressure wave generated by the transducer. The 
amplitude of this wave correlates to the acoustic intensity.  At each tissue interface there is some atten-
uation of the acoustic intensity due to reflection, refraction, scattering or absorption (1). The degree of 
attenuation depends on the distance of propagation, absorption coefficients, acoustic impedance dif-
ference between the layers of tissue and the central frequency used (17-19). The pressure fluctuation 
of the ultrasound wave results in microscopic shearing motion as the US wave propagates through 
the tissue. This shearing motion results in heating of the tissue, thus part of the mechanical energy (i.e. 
intensity) of the ultrasound wave is converted into heat also known as absorption (20). The increase of 
the acoustic intensity as the US beam is bundled within the focal volume result in an increase in absorp-
tion thus an increase of heat deposition. Hereby the absorption is low as the ultrasound wave propagates 
through the tissue, but increases as the acoustic intensity increases within the focal volume (1,21).
 The acoustic impedance of the tissue is of influence to the amount of reflection and scattering of 
the US wave and can be defined as the product of density and speed of sound between two tissue 
layers. While bone has a high impedance and air has very low impedance, other (soft) tissues has almost 
similar acoustic impedance as water. Hereby the reflection and scattering at tissue interfaces is gener-
ally weak and the amount of attenuation is sufficiently low to deliver the required amount of energy 
within the focal volume (1,17). However bone and air should be avoided within the US path to avoid 
scattering or reflection of the US beam.
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 Both the attenuation and absorption coefficient increase with the excitation frequency of the 
generated US wave. Thus as the attenuation of the ultrasound intensity increases, the penetration 
dept decreases with a higher central frequency. Related to this, the higher absorption of the higher 
frequency also results in a higher heat deposition within the focal spot. Therefore in therapeutic 
HIFU generally an excitation frequency between 0.5 and 8 MHz is used for respectively deeper or 
shallower treatment sites (22,23).
 Generally HIFU transducers generate a sinusoidal US wave, however due to the high frequency 
US wave with high intensity (i.e. high pressures) combined with the heterogeneity of the tissue, a 
nonlinear propagation effect occurs (24,25). This nonlinear propagation effect can be explained by 
the fact that the positive pressure (compression) part of the US wave travels faster through the 
tissue then the negative pressure (rarefaction) part, hereby a distortion of the waveform is created. 
When sufficient amount of energy is used, this effect could result in the formation of a so called 
shock-wave (26,27). In the frequency domain this distortion produces higher harmonics of the 
fundamental frequency, which are absorbed more easily and converted into heat. The nonlinear 
effects accumulate as the ultrasound wave propagates in the tissue and with increase of the acous-
tic intensity, thus the effect is the strongest within the focal zone. This mechanism is a significant 
contributor to heating of the tissue, and decreases the time to reach lethal temperatures within the 
focal volume (26).
 The nonlinear propagation effects also induces cavitation effects within the tissue. The large 
negative pressure of high intensity US waves can form small vaporized or gas-filled cavities (mi-
crobubbles) due to extraction of gas from the liquid substances of the tissue. This mechanism is 
known as cavitation (27). Cavitation can be divided into stable cavitation and inertial cavitation. In 
stable cavitation the microbubble oscillates with the ultrasound frequency, hereby gas from outside 
the microbubble is extracted into the microbubble, in which it will grow in size. When the bubble 
resonance frequency becomes larger than the ultrasound frequency, the bubble will collapse which 
is known as inertial cavitation. Due to the collapse of the microbubble, small microjets are formed 
which in turn generate local shock waves in the order of gigapascals. Hereby a mechanical destruc-
tion of cells and tissue is generated. Cavitation effects can be used for either cavitation enhanced 
heating or mechanical destruction of tissue (24,27-31). These aspects will be described in more 
detail in chapter 2 of this thesis.
Treatment
 The size of destroyed tissue, the histopathological and physiological effect to HIFU treatment 
strongly depends on the acoustic parameters, such as applied power, duration of sonication, contin-
uous wave (CW) or pulsed wave (PW) ablation as well as the tissue characteristics. Although this 
would make HIFU treatment more challenging it also gives a wide range of opportunities. Based on 
the method of treatment which is chosen, the required effects can be generated such as (tempo-
rarily) destruction of the blood brain barrier, drug delivery, increased vascular permeability, neuro-
modulation, thermal or mechanical tissue destruction and much more. This thesis is mainly focused 
on pure mechanical destruction via BH, with comparison to the more well known, and clinically 
used, T-HIFU therapy. Therefore T-HIFU will be shortly introduced in this section, mechanical HIFU 
is extensively described in chapter 2.
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Thermal HIFU
 Thermal effects of HIFU are induced by the absorption of the acoustic energy. Temperature rise 
induced by US is especially influenced by the acoustic parameters such as the average intensity and 
duration of ablation, as well as the tissue characteristics such as absorption coefficient and perfu-
sion. Generally, a continuous wave ultrasound beam of a couple of seconds or minutes are used 
to generate thermal coagulation or hyperthermia effects (2,16,18). The increase of temperature is 
proportional to the acoustic intensity and increases with the duration of exposure until a steady 
state is reached (32). However non-linear effects, and cavitation effects, could significantly accel-
erate temperature rise within the focal volume (30). Tissue characteristics, such as the absorption 
coefficients and perfusion of the tissue, are of influence to the temperature rise within the focal 
zone (33-35). Fatty tissues, such as the breast has a higher attenuation and absorption coefficient 
compared to brain or abdominal tissue, resulting in a more rapid and higher temperature rise when 
the same amount of acoustic intensity is used (2,36). Blood perfusion reduces the level of temper-
ature increase due to heat conduction by the blood flow (32). The influence of blood perfusion 
could be reduced by a decrease of the duration and an increase of the acoustic intensity.
 The histopathological and physiological effects of HIFU induced temperature elevation depends 
on the temperature and duration of the exposure (2). Temperatures in the range of 39-46 ̊C result 
in hyperthermia induced effects varying from an increase of the permeability, swelling or temporar-
ily damage to irreversible cell dead (e.g. apoptosis) depending on the duration of ablation (2,37,38). 
Temperatures above 60 ̊C induces instant protein denaturation and cell membrane denaturation 
which is cytotoxic and leads to coagulation of the cells (37,39). The thermal dose, as calculated by 
the equation developed by Sapareto and Dewey (40), is the most widely excepted method to esti-
mate the thermal effects on the tissue. The variety of temperature and time is related to equivalent 
time at 43  ̊C in minutes. The cumulative equivalent minutes at 43  ̊C (CEM43) is the most accepted 
metric for thermal dose as a threshold for the thermal damage of the tissue and can be calculated by:
CEM43 = ∆tR(43-T)      (eq.1)
 In which ∆t signifies summation over the length of exposure, T is the average temperature during 
time interval t. R is a constant based on experimental data and is temperature dependent, R=0.25 
for T=<43  ̊C and R=0.5 for T>43  ̊C (36,40). Although the thermal threshold also depends on the 
tissue characteristics (36), an CEM43 of 240 minutes is clinically accepted as a lethal dose threshold 
to predict irreversible thermal coagulation of the cells (2,36,41,42).
 For thermal HIFU ablation, multiple focal volumes are interconnected positioned to ablate a large 
volume, or the focal volume of the transducer is moved through the region of interest while shoot-
ing continuously (43,44). As multiple focal spots are positioned, a cooling time is required between 
each focal ablation to reduce heat sink effects both in the direct surrounding of the ablation zone, 
as well as near field heating for example at the skin where the US beam enters the body. The ablat-
ed area, i.e. lesion, contains a central area of tissue in which high temperatures are reached which 
undergoes coagulative necrosis. However, due to thermal diffusion the transition zone of lower 
temperatures occurs inducing hyperthermia effects in the tissue between the coagulated tissue and 
intact cells. A more rapid temperature increase results in a smaller transition zone (37,39,45). 
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Mechanical HIFU
 Mechanical induced effects are especially influenced by the wave-form and the peak positive and 
negative pressures of the US wave. Shock waves and the creation of inertial cavitation are the main 
mechanisms responsible for mechanical damage to the tissue. Cavitation cloud histotripsy (CH) 
and BH are the most familiar ablation methods for pure mechanical destruction of the tissue, with 
negligible thermal coagulation of the tissue (46-49). The term ‘histotripsy’, from histo- (soft tissue 
from the Greek histos) and –tripsy (crush, from the Greek tripsis), describes the disintegration of 
soft tissue by high intensity ultrasound pulses. The method used for histotripsy is based on a more 
familiar method called lithotripsy, which is used for breaking kidney stones. 
 The acoustic intensities used for CH and BH are at least five times as high as the intensities 
used for thermal ablation methods. To limit temperature increase during ablation, a pulsed wave 
ablation is used with a low duty cycle, i.e. pulse repetition frequency (16). The multiple shock waves, 
which are created due to the non-linear effect of the high intensities, and the formation of inertial 
cavitation, as discussed earlier, result in destruction of cell membranes and even liquefaction of 
the cells. Thus, while for thermal ablation the average intensity is most important factor for tissue 
destruction, for mechanical treatment the peak intensities and wave-form are most important (18). 
It should be noted that, due to the short pulse duration and low duty cycle, the total amount of 
acoustic energy delivered to the focal zone during mechanical ablation is similar or even lower 
compared to T-HIFU treatment. Both the mechanisms, effects and differences between CH and BH 
are extensively described in chapter 2.
MR	image	guidance	and	treatment	evaluation
 As HIFU is a non-invasive method, precise knowledge of the anatomy of the target organ and 
adjacent tissue is required for accurate treatment planning and detection of structures such as bone 
or gas to determine the correct acoustic window. For this reason focused US treatment was not 
clinically accepted until image guidance modalities such as magnetic resonance imaging (MRI) were 
introduced (50,51). MRI provides good anatomical images with high spatial resolution of both the 
targeted area as well as the surrounding tissue, making it a good modality for treatment planning. 
MR imaging also offers possibilities to be used as treatment guidance and treatment evaluation.
 Magnetic resonance imaging is based on the nuclear magnetic resonance phenomenon of certain 
nuclei, of which those of hydrogen atoms (protons) are the most frequently used in clinical MRI. 
In a simplified view these nuclei can be considered as charged particles that are spinning around 
their axis and therefore act as tiny magnetic dipoles. Normally in an object, i.e. tissue or body, there 
are millions of these so-called spins which have a random orientation and therefore create no net 
bulk magnetization. However, when a main magnetic field is applied to this object the spins will turn 
to a preferred orientation with respect to the axis of the magnetic field and will precess around 
the direction of the main field. More spins will have a preferred orientation with the main field 
than against it. This creates a net magnetization along the direction of the main field, the so-called 
longitudinal magnetization Mz. The precession frequency of the proton spins is given by the Larmor 
equation ν = γ B0. The Larmor frequency (or resonance frequency) of a spin system, depends on 
the main magnetic field strength (B0) and the nucleus dependent gyromagnetic ratio γ.
 By applying a short radiofrequency (RF) irradiation pulse at the Larmor frequency to the object, 
using a coil of copper wire, the preferred spin direction will be affected and the longitudinal mag-
netization Mz will turn away from the axis of the main field and arrive in the plane perpendicular 
to this axis after a so-called 900 excitation pulse. Immediately thereafter, it will precess, like the indi-
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vidual spins, in this so-called transversal plane around the main field axis and induce a current in the 
same coil, which is recorded as the MR signal. In combination with the implementation of a gradient, 
i.e. position dependent magnetic field, water proton spins will obtain slightly different frequencies 
depending on their location in the tissue. In this way images can be reconstructed. After the RF 
pulse, relaxation processes occur because of magnetic interaction between the spins and they re-
turn to their original preferred direction. This causes a decay of the magnetization in the transversal 
direction, called the spin-spin relaxation with a characteristic T2 relaxation time and a recovery of 
the magnetization in longitudinal direction, called the spin-lattice relaxation with a characteristic T1 
relaxation time (Fig. 1.3) (52,53).
 The relaxation times T1 and T2 are tissue dependent (Fig. 1.3). Tissue containing a lot of water 
has a long T1 and T2 relaxation time, while fat has a short T1 and long T2, and more rigid tissue 
(bone or fibrosis) have a short T2 (Fig. 1.3). Thus the contrast of MRI images can be adapted to the 
tissue of interest by tweaking the timing, order and magnitude of different RF pulses and gradients 
in MR measurement sequences. T1 weighted (T1w) images are obtained with sequences using 
short repetition time (TR) and echo time (TE), and T2 weighted (T2w) images are received with 
a long TR and TE. MRI offers a wide range of sequences with different timings which make it ideal 
to differentiate between anatomical structures of healthy and affected tissue with different T1 and 
T2 times and to evaluate pathology changes due to the treatment. The T1 and T2 times can be 
influenced by using MR contrast agents such as Gadolinium DTPA (mostly affects the T1 time). 
 
Figure 1.3  Time curves for longitudinal (T1) relaxation and transversal (T2) relaxation. Different relaxa-
tions are shown for two different tissues. Depending on the repetition and echo time of the 
sequence the contrast of the images are T1, PD or T2 weighted.
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 For T-HIFU ablation, commonly conventional MR techniques such as T1-weighted (T1w), 
T2-weighted (T2w), or contrast enhanced T1-weighted (Ce-T1w) imaging methods are used to 
validate the effect of a treatment (32,39,54). Standard T2w imaging provides good anatomical in-
formation, but is less helpful for thermal treatment evaluation as there is no direct change in cell 
structure or water content (39). With BH it is expected that the liquefaction of the tissue would 
result in major changes in the magnetic properties of the water spin system after the treatment, 
thus T2w imaging might be more useful. Verification of thermal ablation is often done with dynamic 
contrast enhanced (DCE) MR imaging or Ce-T1w imaging, following the change in image signal due 
to the inflow of the contrast agent. These techniques provide information about the vascularization 
of the tissue and the permeability of the blood vessels by administration of an MR contrast agent. 
MR contrast agents, such as Gadolinium or Gadomer, are administered intravenously and decreases 
the T1 (and to some extent T2) relaxation times. As the contrast agent enters the blood vessels, 
(highly) vascularized tumors will become more intense at Ce-T1w images. As time continuous the 
contrast agent will leak out of the vessels into the surrounding tissue, depending on the permeabil-
ity of the vessels. After thermal ablation the vessels are supposed to be clotted or coagulated, thus 
an absent of the contrast enhancement within this area. While in the transition zone hyperemia 
occurs and becomes more hyper-intense on Ce-T1w imaging due to wash out of the contrast 
agent (39,55,56). However the efficiency appeared to be dependent to the tissue type which is 
ablated (39). Limited research has been done to in vivo MR imaging after CH or BH, but it could be 
expected that these MR methods are also useful for treatment evaluation of CH and BH (57,58). 
This will extensively be discussed in chapter 2 and 4. 
 Real time treatment monitoring is an essential aspect for accurate and controlled HIFU treat-
ment. Temperature mapping based on MR imaging is a widely used method for thermal treatment 
of soft tissue. While the last couple of decades multiple MR thermometry methods have been 
developed (59,60). The proton resonance frequency shift method is, in clinical practice, the most 
used method for temperature mapping (32,61,62). This technique is based on phase changes of the 
resonance frequency of water protons which are linearly proportional to changes of the tempera-
ture of the tissue. Generally one or more images are acquired before heating the tissue to eliminate 
temperature-independent phase contributions, such as B0 field inhomogeneities. These images are 
subtracted from the images made during and after heating. The phase difference between these 
images are proportional to the temperature change:
  ∅(T) - ∅(T0)  
(γαB0 TE)      
 Ø(T) and Ø(T0) are the phase in the current and reference image respectively. The base temper-
ature, before heating, is added to ∆T to determine the actual temperature. γ is the gyromagnetic 
ratio, B0 is the magnetic field strength, TE is the echo time and α is the proton resonance frequency 
shift change coefficient. The latter for soft tissue is close to the coefficient of water (0.01 ppm/°C). 
With the use of this information and equation 1, a thermal dose map can be calculated. Conse-
quently an estimation can be made of the damaged size, i.e. lesion size. Two major limitations of 
this proton resonance frequency shift method are the high sensitivity to motion and that it does 
not work in adipose tissue as the temperature dependent on 1H resonance shift. This shift relies 
on variation of the hydrogen bonds in water which is absent in fat (59,60). Many methods are in 
development to avoid these limitations (63-66). 
∆T=  (eq.2)
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Aim and outline of this thesis
 The interest in and knowledge about mechanical HIFU treatment are rapidly growing, but in vivo 
effects due to treatments such as boiling histotripsy are still limited. Boiling histotripsy is one of the 
mechanical HIFU ablation methods to fragment soft tissue into submicron fragments and has great 
potential for treatment of solid tumors. However to get a better understanding of the treatment 
effects and optimal treatment of tumors using boiling histotripsy, large cohort studies are required. 
Mice are most accessible for large cohort studies and there are many disease models available in 
mice. The goal of this thesis was to create a setup for in vivo MR guided HIFU treatment in mice 
with subcutaneous tumors. This setup was further used to investigate methods for mechanical or 
thermal destruction of the tumors as well as to investigate the treatment effects using MRI, histo-
pathological and physiological evaluation.
  Chapter 2 gives a broad overview of the current mechanical ablation methods with HIFU, focus-
ing on CH and BH. The technical aspects of these two techniques are described, and an overview 
of the in vivo pathological and immunological effects are provided.
 In chapter 3 an MRI guided HIFU setup is presented for the treatment of small animals. With 
the setup created, both thermal or mechanical ablation methods can be used for the treatment of 
subcutaneous tumors within a mouse tumor model. This setup enables real time treatment guid-
ance through MR thermometry, but also to evaluate the treatment responses via MR imaging and 
histopathological evaluation of the tumor.
 With the use of this setup, we were able to optimize the treatment settings to generate BH 
methods. In chapter 4 this method is used for the treatment of a subcutaneous thymoma in a 
mouse. The treatment is evaluated using T2, T1 and proton density weighted MR imaging as well 
as (dynamic) contrast enhanced MRI. Furthermore the in vivo pathological effects are evaluated 
immediately after and four days after treatment.
 As tissue characteristics appeared to be of influence to the effectiveness of BH. A study has been 
done to evaluate different pathological effects in different tumor models. In chapter 5 the histo-
pathology immediately after treatment are evaluated in a more vascularized neuroblastoma and a 
less dense, containing less collagen, melanoma tumor model. These are compared to the thymoma 
model.
 In the final	chapter of this thesis at first a short summary is given. Secondly, a general discussion is 
given about limitations of BH (in a mouse model). Thirdly a future perspective will be given. This sec-
tion contains two main issues. First an overview of the literature is given about the effects of HIFU 
on the immune system as well as the first results of our studies of the immunological effects to BH 
in a mouse tumor model. It could be expected that due to a completely different histopathological 
response, between T-HIFU ablation or BH, that the immune response would be different as well. 
The release of proteins, danger signals and tumor antigens might stimulate a stronger immunologic 
reaction to the BH treatment instead of denaturation of these proteins and tumor-antigens by 
T-HIFU. The second part a future perspective is given towards clinical implementation of BH treatment.
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Abstract
 The best known method of high-intensity focused ultrasound is thermal ablation, but interest in 
non-thermal, mechanical destruction is increasing. The advantages of mechanical ablation are that 
thermal protein denaturation remains limited and less damage is created to the surrounding tissue 
by thermal diffusion. The two main techniques for mechanical fragmentation of tissue are cavitation 
cloud histotripsy (CH) and Boiling Histotripsy (BH). These techniques can be used for complete 
liquefaction of tumor tissue into submicron fragments, after which the fragmented tissue can be 
easily removed by natural (immunologic) responses. Interestingly it seems that there is a correlation 
between the degree of destruction and tissue specific characteristics based on the treatment set-
tings used. In this review article, the technical aspects of these two techniques are described, and 
an overview of the in vivo pathologic and immunologic responses is provided.
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Introduction
 Focused ultrasound (US) is used as a non-invasive ablation technique with a millimeter sized 
focus for destruction of tissue without disrupting surrounding tissue (1,2). Focused US to generate 
lesions has been investigated since the 1950’s (3,4). However, interest in the use of focused US for 
ablation increased enormously in the early nineties when US and magnetic resonance (MR) imaging 
for therapy guidance were introduced (5-7). This allowed for controlled ablation by visualizing both 
the focal spot and the targeted region. 
 High intensity focused ultrasound (HIFU) is an ablation technique able to destroy tissue by ei-
ther thermal or mechanical destruction. Thermal destruction is created by the absorption of the 
ultrasound energy using a continuous wave HIFU pulse for a couple of seconds (1), or by a small 
increase of the temperature for a long time (minutes) known as hyperthermia (8). This thermal ab-
lation techniques, which are most widely applied, causes a local temperature increase by absorption 
of the US energy within the focal spot resulting in thermal damage such as protein denaturation 
and irreversible cell damage, collectively referred to as thermal coagulation (2,9). 
 The mechanical HIFU (M-HIFU) ablation application involves non-thermal tissue destruction. 
The mechanical bioeffects of US waves is a much less well understood approach. In general, me-
chanical disruption is achieved by tissue exposure to repeated short (µs - ms) duration pulses of 
high intensity ultrasound with low duty cycles. Using this technique the tissue is fractionated in a 
controlled manner (10,11). There are, however, different methods of mechanical tissue disruption 
using focused US. By varying parameters such as intensity, duty cycle or number of pulses, distinct 
mechanical effects can be generated in the tissue: from low-intensity focused US with or without 
the injection of contrast bubbles to very high-intensity focused US known as cavitation cloud his-
totripsy (CH) or boiling histotripsy (BH) (also known as millisecond-boiling) (10-15). Low intensity 
focused US techniques (<1 kW/cm2) do not result in complete destruction of cells, but into small 
biological changes (16,17). Higher intensities (1- 10 kW/cm2) can result in an increase of the per-
meability of the blood vessels (18,19) to enhance drug delivery or induce cell apoptosis (20-22). 
Extremely high intensity focused US techniques (>10 kW/cm2), such as CH or BH, can lead to 
complete fragmentation of the tissue (10,11).
 An advantage of pure mechanical destruction in comparison to thermal destruction is that the 
treated area is more precisely demarcated as it coincides with the US focal region thereby limiting 
damage to the surrounding tissues. Due to thermal diffusion or inaccurate coupling of the trans-
ducer with the skin, thermal HIFU treatment can lead to damage outside the focal zone (23-25). 
Another advantage of pure mechanical destruction is that complete fragmentation of tissue results 
in an emulsified a-cellular (tumor) debris that can easily be removed via drainage or absorbed as 
part of the physiological healing response (25-27), while after thermal ablation the created necrotic 
lesion evolves into scar tissue, leaving a fibrotic mass at the treated area.
 In this review pure M-HIFU ablation techniques resulting in complete destruction of the tissue 
will be discussed and evaluated. A systematic search of the literature of M-HIFU was carried out 
in EMBASE and PubMed. The articles included were in the English language and focused on pure 
M-HIFU ablation of soft tissues and the analysis of histopathological effects. All included studies, 
in which animals were used, were performed according to the guidelines and by approval of an 
Animal Experiments Committee. Thermal HIFU ablation, lithotripsy or M-HIFU ablation techniques 
in combination with any other treatment or contrast agent have extensively been reviewed else-
where (17,28-31) and were excluded. Conference abstracts, reviews, editorials, meta-analyses and 
non-related studies were excluded, as well as studies focused on bone, teeth, eye, drug delivery or 
wound healing. The two main methods of pure M-HIFU non thermal ablation that remained were 
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CH and BH. First the technical aspects of CH and BH are described. Second an overview of pub-
lished in vivo findings of pathological and immunological responses in both large and small animals 
is provided. Third an overview is given of the imaging modalities for guidance of CH or BH.
  
Figure 2.1   Schematic illustration of a sinus ultrasound wave (top) and a shock wave (bottom).
Technical background and ex vivo studies
 The interaction of US waves and bubbles has been extensively studied (32,33) and is currently 
used in the fields of cancer treatment (34,35), drug delivery (36) and sonodynamic therapies (37). 
In these therapies the (micro)bubbles are either injected before treatment, or bubbles can be cre-
ated using high intensity US waves or by tissue boiling.
 High intensity focused US transducers generally use sinusoidal frequencies in the range of a cou-
ple of megahertz and high acoustic intensities. Higher frequencies with high intensities (e.g. large 
amplitudes) within heterogeneous tissue result in nonlinear propagation effects (1,38). Which can 
shortly be described by the fact that the compression (peak positive) part of the sinusoidal wave 
travels faster through the tissue in contrast to the rarefaction (peak negative) part of the wave 
(Fig. 2.1). Hereby a shock wave is created as soon as the wave penetrates the tissue. Higher 
pressures result in a larger nonlinear effect and a stronger shock wave (1,39,40).
 If the peak rarefaction pressure is sufficiently large, small vaporized or gas filled cavities or 
micro-bubbles can occur. This mechanism is known as cavitation. In contrast to boiling bubbles, 
which has a bubble size of millimeters, cavitation bubbles created by HIFU frequencies are in the 
order of microns (40). The micro-bubbles will interfere with the upcoming US waves. There are 
two types of cavitation: stable or inertial cavitation. With stable cavitation, the cavity or bubble will 
oscillate in size with the upcoming wave and occurs as long as the bubble resonance frequency is 
smaller than the frequency of the US wave (41). Inertial cavitation occurs when the bubble reso-
nance frequency becomes larger than the US frequency. The cavity or bubble will increase in size 
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due to the incoming waves and ultimately collapses (40,41). This collapse of the bubble/cavity cre-
ates a extreme large pressure shock wave in the order of gigapascal, which decays within the first 
100 µm from the bubble wall. The shock waves induces fragmentation of the tissue into sub-cellular 
levels (42). These cavitation effects are extensively described elsewhere (1,34,40,42-44).
Figure 2.2   Schematic overview of BH and CH. The HIFU beam is going up. Boiling Histotripsy: pulses of 
milliseconds creating one millimeter sized boiling bubble during each pulse. The rapid and high tem-
perature increase is limited to micrometer sized region. Due to multiple pulses a liquefied region can 
be created, with only a small amount (<2%) of thermal denaturation. The fragments are “blown” 
into the boiling cavity as a micro-fountain. Cavitation cloud Histotripsy: pulses of microseconds 
creating multiple micrometer sized bubbles. The amount of bubbles increase with each pulse. The 
bubbles interfere with the incoming waves, which is represented by the arrows on top of the bubbles, 
creating tension on the surrounding tissue to fragment the tissue into a liquefied lesion.
 Both nonlinear wave propagation effects and cavitation effects are often used to enhance the 
heating effects of the tissue (45). However by using a pulsed ablation technique, the heating of the 
tissue remains limited and a mechanical way of destruction is created (46). Two methods of me-
chanical destruction will be described in more detail within this review: CH, creating a large cloud 
of micro-bubbles, and BH, creating one millimeter sized boiling bubble.
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Cavitation cloud histotripsy
 CH is a cavitation-based therapy using pulsed high intensity US waves for the destruction of soft 
tissues with negligible heating of the tissue. The technique is comparable to lithotripsy which is used for 
stone fragmentation (47,48), but also has been applied to tumor ablation (49). In lithotripsy only one 
acoustic cycle is used with a long rarefactional phase (+/-2 µs) (50), while in CH pulses of 5-20 cycles 
(4-20 microseconds) are used creating a short rarefactional phase (<1 µs). The pressure levels used 
in CH are similar to lithotripsy. The extreme high pressure waves (peak positive pressure (P+) of 80 
MPa and peak negative pressure (P-) of 20 MPa) develop into shock-waves as a result of the non-linear 
propagation effect. The short rarefactional phase of high negative pressure leads to the development 
of micrometer sized gas bubbles (51) and ultimately results in the creation of a large bubble cloud 
of micro-bubbles within the focal zone during each pulse (11). The expansion and collapse of these 
micro-bubbles cause fractionation of the tissue into a well demarcated liquefied lesion (13).
 The morphology and size of the lesion depend on the duration of the pulses, operating frequency, 
pulse repetition frequency (PRF) and the amount of pulses (11,13,15). As long as the time between 
pulses is long enough (duty cycle <4%) the tissue temperature increase is limited and thermal 
damage is negligible (23,52). However, with each pulse new micro-bubbles are created and these 
micro-bubbles remain intact when the time between pulses is shorter than the time for the bub-
bles to dissolve, i.e. at high PRF (13,53). Consequently, the amount of bubbles in the bubble cloud 
increases within the region of the focal spot. Each of these bubbles will oscillate in size and ultimately 
collapse due to interaction with the new incoming waves (Fig. 2.2). The local stress of each collapsing 
bubble leads to destruction at the cellular and sub-cellular level. A larger bubble cloud produces a 
larger lesion (13). However, to create a homogenous lesion and to limit thermal damage the PRF 
settings and pulse duration have to be tuned. Otherwise PRF can result in non-homogeneous lesion 
formation leaving islets of intact tissue (13,23,24). Too short pulse repetition time (higher PRF) or 
an insufficient number of pulses can lead to inhomogeneous lesion formation (i.e. a reduction in 
pulse repetition time from 200 ms to 50 ms required 5 times the amount of pulses to generate a 
homogenous lesion) (15). Unfortunately in CH the bubble formation is not always possible and is 
a more stochastic phenomenon (11), but in general, it seems that the combination of a high PRF 
(500-2000 Hz) and a large number of pulses (>2000 pulses) would be the best method to create 
a bubble cloud for the formation of a homogeneous and liquefied lesion with smooth and sharp 
boundaries (11,13,52,54,55). The fragmented tissue parts that remain after CH are no larger than 6 
micrometers (56).
 Besides the acoustic intensity and treatment settings, such as pulse repetition time, pulse duration 
and amount of pulses, the intrinsic stiffness of the treated tissue is strongly correlated with the cav-
itation threshold, the threshold at which micro-bubbles appear, of the tissue (57-59). For example, 
fibroblasts have a higher cavitation threshold in comparison to squamous cell carcinoma (50). CH of 
the kidney creates significantly more damage to the cortical tissue than to the medullary tissue, which 
contains more fibrous connective tissue (24). Similar results have been shown for the prostate (60). 
The stiffness of the urethra is higher compared to prostatic tissue, therefore for tissue disintegration of 
the urethra a greater number of acoustic pulses are required than for the surrounding prostate tissue. 
These findings demonstrated that by choosing the optimal HIFU settings, it might become possible to 
preferentially destroy specific soft tissues, while sparing the stiffer tissues within the focal zone. 
 In summary, CH is a method for complete fragmentation of soft tissues using very high intensity 
focused US pulses of only a couple of microseconds. During each pulse a bubble cloud of micro 
bubbles is generated. The cavitation threshold of CH is tissue dependent, but in general high PRF 
settings and more than 1000 pulses are required (Table 2.1).
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Boiling histotripsy
 BH, also known as millisecond boiling, can create small well-defined liquefied lesions without 
thermal denaturation of proteins (61). With the use of relatively high acoustic pressures, peak 
positive pressure (P+) of more than 40 MPa and peak negative pressure (P-) of about 10 MPa, 
a shock front can be created within the focus because of nonlinear propagation effects (10). Of 
notice, these pressures are about half of the pressures required for the earlier developed CH 
(13,52). The absorption of such a shock wave of a couple of milliseconds can lead to temperatures 
over 100 °C within a region of just several microns, resulting in a boiling bubble (Fig. 2.2). This boiling 
bubble expands to a millimeter sized bubble which will further interact with the incoming shock 
wave (10). The high amplitude compressional peak of the shock wave reflects on the surface of the 
bubble into a negative rarefactional pressure and interferes with the incident rarefactional phase 
of the next wave. This results in very high negative pressures in front of the boiling bubble creating 
a bubble cloud of micro-bubbles. These micro-bubbles interact with the tissue in front of the boil-
ing bubble (12). The weakened tissue will then be pushed into the boiling bubble as a miniature 
acoustic fountain, resulting in the fragmentation of tissue in the bubble cavity (14). Directly after 
each US pulse, the bubble shrinks and disappears. With each pulse a new boiling bubble is created 
and as long as the pulse duration is just slightly longer than the time-to-boil, i.e. the time before 
a boiling bubble occurs, and the time between pulses is sufficient, the amount of thermal damage 
is negligible (12). 
 The time-to-boil depends on the acoustic output power and the used operating frequency. 
Higher acoustic output power and higher operating frequencies result in a decreased time-to-boil 
and consequently it results in less thermal damage of the tissue. Khokhlova et al. (2011) showed 
that with their system the time-to-boil by ablation of liver tissue, without varying the amount of 
power, was 5.6, 3.3 and 2.1 ms for respectively 1 ,2 and 3 MHz transducers (12). 
 When the time-to-boil has been determined, the amount of mechanical and thermal destruction 
within the lesion can be controlled by choosing the appropriate sonication parameters for that spe-
cific system. Khokhlova et al. (12) and Wang et al. (61) showed that the histopathology of a lesion 
can change by varying the duty factor or the pulse duration, but is much less affected by increasing 
the amount of pulses. Using a 2 MHz transducer with a focal pressure P+ and P- of respectively 
>67.5 MPa and 12-13 MPa on bovine hart tissue, they distinguished three types of lesions depend-
ing on the HIFU settings: liquefied, paste or vacuolated thermal lesions (Table 2.2). Liquefied lesions 
were pure mechanically disrupted lesions and were observed with a pulse duration of less than 
30 ms which is slightly longer than time-to-boil, and a duty factor of less than 0.02, i.e. a PRF of 1 
Hz. Macroscopically the lesion within the tissue appeared as a cavity filled with liquefied tissue of 
the same color as unaffected tissue (12). Frozen sections with haematoxylin and eosin (H&E) and 
nicotinamide adenine dinucleotide diaphorase (NADH-d) revealed no cellular structure or nuclei 
or thermal denatured proteins (61). Paste lesions presented macroscopically as a mix of mechan-
ically and thermally disrupted tissue with a white coagulated area at the edge of the lesion (pulse 
duration <100 ms, duty factor <0.2, i.e. PRF <2 Hz) (12). Histopathologically, extensive disruptions 
of cellular structures were visible with only some intact nuclei remaining and with 22-27% of 
denatured proteins within the lesion (61). Both the paste and liquefied lesions showed sharp well 
defined borders of less than 40 micrometer. Vacuolated lesions are created by complete thermal 
disruption, using a pulse duration larger than 100 ms and a duty factor larger than 0.2, i.e. PRF >2 
Hz. Histopathologically, the tissue revealed an evaporated core and white solid lesions indicative 
for thermally denatured proteins (70 -90% of total protein). The core of the vacuolated lesions 
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still contained areas of disrupted tissue maintaining some cell structure. The transition zone be-
tween completely destroyed tissue and intact tissue was less sharply demarcated and at least twice 
as large as the liquefied and paste lesions (100 micrometer) (12,61).
Table 2.1:    Technical aspects and treatment settings required for cavitation cloud histotripsy 
and boiling histotripsy.
Table 2.2 Boiling histotripsy parameters and histopathology responses.
 With the liquefied or paste like BH settings, damage to the tissue is highly localized to the focal 
spot and there is a very small border between complete damaged and intact tissue. The lesion size 
depends on the size of the focal spot of the US beam and the amount of pulses. The lesion size 
increases with the amount of pulses until the maximum lesion size is reached. The maximum lesion 
Cavitation cloud Histotripsy Boiling Histotripsy
Cavitation method Cloud of (micro)bubbles One boiling bubble (mm)
Predictability More stochastic character Predictable based 
on time-to-boil
Technical aspects of system required
Operating frequency of 
transducer
0.75-1 MHz 2-3 MHz
General acoustical (positive/ 
negative) pressure required
80/-20 MPa 40/-10 MPa
Acoustic al output Power > 1 KiloWatts 100-300 Watt
Treatment settings
Pulse duration Microseconds (Only  
a couple of US cycles)
Millisecond (a little longer 
than time-to-boil)
Amount of Pulses >1000 +/-100
Duty Cycle <1%  <2%
Pulse repetition frequency 5 Hz to 1 kHz <5 Hz
Pulse 
duration
Duty 
Factor
Pulse 
repetition 
frequency
Protein 
denatur-
ation
Border between 
completely 
destroyed - 
vital intact cells
Effect within the lesion
Liquefied 
lesion
< 30 ms† < 0.02 1 Hz 0% < 40 µm Purely mechanical disruption 
of the tissue. No cellular 
structure or nuclei remain.
Paste lesion < 100 ms < 0.2 < 2 Hz 22-27% < 40 µm Mix of mechanical and 
thermal disruption. Extensive 
cellular disruption, with 
some intact nuclei.
Vacuolated 
lesion
> 100 ms > 0.2 > 2 Hz 70-90% < 100 µm Thermal disruption. A solid 
evaporated lesion containing 
some cell structures.
† slighly longer then time-to-boil. ‡ 2.158 MHz single element transducer, 44 mm aperture and focal length. 
Peak positive pressure 74 MPa, peak negative pressure 13 MPa. (12,61)”
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size is equal to the size of the boiling bubble, which depends on the focal spot size, which in turn is 
strongly dependent on the operating frequency and dimensions of the HIFU transducer (Table 2.3). 
Lower operating frequencies, i.e. larger wave length, generally result in a larger focal spot (12,61,62). 
Lower f-number (focal length divided by transducer diameter) result in a smaller focal spot (44). Still 
little is known regarding the effect of tissue type on the different parameters. Overall similar effects 
have so far been observed for liver and in heart muscle in ex vivo experiments (61) although dif-
ferences in time-to-boil between different tissues have already been suggested. It will therefore be 
extremely interesting to confirm and expand the current data to other tissue types both ex vivo 
and in vivo.
 In summary, BH uses millisecond US pulses to create a millimeter sized boiling bubble within each 
pulse. For the creation of complete fragmentation of the tissue into a homogeneous liquefied lesion 
using BH, the PRF should be less than 1 Hz and the pulse duration should be slightly longer than 
the time-to-boil to limit thermal damage (Table 2.1). The time-to-boil depends on the system used, 
i.e. amount of power and operating frequency, and the targeted tissue. The maximum lesion size is 
equal to the focal spot size, but can be increased using multiple focal spots.
Table 2.3  Overview of Ex vivo studies, transducer parameters and treatment settings,  
and their biological effect.
PRF: pulse repetition frequency, P- = peak negative pressure, P+ = peak positive pressure.
Authors Tissue type  
and model
Transducer characteristics Ablation parameters Most important 
biologic result:
Khokhlova et 
al. 2011
Bovine heart 1.1-MHz and 2.158-MHz 
transducer ; 
Aperture 4.4 cm; 
Focal length 4.4 cm; 
3.4-MHz transducer ;   
Aperture 6.4 cm; 
Focal length 6.26 cm
Pulse duration: 0.2 - 500 
ms; PRF 0.01-250 Hz; 
Total ablation time 50 s; 
P+/P- = 74/13 MPa 
Emulsified lesions 
without thermal 
denaturation can be 
produced (< 30 ms 
pulse, duty factor < 
0.02)
Parsons et al. 
2006
Porcine heart, 
kidney
750 kHz; 11 x 14 cm,   
18-element transducer ; 
Aperture 14.5 cm;
Focal length 10 cm 
PRF: pulse repetition 
frequency, P- = peak neg-
ative pressure, P+ = peak 
positive pressure.
Higher PRF: Fewer 
intact cells, but if PRF 
exceeds a threshold, 
more thermal dam-
age is represented
Simon et al. 
2012
Bovine liver 2.158 MHz single element 
transducer ; 4.4 cm aperture; 
focal length 4.4 cm
Pulse duration: 10 ms; 
PRF 1 Hz; 
P+/P- = 9.5-35/ 5.5-9.2 
MPa
Visualization of at-
omization of tissue at 
air-liquid interfaces
Wang et al. 
2013
Bovine heart 
and liver
2.158 MHz single-element 
transducer ; 
Aperture 4.4 cm;
Focal length 4.4 cm
Pulse duration: 5 - 500 ms; 
PRF 0.01-2 Hz; 
HIFU on time 500 ms; 
P+/P- = 67.5/12 MPa 
Increased number 
of pulses does not 
result in different 
response. No 
substantial protein 
denaturation after 
liquefied BH
Xu et al. 
2012
Porcine 
muscle
1.1-MHz transducer ;
Focal length 6.26 cm
Pulse duration: 20 cycles; 
5000 pulses; in combina-
tion with 5 s heating 
P+/P- = 102/17 MPa;
Lesion volume 
increases with 
increasing amplitude 
of the precondition-
ing pulse, whereas 
lesion width and area 
do not
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Figure 2.3  Schematic illustration of an ultrasound setup. Left: general set up for larger animals (dogs, 
pigs). The HIFU transducer (T) is positioned within a bowl filled with degassed water (W) and 
a cavity, in the front of the transducer, which is closed by a plastic membrane. The thin plastic 
membrane is pressed against the skin of the animal. Within the inner hole (I) in the center of 
the transducer, an US imaging probe can be positioned (60,65,74). Right: for small animals, 
such as a mouse or rabbit, a water bath (W) is used in which the animal is fixated above the 
transducer. An US imaging probe is positioned within the inner hole (I) of the HIFU transducer 
or perpendicular within the water bath (25,52,76,78). O: organ of interest to treat.
In vivo studies
Large animal studies
 Until now only large transducers with relatively low operating frequencies (<1 MHz) and rela-
tively large focal spots (>5 mm in diameter) have been used for in vivo CH. For this reason, CH has 
previously only been possible within large animals such as rabbits (kidney), dogs (prostate), sheep 
(liver, kidney) and pigs (heart), (Table 2.4). Since limited studies have been published about BH in 
large animals, within this part mainly CH treatment will be described. 
 The bubble cloud created with CH is hyperechoic and can easily be visualized by US imaging (Fig. 
2.3). Volumetric ablation is accomplished by guiding the bubble cloud through the tissue volume to 
be treated (63,64). The treated area can be determined and controlled based on the hyperechoic 
bubble cloud localization. The absence of a visible bubble cloud on US has been shown to correlate 
very well with limited or even negligible tissue damage (65).
 Treatment of deeper located tissues requires an increased focal depth. An increased focal depth 
results in enhanced attenuation of the US wave leading to a lower pressure within the focal spot. 
Ultimately, this may cause that the cavitation threshold will not be reached (65). Therefore, organs 
deeper within the body are more difficult to treat with CH. Like in thermal HIFU ablation, cavities 
and obstruction due to bone within the US beam path should be avoided. The attenuation and 
acoustic aberration effect may change the focal pressure profile and yield reduced accuracy of the 
treated focal spot or even prefocal cavitation effects (65,66). Increasing the power to compensate 
for attenuation of targets with longer focal depth and choosing the appropriate acoustic window 
to limit obstruction can solve these issues (54). Treatment of the liver and kidney of ten unborn 
lambs with increasing power of the US pulses until a bubble cloud was visual resulted in well-de-
fined homogeneous lesions with a-cellular debris and red blood cells strongly correlating with the 
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appearance of the bubble cloud. Moreover, approximately 50 days after CH treatment using these 
conditions all lambs were born naturally and showed normal growth (54).
 The cavitation threshold of the tissue strongly depends on the tissue stiffness and structure. By 
choosing the correct settings, such as the amount of pulses and/or PRF, an organ can be treated 
without damaging surrounding tissue. An increase in PRF or the amount of pulses increased the 
amount of urethral disintegration within a canine prostate model (55,67). Schade et al. (63) re-
ported an urethral sparing CH treatment in dogs. In 80% of the dogs a homogeneous lesion with 
cellular fractionation, small areas of hemorrhage and a completely intact urethra was observed after 
treatment. Also seven days after treatment the urethra was still completely intact within the treated 
area showing a sharp delineation between normal and fractionated tissue debris with local inflam-
matory infiltration (macrophages and lymphocytes). Others showed that also the bladder wall (68), 
neurovascular bundles (69) and rectum wall (69) have a higher cavitation threshold, i.e. an increased 
number of pulses was required to destroy the tissue. Similar results have been reported for kidneys 
and livers. The kidneys or livers were fractionated into a homogeneous lesion, while the collective 
system or vessels remained intact (24,52,54). Based on these studies, the damage created by CH in 
tissues appears to be inversely related to the connectivity of the tissue. These findings emphasize 
that tissue parameters co-determine the effects and outcome of CH and suggest that tissues with 
closely packed fibers and bundles are more resistant to CH treatments. These insights are of great 
value for developing safe treatments of organs without damaging surrounding tissues or important 
vessels within the organ.
 A major application of CH is related to its capability to remove pathological tissue in a treated 
organ. For example, benign prostatic hyperplasia impedes urinary drainage and tissue debulking is 
necessary to alleviate these symptoms. Using a sufficient amount of pulses with a high PRF, com-
plete fragmentation of the urethra, periurethral stroma and prostate tissue is feasible (27,60,70). 
The fragmented tissue will be flushed out via the remaining part of the urethra or with the use of 
a catheter, leaving a well demarcated cavity within the prostate (27). If the fragmented tissue is not 
removed, histopathology directly after treatment showed acellular debris with cytoplasm and lique-
fied material with a sharp border between exposed and unexposed tissue (27,60,70). More than 
seven days after treatment normal wound healing responses and inflammatory responses were 
shown (60,70) and the lesions were completely replaced by normal healthy tissue with minimal scar 
formation (25,54). This is visible as fast tissue debulking in the kidney (25), liver (54) and reduction 
of prostate volume of 12.4% within eight weeks (63).
 Due to the complete fragmentation of the tissue, there is an understandable anxiety for large 
hemorrhage and thromboembolic effects. However, so far only minimal blood loss during treatment 
of the prostate, kidneys or liver has been reported. Different studies showed stable hematocrit 
level before and a day after treatment (70). Even CH within anticoagulated dogs revealed minimal 
hemorrhage in the targeted region and minimal blood loss (71). Thromboebolic effects after CH 
are also limited as shown in a porcine cardiac model (72,73). The intermediate-term effects of 
intracardiac communications created with CH were minimal. Directly after treatment the targeted 
area contained acellular debris and platelet/fibrin deposits (72) while after a month follow up, no 
thromboembolic effects were observed based on lung pathology and MR imaging of the brain (73).
Besides the appearance of the treated region, an increased inflammatory response is often visible 
after CH treatment, which can explain the fast absorption of fractionated tissue debris (25,63). An 
increased influx of inflammatory neutrophils was found surrounding the treated area within 24 
hours after treatment of renal VX-2 tumor (66) and normal kidneys (25) in rabbits. Elevated white 
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blood cell counts were measured in the days after treatment and seven days following treatment an 
apparently normal wound healing response was observed with local infiltration of lymphocytes and 
macrophages (63,70). Similar results were reported for CH treatment of immunosuppressed dogs 
with metastatic ACE-1 canine prostate cancer (64). Interestingly, in the same study, treated dogs 
revealed no pulmonary or lymph node metastases, while all control dogs did have metastases. It will 
be extremely important to further investigate the inflammatory and immunological consequences 
of CH as well as the impact of this ablation treatment on the metastatic aspect.
 In vivo studies using BH-like settings have so far been limited to one (74). BH was investigated 
in vivo on a porcine liver using multiple pulse duration times and a fixed exposure time (50 sec-
onds) and duty cycle (0.01). Using pulse durations no larger than 40 times the boiling time (<50 
ms) thermal damage was limited. The lesions created were comparable with their previous ex vivo 
findings (10,12) and contained liquefied tumor debris with fragments no larger than a nucleus (3-4 
microns). Strikingly, the border between untreated and treated tissue was only 1-2 cell equivalents 
wide (20-40 microns). Connective tissue was relatively more resistant to the treatment as vessels 
and the biliary system remained intact, probably due to the high tensile strength of collagen (74). 
However multiple studies need to be performed to prove the relation between the tissue charac-
teristics and tissue resistance to the treatment.
 In summary, initial studies in large animals indicate that both CH and BH can result in complete 
fragmentation of tissue with a sharp border between treated and untreated regions. The microme-
ter-sized tissue fragments created with CH or BH can easily be removed resulting in fast clearance 
from an organ. The structure or stiffness of the tissue co-determines the cavitation threshold and 
should be taken into account for each organ tissue to be able to ablate the entire tissue or to spare 
surrounding tissues or structures, such as vessels or urethra.
Small animal studies
 Mechanical destruction of tissues in small animal models is often a side effect of thermal ablation 
techniques (19,38,75). CH treatments in small animals have not been done so far due to the large fo-
cal point of most HIFU systems that have sufficiently high power. For BH, a higher operating frequency 
(>2 MHz) can be used leading to a smaller focal point. This made it feasible to cause pure mechanical 
ablation within a small focal spot (<1 mm in diameter) in small animals under BH conditions.
 So far, only a limited number of small animal studies have been performed in the field of complete 
mechanical disruption of tissue (Table 2.4). Researchers showed mechanical disruption of different 
tumors in murine models, including MC-38 colon adenocarcinoma (76), RM-9 prostate cancer (77), 
and B16-F10 melanoma (78). In these studies a 3.3 MHz transducer with a focal length of 63 mm 
(H-102 Sonic Concepts) was used. A pulsed wave ablation method of five millisecond pulses was 
used, with a duty cycle of 2%, a PRF of 4 Hz, and US imaging for treatment guidance. The MC-38 
colon and B16-F10 tumors were treated using a peak positive/negative pressure of 34.1/12.5 MPa 
and a total ablation time per focal point of 30 seconds. For the treatment of the RM-9 prostate, 
a slightly lower peak positive/negative pressure was used; 32/10 MPa and a total ablation time of 
20 seconds per focal spot. Of note, in both methods the temperature, measured with a bare-wire 
thermal couple within the focal spot (76), slowly increased to respectively maximum temperatures 
of 55 and 45 °C. At these conditions mechanical destruction will occur and are in the range of BH 
settings, although the PRF is slightly higher ; 4 Hz compared to 1-2 Hz which is generally used for BH. 
The tumors were treated by positioning 10-16 focus points with a step size of one millimeter and a 
Promotieboekje-Binnenwerk-v3.indd   37 08-05-17   17:44
38 MECHANICAL HIFU DESTRUCTION OF SOFT TISSUE  |
2
minimum of 1 mm margin from surrounding tissue. The focal spot was revealed as an hyperechoic 
region by US imaging.
 Histological analysis of the treated MC-38 colon adenocarcinoma one and two days after treat-
ment revealed the presence of cavitation effects and the associated mechanical lysis of the tissue 
(76). In comparison to the control group or thermal treated mice, one day after treatment, an 
increase in dendritic cells (DC) was found within the tumor and lymph nodes. The mere presence 
of infiltrating immune cells does not directly imply that anti-tumor immune responses are induced, 
but at least it suggests that immune activation and mobilization takes place following mechanical 
treatment. The increased activation can be explained by earlier in vitro treatment data, in which 
fragmented acellular structures of tumor debris remained and an increased release of endogenous 
danger signals (ATP and heat shock protein 60) was found after mechanical tumor cell destruction 
(79). When these danger signals would also be released in vivo, they could attract DCs into the 
lesion. Interestingly, mice with a MC-38 colon adenomacarcinoma were challenged with a second 
injection of MC-38 one day after treatment in the contralateral limb. A decreased tumor growth 
was observed for the mechanically treated mice compared to the thermal treated mice. Although 
the rechallenge is given too early to prove involvement of a memory immune reponse, these results 
suggest the innate immune system is significantly involved in eradicating residual tumor cells. 
 Similar results were obtained in the RM-9 prostate tumor model in mice. These mice were 
treated with M-HIFU ablation followed by surgical resection two days after treatment (77). In con-
trast to surgery alone, an increased number of DCs and cytotoxic T cells in the spleen and tumor 
draining lymph nodes was observed. Also, the activity of these DCs was increased, as seen by an 
increase in co-stimulatory molecules such as CD80 and CD86. Similar to the colon adenocarcino-
ma experiments, a second injection of tumor cells revealed decreased tumor growth compared 
to the control group. These results indicate that complete mechanical disruption can stimulate the 
adaptive immune system. It must, however, be noted that in both studies a slow temperature rise 
to a maximum of 55 °C occurred by the treatment. This temperature rise will not directly result 
in thermal coagulation of the cells, but obviously is far from neutral and thus may have significant 
effects on multiple local processes, including immune related processes (26).
 To investigate metastasis rate after treatment, highly metastatic B16-F10 melanoma tumors were 
treated with HIFU followed two days later by surgical amputation of the tumor bearing leg (78). 
In the four weeks follow up, significantly less metastases in the mechanically treated mice were 
observed compared to the control or thermally treated mice. They also observed a higher survival 
rate of the animals and an enhanced cytokine T lymphocyte activity after HIFU, suggesting that HIFU 
may elicit an anti-tumor immune response that may be responsible for the decrease in metastasis.
 However, some authors have suggested that disturbance of the tumor architecture by pulsed 
or M-HIFU treatment may increase the risk of metastasis formation (19,80). It should be noted 
that these studies used M-HIFU treatments without complete destruction of the tumor cells. The 
settings used result in an increased permeability of the vessels, large scale necrosis and hemorrhag-
ing, while the experiments in MC-38 colon adenocarcinoma by Hu et al. (76) created complete 
destruction and the formation of acellular structures. It is possible that tumor cells could enter the 
circulation and metastasize when incomplete destruction is achieved (80). With complete mechan-
ical disruption such as CH or BH, no tumor cells will remain viable and only a liquefied area remains 
with micrometer sized fragments.
 So far, only a limited amount of studies revealed an increased anti-tumor immune response 
after complete mechanical fragmentation of the tumor within small animals. It seems that com-
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plete fragmentation is required to stimulate this increased anti-tumor response. However in the 
described studies the temperature elevation was 55 °C in 30 seconds, for the colon adenocarci-
noma and prostate tumors, and 45 °C in 20 seconds, for the B16-F10 melanoma tumors. Although 
this temperature increase alone will not immediately affect cell viability, it may have effect on 
immune cell processes. Therefore, further research is required to determine the anti tumor effects 
of pure mechanical destruction of the tumor by focused US.
 
Authors Tissue type and model Transducer characteristics Ablation parameters Endpoint Most important biologic result:
Allam et al. 2013 Canine bladder and prostate 750-kHz; 11 x 14 cm, 18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 4 µs (3 cycles); 
PRF 500 Hz; Number of pulses: 
750,000 (over a 2x1.5 cm 
region)
0 and 14 d after 
treatment
More pulses or pressures required for destruction  
of the bladder, compared to prostate tissue; 
Day 0: Mild hemorrhage; 
Day 14: fibrosis
Burks et al. 2011 C3H mice, hamstring muscle 1-MHz transducer ;
Aperture 5 cm;
Focal length 4 cm; 
Max acoustic output power 120 W
Pulse duration: 50 ms; 
PRF 1 Hz;
Total exposure time 1.67 min; 
Acoustic output power 40 W
Pulse duration: 4 s (CW); 
Acoustic output power  
100 W
0, 1, 3, 7 and 8 d after 
treatment
PW ablation induced molecular biological changes in 
muscle tissue and infiltration of macrophages without 
detectable destruction
Hall et al. 2007 Rabbit kidney 750-kHz; 11 x 14 cm, 18-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 10 mm
 
Pulse duration: 20 µs (15 
cycles); 
PRF 1000 Hz; 
Number of pulses: 60,000;
Total treatment time 60 s
0, 1, 2, 7, 21, and 60 d 
after treatment
Day 0: no recognizable cells or cell components; 
Day 2: Sharp boundary and neutrophil influx; 
Day 7: fibroblast and inflammatory remnants; 
Day 21: disruption is partly scar tissue; 
Day 60: small fibrous scar persist
Hall et al. 2009 Canine prostate 750- kHz; 11x14 cm, 18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 10 mm
Pulse duration: 4 µs (3 cycles); 
PRF 300 Hz; 
Number of pulses: 56,000, 
16,000 and 540,000; 
P- = 20 MPa
0,7 and 28 d after 
treatment
Urethra more resistant to the treatment compared to 
prostate tissue; 
Day 0: complete cellular disruption; 
Day 7: disrupted material was removed, neutrophil 
infiltration; 
Day 28: cavity remaining, urethra partly absent, minimal 
scar formation
Hancock et al. 2009 FVB/NJ mice, Mvt-1  
tumor cell line.
1-MHz Transducer ;
Aperture 5 cm; Focal length 4 cm; 
Focal spot size: 7.2 x 1.2 mm; 
Max acoustic output power 120 W
Pulse duration: 50 ms; 
PRF 1 Hz;
Number of pulses: 100; 
Acoustic output power 40 W; 
P-= 8.95 MPa
1 d after treatment Cavitation alters vessel permeability, improved antibody 
delivery. 
Irreversible destruction of cells. 
30% more metastases after treatment
Hempel et al. 2011 Canine prostate 750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm;  
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 4 µs (3 cycles); 
PRF 300 Hz; 
Number of pulses: 270,000 
per cm3
0, 7, 28 and 56 d after 
treatment
Stable hematocrit before and after treatment. Minimal 
hematuria after treatment; 
Day 1: elevated aspartate amino transferase, creatine 
kinase and mild leukocytosis within the blood; 
Days 7,28 and 56: normal wound healing responses 
with minimal fibrosis and urothelalization of the treat-
ment cavity
Hu et al. 2007 C57BL/6 mice, MC-38 colon 
adenocarci-noma
3.3-MHz transducer ; Aperture 6.4 cm;
Focal length 6.26 cm;  
Focal spot size: 5 x 0.6 mm
Pulse duration: 5 ms; PRF 4 Hz; 
30 second; P+/P- = 31.7/12.5 
MPa; 
Pulse duration 3 s (CW); 
P+/P- = 12/6.7 MPa 
1, 2 and 12 d after 
treatment
Increased dendritic cell activation after PW ablation. 
Enhanced CTL and tumor specific IFN-y-secreting cells
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Authors Tissue type and model Transducer characteristics Ablation parameters Endpoint Most important biologic result:
Allam et al. 2013 Canine bladder and prostate 750-kHz; 11 x 14 cm, 18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 4 µs (3 cycles); 
PRF 500 Hz; Number of pulses: 
750,000 (over a 2x1.5 cm 
region)
0 and 14 d after 
treatment
More pulses or pressures required for destruction  
of the bladder, compared to prostate tissue; 
Day 0: Mild hemorrhage; 
Day 14: fibrosis
Burks et al. 2011 C3H mice, hamstring muscle 1-MHz transducer ;
Aperture 5 cm;
Focal length 4 cm; 
Max acoustic output power 120 W
Pulse duration: 50 ms; 
PRF 1 Hz;
Total exposure time 1.67 min; 
Acoustic output power 40 W
Pulse duration: 4 s (CW); 
Acoustic output power  
100 W
0, 1, 3, 7 and 8 d after 
treatment
PW ablation induced molecular biological changes in 
muscle tissue and infiltration of macrophages without 
detectable destruction
Hall et al. 2007 Rabbit kidney 750-kHz; 11 x 14 cm, 18-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 10 mm
 
Pulse duration: 20 µs (15 
cycles); 
PRF 1000 Hz; 
Number of pulses: 60,000;
Total treatment time 60 s
0, 1, 2, 7, 21, and 60 d 
after treatment
Day 0: no recognizable cells or cell components; 
Day 2: Sharp boundary and neutrophil influx; 
Day 7: fibroblast and inflammatory remnants; 
Day 21: disruption is partly scar tissue; 
Day 60: small fibrous scar persist
Hall et al. 2009 Canine prostate 750- kHz; 11x14 cm, 18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 10 mm
Pulse duration: 4 µs (3 cycles); 
PRF 300 Hz; 
Number of pulses: 56,000, 
16,000 and 540,000; 
P- = 20 MPa
0,7 and 28 d after 
treatment
Urethra more resistant to the treatment compared to 
prostate tissue; 
Day 0: complete cellular disruption; 
Day 7: disrupted material was removed, neutrophil 
infiltration; 
Day 28: cavity remaining, urethra partly absent, minimal 
scar formation
Hancock et al. 2009 FVB/NJ mice, Mvt-1  
tumor cell line.
1-MHz Transducer ;
Aperture 5 cm; Focal length 4 cm; 
Focal spot size: 7.2 x 1.2 mm; 
Max acoustic output power 120 W
Pulse duration: 50 ms; 
PRF 1 Hz;
Number of pulses: 100; 
Acoustic output power 40 W; 
P-= 8.95 MPa
1 d after treatment Cavitation alters vessel permeability, improved antibody 
delivery. 
Irreversible destruction of cells. 
30% more metastases after treatment
Hempel et al. 2011 Canine prostate 750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm;  
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 4 µs (3 cycles); 
PRF 300 Hz; 
Number of pulses: 270,000 
per cm3
0, 7, 28 and 56 d after 
treatment
Stable hematocrit before and after treatment. Minimal 
hematuria after treatment; 
Day 1: elevated aspartate amino transferase, creatine 
kinase and mild leukocytosis within the blood; 
Days 7,28 and 56: normal wound healing responses 
with minimal fibrosis and urothelalization of the treat-
ment cavity
Hu et al. 2007 C57BL/6 mice, MC-38 colon 
adenocarci-noma
3.3-MHz transducer ; Aperture 6.4 cm;
Focal length 6.26 cm;  
Focal spot size: 5 x 0.6 mm
Pulse duration: 5 ms; PRF 4 Hz; 
30 second; P+/P- = 31.7/12.5 
MPa; 
Pulse duration 3 s (CW); 
P+/P- = 12/6.7 MPa 
1, 2 and 12 d after 
treatment
Increased dendritic cell activation after PW ablation. 
Enhanced CTL and tumor specific IFN-y-secreting cells
Table 2.4  Overview of In vivo animal studies, transducer parameters and treatment settings, and their 
biological effect.
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Authors Tissue type and model Transducer characteristics Ablation parameters Endpoint Most important biologic result:
Huang et al. 2012 C57BL/6 mice, RM-9 prostate 
cancer
3.3-MHz transducer ; 
Aperture 6.4 cm;
Focal length 6.26 cm;
Pulse duration: 5 ms; PRF 4 Hz; 
Duration 20 s;
Acoustic output power 60 W; 
P+/P- = 32/10 MPa 
30 d after treatment Inhibited tumor growth in rechallenged  
tumors and increase in survival.
Increase of CTL and down regulation of intra tumoral 
STAT 3
Lake et al. 2008 Canine prostate 750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 20 µs  
(15 cycles); 
PRF 100-500 Hz;  
Acoustic power 22 kW/cm2
Immediately after 
treatment
Immediate debulking and remove fluid  
remaining via drainage 
Roberts et al. 2006 Rabbit kidney (New Zealand white 
rabbit)
750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 20 µs (15 
cycles); 
PRF 100 Hz; 
Number of pulses: 10, 100, 
1000, 10,000; 
Acoustic Power 20 kW/cm2; 
P- = 25MPa
Immediately after 
treatment
After 10-100 pulses small areas of cellular injury  
and focal hemorrhage was seen. 
After 1000-10,000 pulses complete destruction  
of targeted volume
Khokhlova et al. 2014 Domestic swine liver 2-MHz transducer ; 
Aperture 6.4 cm 
Pulse duration: 1-500ms; 
PRF 0.1-10 Hz; 
Duration 50 s;  
Acoustic output power 240W
Immediately after 
treatment
BH protocol design is tissue specific.
In vivo lesions are similar as seen in ex vivo tissue
Kim et al. 2011 Fetal sheep: kidney, liver, lung 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 200-1000 Hz;  
Number of pulses: 270,000 
pulses/cm3 
Immediately after 
treatment
Difficulties to reach cavitation threshold, but no dam-
age created to surrounding tissue. Lesion contained 
acellular debris, erythrocytes and some islands of intact 
cells within the lesion
Kim et al. 2013 Fetal sheep: kidney and liver 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 500 Hz;
Number of pulses: 2000; 
P- = 10- 16 MPa
Immediately after treat-
ment, and 1 w after 
birth (43-55 d after 
treatment)
Day 0: acellular debris and erytrocytes. 
Days 43-55: normal birth and growth of the lambs. 
Lesion was absorbed and replaced by normal tissue
Miller et al. 2006 C57/Bl6 mice, B16-D5 melanoma 1.35-MHz transducer ;
Aperture 2.5 cm 
Pulse duration: 1 ms;  
PRF 1 Hz;
P= 5 MPa
28 d after treatment Enhanced metastasis after treatment
Owens et al. 2011 
and 2013
Pig, heart 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 1000 Hz; 
P- = 13 MPa
2 h, 2 and 3 d, 1 m after 
treatment
Intracardiac communications created non invasively 
with an accurate and safe method. 
No thromboembolic effects
Rabkin et al. 2006 Rabbit kidney 1.1- and 3.3-MHz single element transducer ; 
Aperture 8.2 cm;
Focal length 6.26 cm 
Pulse duration: 30-60 ms; 
PRF 6.26 Hz; 
In situ intensity 220-1710 W/
cm2
2, 7 and 14 d after 
treatment
Day 2: cellular necrosis; 
Day 7 and 14: wound healing and scar tissue formation
Schade et al. 2012 Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 5 cycles; 
PRF 500 Hz
0, 7 and 56 d after 
treatment
Urethra sparing treatment in 80% of the dogs. 
Day 0: increase of white blood cell count, C-reactive 
protein and lactate dehydrogenases; 
Day 56: cavity was completely epithelized, containing 
fluid with minimal cellular debris
Schade et al. 2012b Canine prostate (ACE-1 tumor, 
immune suppressed)
750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 5 cycles; 
PRF 500 Hz; 
0 and 21 d after 
treatment
Treated dogs did not reveal any metastases, which 
were seen in the controls
Table 2.4  Overview of In vivo animal studies, transducer parameters and treatment settings, and their 
biological effect. (Continued)
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Authors Tissue type and model Transducer characteristics Ablation parameters Endpoint Most important biologic result:
Huang et al. 2012 C57BL/6 mice, RM-9 prostate 
cancer
3.3-MHz transducer ; 
Aperture 6.4 cm;
Focal length 6.26 cm;
Pulse duration: 5 ms; PRF 4 Hz; 
Duration 20 s;
Acoustic output power 60 W; 
P+/P- = 32/10 MPa 
30 d after treatment Inhibited tumor growth in rechallenged  
tumors and increase in survival.
Increase of CTL and down regulation of intra tumoral 
STAT 3
Lake et al. 2008 Canine prostate 750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 20 µs  
(15 cycles); 
PRF 100-500 Hz;  
Acoustic power 22 kW/cm2
Immediately after 
treatment
Immediate debulking and remove fluid  
remaining via drainage 
Roberts et al. 2006 Rabbit kidney (New Zealand white 
rabbit)
750-kHz; 11 x 14 cm  18-element transducer ; 
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 20 µs (15 
cycles); 
PRF 100 Hz; 
Number of pulses: 10, 100, 
1000, 10,000; 
Acoustic Power 20 kW/cm2; 
P- = 25MPa
Immediately after 
treatment
After 10-100 pulses small areas of cellular injury  
and focal hemorrhage was seen. 
After 1000-10,000 pulses complete destruction  
of targeted volume
Khokhlova et al. 2014 Domestic swine liver 2-MHz transducer ; 
Aperture 6.4 cm 
Pulse duration: 1-500ms; 
PRF 0.1-10 Hz; 
Duration 50 s;  
Acoustic output power 240W
Immediately after 
treatment
BH protocol design is tissue specific.
In vivo lesions are similar as seen in ex vivo tissue
Kim et al. 2011 Fetal sheep: kidney, liver, lung 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 200-1000 Hz;  
Number of pulses: 270,000 
pulses/cm3 
Immediately after 
treatment
Difficulties to reach cavitation threshold, but no dam-
age created to surrounding tissue. Lesion contained 
acellular debris, erythrocytes and some islands of intact 
cells within the lesion
Kim et al. 2013 Fetal sheep: kidney and liver 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 500 Hz;
Number of pulses: 2000; 
P- = 10- 16 MPa
Immediately after treat-
ment, and 1 w after 
birth (43-55 d after 
treatment)
Day 0: acellular debris and erytrocytes. 
Days 43-55: normal birth and growth of the lambs. 
Lesion was absorbed and replaced by normal tissue
Miller et al. 2006 C57/Bl6 mice, B16-D5 melanoma 1.35-MHz transducer ;
Aperture 2.5 cm 
Pulse duration: 1 ms;  
PRF 1 Hz;
P= 5 MPa
28 d after treatment Enhanced metastasis after treatment
Owens et al. 2011 
and 2013
Pig, heart 1-MHz transducer ;
Aperture 10 cm;
Focal length 9 cm
Pulse duration: 5 µs (5 cycles); 
PRF 1000 Hz; 
P- = 13 MPa
2 h, 2 and 3 d, 1 m after 
treatment
Intracardiac communications created non invasively 
with an accurate and safe method. 
No thromboembolic effects
Rabkin et al. 2006 Rabbit kidney 1.1- and 3.3-MHz single element transducer ; 
Aperture 8.2 cm;
Focal length 6.26 cm 
Pulse duration: 30-60 ms; 
PRF 6.26 Hz; 
In situ intensity 220-1710 W/
cm2
2, 7 and 14 d after 
treatment
Day 2: cellular necrosis; 
Day 7 and 14: wound healing and scar tissue formation
Schade et al. 2012 Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 5 cycles; 
PRF 500 Hz
0, 7 and 56 d after 
treatment
Urethra sparing treatment in 80% of the dogs. 
Day 0: increase of white blood cell count, C-reactive 
protein and lactate dehydrogenases; 
Day 56: cavity was completely epithelized, containing 
fluid with minimal cellular debris
Schade et al. 2012b Canine prostate (ACE-1 tumor, 
immune suppressed)
750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 5 cycles; 
PRF 500 Hz; 
0 and 21 d after 
treatment
Treated dogs did not reveal any metastases, which 
were seen in the controls
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Schade et al. 2012c Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
PRF 50-2000 Hz;
Number of pulses: 3000- 
200,000 pulses/mm
14 and 28 d after 
treatment
Endoscopic guidance can be used to reduce urethral 
disruption
Schade et al. 2013 Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm;  
Focal spot size: 3 x 3 x 8 mm
PRF 50, 500, 2000 Hz;   
Number of pulses: 12500, 
25,000, 50,000, 100,000 pulses/
mm  
14 d after treatment Increasing number of pulses and/or increasing PRF 
increases the rate of urethral disintegration
Styn et al. 2010 Rabbit kidney (VX2 Tumor) Four 1-MHz 5x7 cm transducers;
Aperture 7 cm
Pulse duration: 3 µs;
PRF 300 Hz; 
P= 20 MPa
0 and 1 d after treat-
ment
Day 0: fractionated material of cytoplasmic 
and nuclear debris;  
Day 1: neutrophil influx, nuclear debris, hemorrhage
Styn et al. 2011 Canine prostate, rectum, urinary 
spincter, NVB.
1-MHz, 16- element transducer ;
Focal length 11 cm,  
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 3 µs (3 cycles); 
PRF 500 Hz;
Number of pulses: 1000, 
10,000, 100,000; 
P= 20 MPa
0, 3 and 14 d after 
treatment
Sphincter and NVB: intact, only some mild hematoma 
surrounding NVB directly after treatment; 
Rectum: damaged immediately after treatment,  
complete recovery after 14 d
Vykhodtseva et al. 
1995
Rabbit brain 0.936 to 1.72 –MHz transducer ;
Aperture 8 cm
Pulse duration: 0.1-1000 ms;
PRF 0.1-5 Hz;
Number of pulses: 1-35; 
P+= 7000 W/cm2
Immediately after 
treatment
Tissue damage increases with pulse duration number 
of pulses and PRF
Wang et al. 2012 Athymic mice, xenograft (A431) 
tumor
1-MHz transducer ;
Aperture 5 cm;
Focal length 4 cm;  
Focal spot size: 7.2 x 1.38 mm
Pulse duration: 50 ms; 
PRF 1 Hz; 
Number of pulses: 100; 
Acoustic output power 40 W; 
P-= 8.95 MPa;
0- 22 d after treatment PW HIFU improved survival over control treatments 
and increased penetration of antibodies into the tumor
Wheat et al. 2010 Canine prostate (anticoagulated 
dogs)
75- kHz; 11 x 14 cm, 16-element transducer ; 
Focal length 10 cm
Pulse duration: 4 µs (3 cycles); 
PRF 500 Hz;
Number of pulses: 56,000, 
16,000 and 540,000; 
P- = 20 MPa
7 and 28 d  after 
treatment
Minimal haematuria and minimal hemorrhage. 
Large debulking of the prostate
Xing et al. 2008 C57BL/6 mice, B16-F10-luc-G5 
melanoma
3.3-MHz transducer ;
Aperture 6.4 cm;
Focal length 6.26 cm
Pulse duration: 5 ms; PRF 4 Hz; 
30 s ablation time; P+/P- = 
31.7/12.5 MPa; 
Pulse duration 3 s (CW 
ablation); 
P+/P- = 12/6.7 MPa 
1,2, 7, 14, 21 and 28 d 
after treatment
Higher animal survival rate after mechanical ablation, 
increase of CTL activity.
Reduced amount of metastasis after mechanical 
ablation
Table 2.4  Overview of In vivo animal studies, transducer parameters and treatment settings, and their 
biological effect. (Continued)
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Schade et al. 2012c Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm; 
Focal spot size: 3 x 3 x 8 mm
PRF 50-2000 Hz;
Number of pulses: 3000- 
200,000 pulses/mm
14 and 28 d after 
treatment
Endoscopic guidance can be used to reduce urethral 
disruption
Schade et al. 2013 Canine prostate 750-kHz; 11 x 14 cm 16-element transducer ;
Focal length 10 cm;  
Focal spot size: 3 x 3 x 8 mm
PRF 50, 500, 2000 Hz;   
Number of pulses: 12500, 
25,000, 50,000, 100,000 pulses/
mm  
14 d after treatment Increasing number of pulses and/or increasing PRF 
increases the rate of urethral disintegration
Styn et al. 2010 Rabbit kidney (VX2 Tumor) Four 1-MHz 5x7 cm transducers;
Aperture 7 cm
Pulse duration: 3 µs;
PRF 300 Hz; 
P= 20 MPa
0 and 1 d after treat-
ment
Day 0: fractionated material of cytoplasmic 
and nuclear debris;  
Day 1: neutrophil influx, nuclear debris, hemorrhage
Styn et al. 2011 Canine prostate, rectum, urinary 
spincter, NVB.
1-MHz, 16- element transducer ;
Focal length 11 cm,  
Focal spot size: 3 x 3 x 8 mm
Pulse duration: 3 µs (3 cycles); 
PRF 500 Hz;
Number of pulses: 1000, 
10,000, 100,000; 
P= 20 MPa
0, 3 and 14 d after 
treatment
Sphincter and NVB: intact, only some mild hematoma 
surrounding NVB directly after treatment; 
Rectum: damaged immediately after treatment,  
complete recovery after 14 d
Vykhodtseva et al. 
1995
Rabbit brain 0.936 to 1.72 –MHz transducer ;
Aperture 8 cm
Pulse duration: 0.1-1000 ms;
PRF 0.1-5 Hz;
Number of pulses: 1-35; 
P+= 7000 W/cm2
Immediately after 
treatment
Tissue damage increases with pulse duration number 
of pulses and PRF
Wang et al. 2012 Athymic mice, xenograft (A431) 
tumor
1-MHz transducer ;
Aperture 5 cm;
Focal length 4 cm;  
Focal spot size: 7.2 x 1.38 mm
Pulse duration: 50 ms; 
PRF 1 Hz; 
Number of pulses: 100; 
Acoustic output power 40 W; 
P-= 8.95 MPa;
0- 22 d after treatment PW HIFU improved survival over control treatments 
and increased penetration of antibodies into the tumor
Wheat et al. 2010 Canine prostate (anticoagulated 
dogs)
75- kHz; 11 x 14 cm, 16-element transducer ; 
Focal length 10 cm
Pulse duration: 4 µs (3 cycles); 
PRF 500 Hz;
Number of pulses: 56,000, 
16,000 and 540,000; 
P- = 20 MPa
7 and 28 d  after 
treatment
Minimal haematuria and minimal hemorrhage. 
Large debulking of the prostate
Xing et al. 2008 C57BL/6 mice, B16-F10-luc-G5 
melanoma
3.3-MHz transducer ;
Aperture 6.4 cm;
Focal length 6.26 cm
Pulse duration: 5 ms; PRF 4 Hz; 
30 s ablation time; P+/P- = 
31.7/12.5 MPa; 
Pulse duration 3 s (CW 
ablation); 
P+/P- = 12/6.7 MPa 
1,2, 7, 14, 21 and 28 d 
after treatment
Higher animal survival rate after mechanical ablation, 
increase of CTL activity.
Reduced amount of metastasis after mechanical 
ablation
PRF: pulse repetition frequency, P- = peak negative pressure, P+ = peak positive pressure, CTL: cytotoxic T 
lymphocyte, STAT3: Signal Transducer and Activator of Transcription 3, NVB: neuro-vascular bundle, CW: contin-
uous wave, PW: pulsed wave
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Image guidance and follow up imaging
 Until now mainly B-mode US imaging has been used for image guidance of M-HIFU, such as 
BH or CH, via detection of respectively the millimeter sized bubble or a bubble cloud created 
(67,69,74). After the ablation a liquefied lesion of micrometer sized tissue debris remained. The 
more liquefied lesion reduces the scattering of the US imaging, and therefore represents as an 
hypoechoic region (63,64). The amount of reduction of the scattering can be measured and corre-
lated with the amount of tissue fractionation (81).
 However, quantification of the amount of fractionation with B-mode imaging is difficult. Shear 
wave elastography (82) or acoustic radiation force impulse (ARFI) induced shear wave excitation 
(83) might be two alternative possibilities for quantification of the amount of fractionation. In shear 
wave elastography, the shear wave propagation speed is determined, while in ARFI the dynamics 
(peak-to-peak displacement and time-to-peak displacement) of the shear wave is measured. More 
fractionated tissues are visible as regions with decreased shear wave propagation speed by shear 
wave elastography (82) and a decreased peak-to-peak displacement and an increased time-to-peak 
displacement by ARFI imaging (83). Both methods show good correlations with the amount of 
fragmentation ex vivo (82,83). Additional studies are eagerly awaited to validate these techniques 
in vivo. Furthermore, disadvantages of US imaging approaches such as ARFI for treatment guidance 
is that they can interfere with the therapeutic US waves. 
 Magnetic resonance imaging (MRI) is widely used for guidance of therapeutic US using MR ther-
mometry (6,7,84). However with either BH or CH there is barely any measurable heat production, 
therefore MR thermometry is less suitable for the guidance of M-HIFU treatment strategies. The 
bubbles created cause signal attenuation in gradient echo images (85). This signal attenuation is the 
effect of intra-voxel incoherent motion (IVIM) of water molecules. Consequently pulse sequences 
with high sensitivity to IVIM will show strong contrast at the therapy site. Allen et al. (85) describes 
a pulse sequence, which is an extension of diffusion coefficient measurements, to visualize the cav-
itation effects during histotripsy. Another possibility for guidance of histotripsy might be magnetic 
resonance acoustic radiation force imaging (MR-ARFI). MR-ARFI uses the same aspects, shear wave 
displacement, as US-ARFI but uses an MR gradient to encode the tissue displacement which is 
generated by an ARFI ultrasound wave (86). MR-ARFI is already widely known to visualize the focal 
spot prior to thermal HIFU ablation (87), but is not used for either BH or CH yet. Beside treatment 
guidance, MR-ARFI can also be used to evaluate the tissue stiffness changes immediately after the 
treatment (88). 
 A major advantage of MR guidance is the high spatial resolution and anatomical information 
of the treated focal spot and surrounded tissue. Furthermore, a broad range of MR methods are 
available for visualization of the tissue response imaging after treatment, such as diffusion weighted 
imaging, contrast enhanced imaging, T2 weighted or T1 weighted imaging. A lot of research on treat-
ment response imaging after thermal ablation has already been done (54,89-91), but little is known 
of MR imaging after BH or CH. The immediate fragmentation of the tissue into a homogenous 
lesion could result in major changes on T1w, T2w or diffusion weighted contrast MR imaging (92).
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Summary and Future perspective
 CH and BH are the two main techniques that create complete mechanical destruction of tis-
sue without ample temperature increase, i.e. minimal thermal damage. Both techniques result in 
complete fragmentation of the tissue in submicron fragments, creating a liquefied region which can 
easily be removed by natural wound healing responses. This is the main advantage of mechanical 
ablation versus thermal ablation techniques, after which a necrotic lesion or scar tissue will remain. 
CH has promising results in vivo: tumors and soft tissue in larger animals can be treated safely 
without major complications. A single article reports promising results with BH in large animals 
and pathologic effects similar to CH (74,93,94). Another advantage of both techniques is that there 
is no thermal diffusion or heat-sink effects, which is seen during thermal treatment. These effects 
result in a large border between vital and destroyed tissue and damage to surrounding tissue. The 
area of destruction remains limited to the treated area with a very sharp border of 100 or 40 
micrometers between treated and non treated tissue for CH (83) and BH respectively (74). A 
correlation between tissue stiffness or structure and the cavitation threshold has become apparent. 
Therefore, the treatment settings need to be adapted for each organ or tumor. However, when the 
correct settings are known, these may be used to treat an organ without destroying surrounding 
tissue such as vessels, nerves or surrounding organs. Until now, systems used for CH consist of 
large transducers with an operating frequency of <1 Hz and an amplifier generating extreme high 
acoustic powers. But since less power is required for BH, this technique is more suitable for clinical 
systems. BH is less restricted to transducer size or source frequency of the HIFU system. Therefore 
smaller transducers can be used for BH, which may be inserted transrectal or endoscopic. Another 
advantage of BH is that a low PRF is used, so that respiratory or cardiac triggering might be feasible 
during treatment to reduce movement artifacts. The higher source frequency of 2 or 3 MHz which 
can be used creates a smaller focus spot resulting in a higher accuracy. However, due to a pulse 
repetition frequency of 1-2 Hz and >100 pulses per focal spot, it would take a lot of time to treat 
a large volume.
 A major challenge in CH or BH is image guidance. Although the treated area can easily be visual-
ized as a hyperechoic region during US-guidance, US still has drawbacks like a limited field of view 
and anatomical information. MR guidance might be feasible but very little is known about to visual-
ization of the bubble cloud or boiling bubble. The biggest challenge is to correctly synchronize the 
MR with the appearance of the bubble(s), as these are only shortly present during each pulse. Little 
is known about the visualization of the treatment reaction immediately after histotripsy treatment. 
Therefore more research in image guidance is required before accurate treatment in vivo is feasible.
 Currently only local tumors with a considerable size can be treated, while distant (micro)me-
tastases cannot be treated. It is not known what the pathologic and immunologic effects are of 
HIFU strategies. Some people suggest that (thermal) HIFU increases distant metastases (80,95), 
while others suggest a decrease in distant metastases (76,96). For the comparison of the biological 
effects of HIFU treatments, it is very important to accurately describe the system used and the 
treatment settings. It seems that complete cell destruction is required for good tumor response 
and might even stimulate immune activation and (anti-tumor) immune responses (64,76). However, 
if only minimal damage is achieved, such as an increase of permeability or small cell damage (97), 
metastasis formation might be stimulated . Although the results are limited, intensive investigation is 
required to investigate these mechanisms.
 For accurate comparison between different ablation techniques and quantitative exposure re-
sponse studies, it is important to describe the treatment method and system used (e.g. acoustic 
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output, source frequency, pulse duration, duty cycle, pulse repetition frequency etc.). Sometimes 
terms such as M-HIFU, pulsed HIFU (16,98,99) or cavitation are used in studies, while the system 
and treatment settings, and the corresponding biological effect, are completely different. For ex-
ample cavitation can be used to increase the permeability or to create minimal cell destruction 
(100-102), while others use the term cavitation for complete fragmentation of tissue (65). In other 
studies cavitation is combined with or a side effect of thermal destruction or hyperthermia (75). 
Therefore it is important to accurately describe which ablation strategy is used so that meaningful 
comparisons can be made between different strategies. Ter Haar et al. (103) published excellent 
guidelines and recommendations on how to report data and methods of treatments so proper 
evaluation of ablation strategies becomes feasible. Besides these guidelines, especially the tempera-
ture rise is important to measure to be able to distinguish between pure mechanical ablation or the 
combination of mechanical ablation with thermal ablation. This is particularly important as thermal 
effects have been shown to play an important role in many different processes, including endothelial 
cell and immune cell function. 
Conclusion
 CH and BH are very promising non-invasive, non-thermal ablation techniques. To fully understand 
the mode of action of non-thermal HIFU and the pathological and immunological consequences, 
more research is required to get more insights to long term in vivo tumor response after treatment. 
Hereby, good evaluation of the treatment method and pathologic effects is necessary.
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Abstract
 Background: Thermal and mechanical HIFU ablation techniques are in development for non-inva-
sive treatment of cancer. However, knowledge of in vivo histopathologic and immunologic reactions 
after HIFU ablation is still limited. This study aims to create a setup for evaluation of different high 
intensity focused ultrasound (HIFU) ablation methods in mouse tumors using high-field magnetic 
resonance (MR) guidance. An optimized MR-guided-HIFU setup could be used to increase knowl-
edge of the different pathologic and immunologic reactions to different HIFU ablation methods. 
 Methods: Three different HIFU treatment strategies were applied in mouse melanomas (B16): a 
thermal (continuous-wave), a mechanical (5 ms pulsed wave) and an intermediate setting (20 ms 
pulsed wave) for HIFU ablation, all under MR guidance using a 7 T animal MR system. Histopatho-
logic evaluation was performed three days after treatment. 
 Results: The focus of the ultrasound transducer could accurately be positioned within the tumor 
under MR image guidance, without substantial damage to the surrounding tissue and skin. All mice 
retained complete use of the treated leg after treatment. Temperatures of >60, <50 and <44 °C 
were reached during thermal, intermediate and mechanical HIFU ablation, respectively. Thermal 
treated tumors showed large regions of coagulative necrosis. Tumors of both the mechanical and 
intermediate groups showed fractionated tissue with islands of necrosis and some pseudocysts 
with hemorrhage.
 Conclusion: A stable small animal MR guided HIFU setup was designed and evaluated for follow 
up MR imaging and histopathologic responses of the treated tumors. This will facilitate further 
studies with a larger number of mice for detailed evaluation of the pathologic and immunologic 
response to different HIFU strategies.
 
Promotieboekje-Binnenwerk-v3.indd   57 08-05-17   17:44
58 DEVELOPMENT OF A MR-GUIDED HIFU SETUP  |
3
Introduction
 During the last decades, new treatment options have been developed to treat localized tumors 
while sparing surrounding tissue. High intensity focused ultrasound (HIFU) is a non-invasive ablation 
technique to deliver large amounts of energy into a small millimeter-sized ablation zone, resulting in 
tissue destruction through cellular disruption and irreversible coagulation necrosis (1-3). If correctly 
targeted, the energy of the ultrasound (US) beam penetrates the body without damaging the sur-
rounding tissue. Using multiple focal ablations, different tumor volumes can be treated.
 Both thermal and mechanical effects can be generated using HIFU (4). The thermal effect is the 
consequence of absorption of ultrasound energy by the tissue and conversion into heat, inducing 
irreversible damage and local coagulative necrosis (4,5). The mechanical effect is created by the 
mechanical force and shock-wave effect of the ultrasound wave which could result in acoustic 
cavitations (chapter 2). With a low duty cycle, the local temperature rise remains limited due to 
thermal diffusion. Expansion and rarefaction of tissue due to high acoustic waves of a sufficient pres-
sure magnitude, result in alternating compression and expansion of the tissue. Subsequently, gas is 
extracted from the tissue and (micro)bubbles are created. The interaction of these bubbles with the 
ultrasound waves will result in disruption of the vascular structure (7,8), connective tissue (9) and 
cellular damage. Extreme high ultrasound pressure can destroy the tissue in submicron fragments, 
so-called cavitation cloud histotripsy (10-12) or boiling histotripsy (also known as millisecond boiling) 
(13-16). 
 While thermal HIFU ablation is already clinically used for more than a decade, mechanical HIFU 
ablation techniques are still in an early stage of development (chapter 2,17). Whether thermal or 
mechanical HIFU is the best possible way to treat tumors is not known. Moreover, the different 
pathological and immunological effects due to in vivo thermal or mechanical HIFU treatment are 
poorly understood. Immune effects have been observed as a response to the HIFU treatment, 
but further studies are needed to distinguish wound healing from relevant anti-tumor responses 
(9,17,18). For evaluation of different tumor ablation techniques and their histopathologic changes 
and immunologic reactions, an adequate small animal HIFU system is required (19,20), which can 
be used to test in vivo HIFU treatments (21).
 HIFU guided by ultrasound (US) or magnetic resonance imaging (MRI) is widely used (22). The 
latter technique offers better anatomical information compared to US-guided techniques, better 
tumor detection and a broader field of view to visualize both the treatment area and surrounding 
tissue (1). Different MRI methods allow accurate targeting before treatment, real time temperature 
monitoring and control of the energy deposited during treatment (1,2,21,23,24).
 The purpose of this feasibility study was to create a controllable setup for evaluation and differ-
entiation between different magnetic resonance (MR) guided HIFU ablation methods in vivo. Three 
different methods are tested; 1) thermal (T-HIFU), 2) mechanical (M-HIFU) and 3) a mixed ablation 
method, termed intermediate temperature-HIFU (inT-HIFU), that resulted in a limited but signif-
icant temperature rise in between both other HIFU settings. Tumor response after the different 
ablation techniques is evaluated with T2-weighted (T2w) MR imaging immediately after treatment. 
Histopathologic evaluation is performed three days after treatment.
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Materials and Methods
Animal preparation
 Nine- to eleven-week old female C57Bl/6n wild type mice were purchased from Charles Riv-
er Wiga (Sulzfeld, Germany) and kept under specific pathogen-free conditions in the Central 
Animal Laboratory of the Radboud University (Nijmegen, the Netherlands). All animal experiments 
were performed according to the guidelines and by approval of the Nijmegen Animal Experiments 
Committee.
 Twenty-one mice were injected subcutaneously in the right leg with 0.5 x 106 cells of the oval-
bumine (OVA)-transfected murine melanoma cell line (B16F10-OVA) as previously described (19). 
The volume of the tumors were calculated with the formula (A × B2) × 0.4 in which A is the largest 
and B is the shortest dimension, measured using a caliper. Eight to nine days after injection, a tumor 
diameter of more than 7 mm is reached and the mouse was ready for HIFU treatment.
 Isoflurane gas at 3.5% was used for anesthetic induction. The anesthetic concentration was 
adjusted to 1-2% during the experiment in order to maintain the breathing frequency at 40-60 per 
minute. The body temperature was measured during the treatment using a rectal thermometer 
and maintained using a heated air flow device. The mice were euthanized 3 days after treatment 
by cervical dislocation.
Figure 3.1 An schematic overview of the high intensity focused ultrasound (HIFU) setup.
MR-HIFU	treatment
Animal setup and protocol
 An MR compatible animal-HIFU system (Image Guided Therapy –IGT–, Pessac, France) was used 
in all experiments. A 16 channel annular array HIFU transducer (3 MHz central frequency, 37 W 
acoustic peak power, 52 W electrical peak power, 86.58˚ aperture, 48 mm diameter, adjustable fo-
cus depth 30-80 mm) was embedded in a positioning system (MR compatible piezoelectric motors, 
30 x 30 mm trajectory execution range, active transducer cooling system) which was controlled by 
trajectory planner software (Thermoguide, IGT, Pessac, France). The spherical cap of the transducer 
is divided into 16 concentric annuli of identical surface. Due to the cylindrical symmetry, the steer-
ing of the ultrasound focus is possible along the axis of the symmetry i.e. longitudinal positioning of 
the focal zone. Lateral positioning of the focal zone is processed due to transducer displacement via 
piezoelectric motors. The trajectory of ablation was manually implemented based on MR imaging.
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Figure 3.2  Images of the setup and treatment planning. (A): T1w MRI localizer (TR/TE = 196/4 ms) for 
visualization of possible air bubbles within the ultrasound beam. The white line is the acoustic 
beam overlay. Dashed line is the plastic sheet on top of a water bath. Dotted line indicates the 
gel pad. Focal length ranges between 30-80 mm, acoustic window 48mm in diameter. (B) T2w 
MR images (TR/TE =3350/26 ms) to determine the tumor (T) and focus spots (Dot within 
the tumor) using the trajectory planner software (Thermoguide, Image Guided Therapy, Pessac, 
France). The white box indicates the execution range (30 x 30 mm) of the high intensity focused 
ultrasound system. The mouse leg with tumor is visualized in a water bath. A small phantom (P) 
is positioned next to it for focus corrections. (C): Mouse positioned on its side, with the tumor 
inside a water bath and the nose of the mouse within a tube for anesthesia (An). The phantom 
cube (P) is position next to the mouse. Breathing rate (B) and rectal temperature are measured 
during treatment, an air-heater (H) is connected to the rectal thermometer to maintain the 
mouse core temperature.
 The pressure field of the HIFU transducer was scanned using a 0.075 mm needle-type hydro-
phone (HPM075/1, Precision Acoustics, Dorchester, UK) and 50 µs pulses with an acoustical output 
power of 0.73 W (electrical output power of 1.04 W). The measurements were performed in a 
degassed water tank. The hydrophone was positioned into a 3D mechanical positioning system 
enabling a 0.05 mm measurement resolution. 
 For good acoustic coupling of the US beam, the tumor area was shaved and remaining hair was 
removed using standard hair removal cream. The mouse was positioned on top of an in-house 
made gel pad in lateral decubitus position, with the tumor inside a cavity (approximately 3.5 x 3.5 
x 1 cm) made in the gel pad, filled with degassed water. The gel pad was positioned on top of a 
plastic sheet covering the HIFU transducer. The space between the plastic sheet and the transducer 
was filled with degassed water for good acoustic coupling. (Fig. 3.1)
 The HIFU system was calibrated with the MRI in each experiment for localization of the focus 
of the US beam. A small phantom (approximately 1 x 1 x 1 cm) was positioned next to the tumor, 
within the cavity of the gel pad (Fig. 3.1 and 3.2). Preceding the HIFU treatment of the tumor a test 
HIFU pulse (4 seconds, 28 W acoustic output power) was sent to this phantom cube. With MR 
thermometry the focus region was visualized and compared to the preset coordinates (Fig. 3.2B). 
Any possible mismatch was corrected for.
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 To visualize the border between treated and non-treated tumor tissue, three to six focused spots 
were positioned in the center of the tumor depending on tumor size and treatment method used. 
Thermal diffusion, which occurs in thermal HIFU treatment, results in an increased area of tumor 
destruction of each ablation compared to the M-HIFU or inT-HIFU treatment. Therefore, three to 
four focal sonications, 2 mm apart, were used during thermal treatment (T-HIFU) and a maximum 
of six focal sonications (1.5 mm apart) for M-HIFU and inT-HIFU treatment. Six mice were subject-
ed to T-HIFU with a continuous wave HIFU pulse of four seconds per sonication. Five mice were 
treated with the inT-HIFU method,120 pulses of 20 ms (inT-HIFU treatment) with a pulse repeti-
tion frequency of 4 Hz. Six mice received a more mechanical HIFU ablation method (M-HIFU) with 
500 pulses of 5 ms with a pulse repetition frequency of 4 Hz. For all methods, T-HIFU, M-HIFU and 
inT-HIFU, an acoustic output power of 40-48 W was used, which correlates approximately to an 
acoustic dose per sonication of 160, 100 and 96 Joules. One mouse was excluded due to bursting 
of the tumor before treatment was feasible. Three tumor bearing mice did not receive any treat-
ment and were used as a control group.
 The HIFU settings were directed by the temperature rise during ablation and the corresponding 
response in phantoms and ex vivo experiments. The T-HIFU group received a continuous US wave 
causing the temperature to rise within the focal region. Ex vivo experiments showed, with these 
settings, an increase of a minimum of 30 °C. The pulsed waved character of M-HIFU and inT-HIFU 
methods was used to limit the temperature rise and give a more mechanical character to the 
treatment method. The same pulse repetition frequency (4 Hz), but a different pulse duration and 
amount of pulses was chosen for the M-HIFU and inT-HIFU methods (500 pulses of 5 ms and 120 
pulses of 20 ms, respectively). The HIFU on time was similar, i.e. 2400 and 2500 ms respectively, and 
the temperature increase in ex vivo specimens was respectively 8 and 15 °C.
MR	imaging	and	thermometry
 For MR imaging and treatment guidance a 7 T horizontal wide bore (20 cm) animal MR scanner 
was used (ClinScan, Bruker Biospin GmbH, Rheinstetten, Germany), with an additional body coil 
insert (free bore diameter 15 cm). Before treatment an axial susceptibility sensitive T1 weighted 
(T1w) gradient echo (GRE) sequence (repetition time/ echo time (TR/TE) of 196/4 ms, flip angle 
(FA) of 25°, voxel size 0.51 × 0.51 × 2.50 mm) was acquired to check for the presence of air bub-
bles within the line of the acoustic beam (Fig. 3.2A). Mice were repositioned if gas bubbles were 
present. Subsequently localized T1w MR images were acquired with a gradient echo fast low angle 
shot (GRE-FLASH) sequence (TR/TE= 236/4 ms, FA= 25°, voxel size 0.78 × 0.78 × 1.50 mm) 
were acquired and transferred to the HIFU workstation for synchronization of the coordinates of 
the HIFU transducer with the coordinates of the MR scanner. Before and after the HIFU treatment, 
anatomical T2w MR images were acquired for tumor localization (Fig. 3.2B), trajectory planning and 
tumor response analysis, using a turbo spin echo (TSE) scan (TR/TE= 3350/26 ms, FA= 180°, voxel 
size 0.25 x 0.25 x 1 mm, TSE-factor : 7). The T2w images were sent to the HIFU trajectory planning 
software (Thermoguide, IGT).
 The ablation process was guided by MR thermometry. Two different thermometry sequences 
have been tested. In three mice of each group an interleaved GRE-FLASH sequence (TR/TE= 40/4 
ms, FA= 25°, voxel size 0.78 x 0.78 x 1.5 mm , matrix size: 128x128, five slices with distance factor 
20%, temporal resolution 3.8 seconds) was used. Data was manually transmitted to the HIFU sys-
tem and temperature maps were calculated and visualized after each ablation instead of during the 
ablation (Fig. 3.3). Cooling time of at least 30 seconds before the next sonication was stated and 
before each focused sonication a new reference scan was made. For the other mice (3 per group) 
an echo planar imaging (EPI) sequence (Siemens, Erlangen, Germany) was used (TR/TE=30/4.5 ms, 
Promotieboekje-Binnenwerk-v3.indd   61 08-05-17   17:44
62 DEVELOPMENT OF A MR-GUIDED HIFU SETUP  |
3
FA= 15°, voxel size 1 x 1 x 1.5 mm3, 3 axial and 1 coronal slices, 20% inter-slice distance, temporal 
resolution 1.9 seconds). Temperature maps were automatically sent to the HIFU system and imme-
diately visualized (Fig. 3.3), also for this sequence at least 30 second cooling time after each sonica-
tion was included. A proton resonance frequency shift method was used to determine temperature 
changes (23,25-27). The temperature in the treated area was determined by adding up the calculated 
temperature rise to the body temperature, measured by a rectal thermometer. The thermal dose map 
was calculated using the Sapareto and Dewey model (5) and visualized with a threshold defined at 
the lethal dose of the tissue in 240 cumulative equivalent minutes at 43 °C (CEM43).
Figure 3.3  Workflow chart of the high intensity focused ultrasound treatment using both magnetic reso-
nance thermometry methods with the gradient echo flash (GRE-FLASH) and echo planner 
imaging (EPI) sequence. GRE-FLASH uses a method with interleaved ablation and temperature 
calculations. With EPI the temperature is defined during the ablation. TMAP: temperature map.
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 Before the in vivo mouse experiments, the stability and accuracy of the MR thermometry se-
quences were determined within chicken filet and a 3% agarose phantom. The stability of the 
MR thermometry was measured in a chicken filet and in a mouse. The temperature within the 
chicken filet without heating was measured for 2 minutes. The accuracy of the MR thermometry 
was assessed with a 3% agarose phantom. The agarose phantom was positioned in boiled water to 
increase the temperature. The temperature changes were measured with MR thermometry. Within 
both experiments a fiber optic temperature probe (T1S-2M probe, Neoptix, Québec, Canada) 
was positioned within the phantom or chicken filet as a standard of reference. Within the mouse a 
rectal thermometer was used as standard of reference.
Histopathology
 Mice were sacrificed three days after HIFU treatment. The tumors were removed and inked for 
visual orientation after which they were fixated in formalin. The tumors were cut in half, parallel to 
the surface of the epidermis using the same orientation as the T2w MR imaging made after treat-
ment, under visual inspection. After paraffin embedding, 4 µm thick tissue sections were stained 
with hematoxylin and eosin (H&E). Immunohistochemical staining by F4/80 was used to investi-
gate macrophage infiltration in the tumor. Paraffin tissue sections (4 µm) were deparaffinized and 
subjected to antigen retrieval by citrate (10 mM) with microwave treatment for 10 minutes. Then 
the tissue sections were incubated with serum to block aspecific bindings, after which the sections 
were incubated with F4/80 antibodies (1:20 in 2% normal goat serum (NGS), eBioscience, Vienna, 
Austria) at room temperature. The first antibody was coupled with a goat anti rat-biotin antibody 
(1:100 in 1% NGS/ 1% normal mouse serum) and colored with Fast Red bound to ABC-Horse-
radish Peroxidase. The sections were counterstained with hematoxylin. 
 Therapy effects were evaluated and scored on H&E slides by a pathologist. Morphologic changes 
were evaluated, such as percentage of necrosis, type of tissue damage (apoptosis versus coagulative 
necrosis) and type of tumor necrosis (confluent versus fractionated). Furthermore, ballooning de-
generation, dilatation of capillaries, cysts and bleeding were recorded. Finally, lymphocytic infiltration, 
both within and on the tumor edge, was assessed.
Results
MR	thermometry	and	Ex	vivo	experiments
 The hydrophone measurements of the focal region revealed a cigar shaped volume of 0.5 x 0.5 x 
2 mm (full width half maximum, FWHM). At an acoustic output power of 1.04 W the peak pressure 
was 1.8 MPa. The gel pad positioned within the US beam did not show any interference with the  
US beam or a decrease of the focal pressure, data not shown.
 The stability and accuracy of the MR thermometry was evaluated by measuring the temperature 
within a chicken filet, one mouse and an agarose phantom. The temperature stability was assessed 
in the absence of heating. The standard deviation of the temperature measured in a chicken filet 
over 2 minutes was +/- 0.34 ˚C with the GRE-flash sequence (temporal resolution 3.8 s) and +/- 
0.16 ˚C with the EPI sequence (temporal resolution 1.9 s). The temperature accuracy was deter-
mined while heating up an agarose phantom. The average deviation between the MR thermometry 
and the fiber optic temperature probe was -0.21 ˚C (±0.52) and 1.6 ˚C (±1.8), respectively with 
the GRE-flash and EPI sequences. Within a non-heated area of the mouse tumor MR thermometry 
with the EPI sequence revealed a variation of +/- 0.31 ˚C with baseline corrections. 
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Mice studies
 The mean tumor dimensions were A= 8.7 mm (±1.5) and B= 7.3 mm (±1.1) on the day of 
treatment. The mean tumor volume of the mice was 194 mm3, with a range between 111 and 
285 mm3, but one mouse had a relatively small (82 mm3) and another a large (364 mm3) tumor in 
contrast to the other tumors. For T-HIFU or M/inT- HIFU treatment, respectively 3 or 6 sonications 
were positioned within the tumor except one mouse of the M-HIFU group with a tumor size of 82 mm3, 
for which only 2 focused sonications were applied. One mouse was excluded due to unexpected 
tumor burst before treatment, leaving a total of 17 mice which were treated with HIFU. Six of them 
in the thermal HIFU group, five in the M-HIFU and six mice in the inT HIFU group respectively. 
Three mice were used as a control. In three mice tumor growth was restricted by adjacent muscle 
tissue, which might have influenced the treatment due to difference in absorption rate of the tissue. 
The ultrasound beam path was clearly visualized in all mice in T1w MR images (Fig. 3.2A).
 The body temperature during treatment of the anesthetized mice ranged between 34 and 37 ˚ C. 
Two mice had to be repositioned due to air bubbles within the US beam path, which resulted in a 
drop of the body temperature (30 ˚C), but the body temperature stabilized after repositioning and 
both mice recovered normally after treatment. In all experiments the focus of the HIFU system was 
well aligned after one or two test pulses inside the phantom cube. As observed on the MR images 
and histopathological slices, all ablations were accurately positioned inside the tumor in all mice. 
No skin burns were observed immediately after the HIFU treatment. All mice (n=17) retained 
complete use of the treated leg within 15 minutes after treatment without showing signals of pain.
 Two mice of the T-HIFU group showed a small skin defect covering the tumor two and three days 
after treatment, respectively. They had some difficulties using the leg with the tumor, possibly due 
to necrosis of the tumor directly underneath the skin or heating of tissue next to the tumor. Two 
mice of the inT-HIFU group also revealed small skin defects on top of the tumor. However they did 
not show any discomfort and used their legs properly. The size of the tumors of five mice treated 
with T-HIFU ablation, four tumors of the inT-HIFU treated mice and three tumors of the M-HIFU 
treated mice diminished in the days after treatment, which was not seen in the control mice.
MRI	measurements	
 During treatment, the temperature in the tumors was measured in all mice. Each mouse of the 
T-HIFU group received three focused sonications. In one mouse the accuracy of the temperature 
measurements was questionable due to boiling or movement artifacts. The average peak temper-
ature within the other ablation zones (16) were 67.6 ˚C (±9.6) within 4 seconds of HIFU ablation 
(Fig. 3.4A,D). The mean of the total volume that received at least the lethal dose of 240 CEM43 was 
65 mm3 (±25). The M-HIFU and inT-HIFU treated mice received 2-6 focused sonications. During 
inT-HIFU treatment the temperature slowly increased 9-13 ˚C within 40 seconds (Fig. 4B,D). The 
mechanical HIFU treated mice presented a small temperature increase of 7˚C within 30 seconds, 
after which it stabilized around a peak temperature of maximum 44 ˚C (Fig. 3.4C,D). The mice of 
the inT-HIFU group received a maximum thermal dose of 9.6 CEM43 within each focal spot, while 
the M-HIFU treated mice showed a thermal dose of less than one CEM43.
 The magnitude MR images recorded during thermal treatment showed a transient large signal 
drop inside the focal region. The intensity immediately returned after the HIFU pulse was turned 
off. This was probably the result of local boiling. Because of this, with the real time EPI sequence, 
the temperature in three focal ablation spots could not be determined accurately. Very little or no 
signal drop was observed during respectively inT-HIFU or M-HIFU ablation. In the high resolution 
anatomical T2W MR images directly after treatment, in three out of six T-HIFU treated mice high 
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intensity focal spots were visible within the tumor after ablation which correlated, by visual orienta-
tion, with the lesion found on histopathology sections (Fig. 3.5). These spots might be the cause of 
edema due to the treatment. The other three mice also showed lesions on the histopathology but 
no clear signal changes were found with T2w imaging. Only in one mouse subjected to inT-HIFU 
the signal intensity in T2w MR images decreased after treatment. Within the M-HIFU treated group 
no signal changes were seen.
Figure 3.4  Gradient echo- flash (GRE-FLASH) image with temperature map overlay, during treatment with 
T-HIFU (a), inT-HIFU (b) and M-HIFU (c). Temperature increase of respectively >30, <13 or <7 ˚C 
are reached during treatment (d). The tumor is delineated with a blue line, the temperature of 
one focal spot is visualized as a temperature increase.
Tumor appearance
 Histologically, the different focal ablations were not recognized as separate spots in the sections 
from tumors isolated three days after HIFU ablation. The H&E staining revealed clear morphologic 
changes in the tumor tissue, but the necrotic area after thermal ablation appeared as a single big 
lesion at three days after treatment (Fig. 3.6), probably due to heat diffusion. The T-HIFU group 
showed large regions of coagulative necrosis (47% ±11) of the tumor, corresponding with a lesion 
with an approximate diameter of 4.6 mm (±0.6). The control group also showed necrosis (33% 
±12 over a diameter of 2.8 mm ±0.3), which is normal necrosis of the inner part of larger tumors. 
However, this was a homogeneously appearing old necrotic area with sharp edges, while T-HIFU 
treated tumors had more coarse bordered necrotic tissue, which still contained areas with irre-
versible dying cells. The necrotic region was surrounded by ballooning degeneration (cell swelling, 
which is an early stage of cell apoptosis). Five of the six T-HIFU treated mice also presented vessel 
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remnants within the necrotic regions, which was not seen in the necrotic regions of the control 
tumors (Fig. 3.6 A-D).
 Both the M-HIFU and inT-HIFU group revealed less coagulative necrosis, and more fractionated 
necrosis and apoptotic cells, compared to one big necrotic region seen in the T-HIFU treated group. 
These tumors showed islands of necrosis within vital tumor cell areas. The total necrosis within the 
treated area was 26% (±11%) in the inT-HIFU group and 22% (±9%) in the M-HIFU treated mice. 
Histopathologically, the H&E sections revealed similar results between the M-HIFU or inT-HIF abla-
tion settings. In both groups some hemorrhage and ballooning degeneration was observed. In two 
mice of the inT-HIFU treated mice small pseudocysts within the tumor were found, most of which 
were filled with erythrocytes (Fig. 3.6E-H).
 All tumors showed moderate lymphocyte infiltration surrounding the tumor. The M-HIFU and 
inT-HIFU treated mice also showed additional lymphocyte infiltration within the center of the tu-
mor, without differences between the two other groups. In all mice, the F4/80 macrophage staining 
detected macrophages in the immediate surroundings of the tumor, and sometimes near fragment-
ed necrotic regions. However, no quantitative differences were found between the three treatment 
methods at the time points analyzed.
Figure 3.5  Comparison of the tumor on magnetic resonance (MR) imaging and pathology. T2w MR images 
before (a) and immediately after (b) 3 ablation spots. Yellow circle is the tumor, red squares are the 
thermal dose overlay. (c):Temperature map (EPI sequence) of one focal spot corresponding with 
blue circle at pathology and T2w image after treatment. (d): hematoxilin and eosin slice of the tu-
mor, 3 days after treatment. Showing a focal necrotic region and a confluent necrotic region, caused 
by heat distribution resulting in fusion of the lesions in the days after treatment.
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Figure 3.6   Digitalized hematoxilin and eosin stained sections of the mice tumors. 1x magnification of the 
tumor control (a), thermal (c), intermediate (e) and mechanical high intensity focused ultra-
sound treatment (g). 6.6 x magnification of the corresponding rectangle on the left: (a,b): well 
demarcated “old” necrosis without ballooning degeneration surrounding the necrotic area. c,d: 
large pink necrotic area in the centre of the tumor surrounded with ballooning degeneration 
(arrow head) and dying cells and remnants of vessels (arrow) within the necrotic lesion. (e,f): 
fractionated tissue with islands of necrosis, and ballooning degeneration (arrow heads) of cells. 
(g,h): Fractionated tissue with bleeding and formation of a cavity filled with erythrocytes.
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Discussion 
 A new MR guided HIFU setup for the treatment of small animals was designed and evaluated 
with three different ablation methods. This setup can be used to distinguish between thermal and 
mechanical ablation methods. The small focus (0.5x0.5x2.0 mm FWHM) of the HIFU system results 
in a high ablation accuracy. The HIFU focus can accurately be positioned within the tumor with min-
imal to no damage to the surrounding tissue, such as the skin or leg muscles. In combination with 
the high field small animal MR system, the temperature within the focal region and surrounding 
tissue can accurately (+/- 0.31 ˚ C) be measured with a high spatial resolution in real time (temporal 
resolution 1.9 sec). Thus, it is now feasible to do larger follow up studies in mice after MR-guided 
HIFU treatment to improve treatment methods and monitoring of tumor response.
 Two different thermometry methods were used, a GRE-FLASH sequence and an EPI sequence. 
With the GRE-FLASH sequence the temperature can only be visualized after each sonication in-
stead of real time visualization due to technical limitations of the sequence. Using the EPI sequence 
a thermal map can be displayed immediately during the ablation. The GRE-FLASH sequence creat-
ed accurate thermometry maps (temperature uncertainty <0.52 ˚C) and anatomical imaging with 
a relatively high spatial resolution (0.78 x 0.78 x 1.5 mm3, five slices) each 3.8 seconds. This allowed 
controllable HIFU and proper follow up. However, due to the interleaved ablation and visualiza-
tion of the thermal map occasionally heating of the surrounding tissue was noticed after ablation, 
which suggests that direct visualization is required to observe heating of surrounding tissue on 
time. Furthermore, the fast temperature rise combined with a relatively low temporal resolution 
(3.8 sec) might result in under-sampled and inaccurate temperature measurements due to partial 
volume effects. With the real time EPI sequence, a less accurate thermometry map was obtained 
(uncertainty <1.8 ˚C), in comparison with the GRE-FLASH sequence, and a decreased contrast 
of the images, making tumor border detection more difficult. However, due to the fast imaging 
(1.9 seconds per dynamic per 4 slices), less under-sampling occurred. Also a slice perpendicular 
to the transversal slices was used to visualize the tissue above the focus of the US beam. Due to 
the direct visualization of the tumor and surrounded tissue, immediate abortion of the ablation 
was feasible and any heating of surrounding tissue was noticed immediately. Optimization of the 
real time imaging is required for better visualization of the tumor margins. While the focal region 
was easily visualized with T-HIFU or inT-HIFU ablation, during M-HIFU treatment the temperature 
change was limited (<7 ˚C increase) and little or no signal changes were observed in the images 
during treatment. This results in difficulties to confirm the location of the focus in real time and to 
determine the treatment size created by M-HIFU treatment. Possibilities to visualize the focal zone 
with mechanical HIFU treatment, might be MR acoustic radiation force imaging (28).
 Only in three out of six T-HIFU treated mice, high intensity focal spots were seen in T2w MR 
images after treatment, while all mice showed histopathologic changes. This might be because T2w 
MR images were acquired immediately after treatment. Tissue response might become more ap-
parent some hours after treatment (29). Next to T2w MR imaging, other MRI techniques such as 
(dynamic) contrast enhanced MR imaging, diffusion weighted or T2* weighted MR imaging could 
be used for treatment evaluation and follow up (21,30-33). It has previously been shown that the 
permeability of vessels increases or the vessels are destroyed by mechanical destruction for ex-
ample due to cavitation effects (8). The permeability decreases due to tissue necrosis by thermal 
destruction of tissue, which results in respectively an increase and decrease of contrast uptake 
(34). Therefore, contrast MR imaging could visualize both thermal or mechanical HIFU treatment 
response and to help distinguish the thermal or mechanical bioeffects of different ablation methods.
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 Although no significant changes were observed in the MR images directly after treatment, mi-
croscopic changes due to treatment were found in all tumors. Instead of treating the entire tumor, 
only a small amount (3-6) of focal ablations were positioned inside the tumor. Histopathologically, 
the thermal treated mice revealed more confluent coagulation necrosis, while both M-HIFU and 
inT-HIFU treated groups showed more fractionated tissue necrosis and hemorrhage. These effects 
are similar as found in earlier studies on sheep, rats or rabbits (8,35,36). The mechanical effects 
were limited compared to thermal effects, still some dying cells and living cells were found between 
the fractionated tissue three days after the ablation. Real cavitation effects were not found, possibly 
because only transient damage was created while the tumor was removed after three days. Fur-
ther increasing the acoustical output power might be a solution for a more complete mechanical 
destruction of the tissue, as is shown in boiling histotripsy ablation methods (6,14). In future studies 
a longer follow up after treatment is of interest to evaluate further tumor responses after the dif-
ferent ablation techniques.
Conclusion
 In this study a stable MR guided HIFU treatment setup is designed to treat mice using either 
T-HIFU, M-HIFU or an inT-HIFU approach. It is shown that HIFU ablation of murine melanoma 
tumors is feasible and causes different pathologic effects within the tumor with high accuracy, with-
out damaging the surrounding tissue and with little or no damage to the skin. This design allows to 
improve and to investigate different HIFU treatment methods and their effects in vivo for larger 
cohort of animals.
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Abstract
 Boiling histotripsy (BH) is a new high intensity focused ultrasound (HIFU) ablation technique to 
mechanically fragmentize soft tissue into submicron fragments. So far ultrasound has been used for 
BH treatment guidance and evaluation. The in vivo histopathological effects of this treatment are 
largely unknown. 
 Here, we report on an MR guided BH method to treat subcutaneous tumors in a mouse model. 
The treatment effects of BH were evaluated one hour and four days later with MR imaging and 
histopathology, and compared with the effects of thermal HIFU (T-HIFU). 
 The lesions caused by BH were easily detected with T2w imaging as a hyper-intense signal area 
with a hypo-intense rim. Histopathological evaluation showed that the targeted tissue was com-
pletely disintegrated and that a narrow transition zone (<200 µm) containing many apoptotic cells 
was present between disintegrated and vital tumor tissue. A high level of agreement was found 
between T2w imaging and H&E stained sections, making T2w imaging a suitable method for treat-
ment evaluation during or directly after BH. After T-HIFU, contrast enhanced imaging was required 
for adequate detection of the ablation zone. On histopathology, an ablation zone with concentric 
layers was seen after T-HIFU. In line with histopathology, contrast enhanced MR imaging revealed 
that after BH or T-HIFU perfusion within the lesion was absent, while after BH in the transition 
zone some micro-hemorrhaging appeared. Four days after BH, the transition zone with apoptotic 
cells was histologically no longer detectable, corresponding with the absence of a hypo-intense rim 
around the lesion in T2w images. 
 This study demonstrates the first results of in vivo BH on mouse tumor using MR imaging for 
treatment guidance and evaluation and opens the way for more detailed investigation of the in vivo 
effects of BH.
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Introduction
 High intensity focused ultrasound (HIFU) is a non-invasive localized ablation method with a 
rapidly growing range of clinical applications (1). Ultrasound (US) energy is focused within a milli-
meter sized volume, resulting in localized tissue destruction without damaging adjacent tissue (2,3). 
The best known application of HIFU is the use of thermal destruction, either by hyperthermia or 
thermal HIFU (T-HIFU). These methods create denaturation and coagulation of proteins in the 
targeted tissue (3,4). Alternatively, tissues can be fractionated using mechanical disruption such as 
cavitation cloud histotripsy (CH) or BH (chapter 2,6). However, in vivo effects on tissue pathology 
and immune infiltration are poorly understood. Here, we describe in vivo BH for treatment of a 
subcutaneous tumor in a mouse ablation model.
 The BH technique uses millisecond pulses with acoustic pressures that are approximately five 
times higher than the pressures used for thermal ablation methods (7). The specific mechanisms of 
BH have so far mainly been studied in ex vivo specimens (8-11). With BH, the tissue is mechanically 
vaporized resulting in the formation of a cavity filled with liquefied tissue (9). Thermal denaturation 
of this tissue will be limited if the pulse duration is only slightly longer than the time-to-boil and if a 
low duty factor (<0.02) is used (8,11). 
 Until now, one study described in vivo BH in a porcine liver and revealed that the lesion was 
comparable to the lesions generated in ex vivo samples (12). However, studies in large animals, 
such as pigs, are costly and it is therefore challenging to perform larger cohort studies to investigate 
tissue pathology and immunologic effects. Murine models are more suitable to explore the in vivo 
effects on a larger scale. A small number of papers reported on a BH-like method for the treatment 
of mouse tumors (13-15). These papers describe BH treatment of subcutaneous tumors and the 
immunologic reactions, and all reports used ultrasound imaging for treatment guidance.
 For successful eradication of malignant tumors adequate treatment planning, monitoring and 
evaluation are required (16,17). Until now, US imaging is the most frequently used method for this 
purpose. However, MR imaging provides more detection options with better anatomical informa-
tion and a broader field of view compared to US (17,18). MR thermometry is already widely used 
in clinical practice for the real-time guidance of thermal HIFU ablation (17,19-22), while for treat-
ment evaluation T2 weighted (T2w), dynamic contrast enhanced (DCE) and contrast enhanced T1 
weighted (Ce-T1w) imaging are often applied (23-25). 
 The aims of this study are: 1) to establish an MR guided HIFU setup for in vivo BH treatment in 
a murine subcutaneous tumor ablation model with the use of MR thermometry, and 2) to assess if 
the treatment effects can be investigated using (Ce-)T1w, T2w, proton density weighted (PDw) and 
DCE MR imaging, immediately and four days after BH. The results were compared to T-HIFU and 
correlated with histopathological evaluation of the corresponding tissue sections.
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Figure 4.1 Treatment setup. Gel pad positioned underneath the mouse, centered in the receive coil.
Materials and Methods
Animal preparation
 Female C57Bl/6NCrl mice (9-11 weeks old) were purchased from Charles River Wiga (Sulzfeld, 
Germany). Animals were maintained under pathogen-free conditions in the Central Animal Labora-
tory (Radboud University Medical Center –Radboudumc–, Nijmegen, The Netherlands). All animal 
experiments were performed according to the guidelines for animal care of the Radboudumc.
 Murine EL4 thymoma cells (American type culture collection, Manassas, VA) were cultured in the 
presence of IMDM with 10% FCS and 1% antibiotic/antimycotic (100 units/ml penicillin and 100 
µg/ml streptomycin, Gibco). The cells were suspended in a 2:1 mixture of PBS and Matrigel Matrix 
(Corning, MA, USA) and injected subcutaneously at the right femur (0.5 x 106 cells). The tumor 
growth was evaluated with calipers. When the largest diameter reached >7.5 mm (generally after 
9-11 days), BH or T-HIFU was applied to the tumor. After the experiment the mice were scarified 
by cervical dislocation.
Treatment setup
 Before treatment, the area around the tumor was shaved and remaining hair was removed using 
standard hair removal cream. Animals were anesthetized by 3% Isoflurane gas inhalation for induc-
tion and maintained with 1-2% Isoflurane during the treatment. Breathing frequency was monitored 
and kept constant between 30-60 per minute. Body temperature was measured with a rectal ther-
mometer and maintained using a heated air flow device.
 The mouse was positioned in a right lateral position, with the tumor inside a degassed water 
bath within a gel pad. The gel pad (10% polyvinyl alcohol) was positioned on top of a plastic sheet 
to facilitate good acoustic coupling with the HIFU transducer (16 channels annular array cylindrical 
transducer, 3 MHz central frequency, transducer diameter 48 mm, focal spot size 0.5 x 0.5 x 2 
mm) of the MR compatible animal HIFU system (Image Guided Therapy –IGT–, Pessac, France). 
Treatment planning and monitoring was done with trajectory planning software (Thermoguide, 
IGT, Pessac, France). Some adjustments in contrast to the setup described in chapter 3 were made: 
1) the electrical output power was increased from 52 W to 350 W by implementing additional 
amplifiers, to reach sufficient output power required for BH treatment; 2) In order to obtain good 
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visualization of the focal region with MR thermometry, an in-house built receive-only (Rx) surface 
coil surrounding the tumor and gel pad was implemented (Fig. 4.1). The Rx surface coil was used in 
combination with the built-in body coil as transmit (Tx) coil and increased the signal-to-noise ratio 
(SNR) by a factor of more than 8 compared to images acquired by the body coil in transmit-receive 
(TxRx) mode.
Figure 4.2  Flow chart of treatment. Flow chart of MR imaging and treatment. In twelve mice multiple MR 
images and a dynamic contrast enhanced (DCE) scan was made immediately after treatment 
and the tumor was removed within one hour after treatment (n=4 for BH, T-HIFU and controls). 
Eleven mice received complementary MR scans two and four days post treatment (n=4 for BH 
and T-HIFU and n=3 for controls).
Table 4.1 Treatment settings.
Thermal HIFU Boiling histotripsy 
Treatment settings Continuous wave 4-5 s 
Cooling time 40 s 
Pulsed wave 
150 x 5 ms pulse 
Duty factor 0.005 
Acoustic power 35-37 W 155-160 W 
Acoustic Dose 140 J 117 J 
Focal spots 12-15 22-25 
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Animal treatment protocol
 Twenty-three mice were used for the in vivo mouse experiment. These mice were divided into 
three treatment groups: T-HIFU (n=8), BH (n=8) and a non-treated control group (n=7). Imme-
diately after treatment a series of MR scans were made (see below). After finishing MR evaluation 
of treatment effects the groups were further divided into two subgroups, in which the tumor was 
removed within one hour (n=4 per group) or four days (n=4 for T-HIFU and BH, n=3 for controls) 
after treatment for histopathological evaluation (Fig. 4.2).
 Previous ex vivo studies suggested that for BH, with a 3 MHz transducer, an acoustic power 
between 110-236 W is required with a pulsation time in the range of 5 ms and a low duty factor 
(0.005) (8,9,11). It has also been reported that increasing the amount of pulses will increase the 
lesion size until a maximum size is reached (9,11). Based on this information and the settings dis-
covered in our previously performed non-published ex vivo experiments and in vivo mouse pilots, 
the mice were treated using 150 pulses of 5 ms, with a duty factor of 0.005 and an acoustic output 
power of 155-160 W (acoustic dose approximately 117 J per focal spot). A total of 22 to 25 son-
ication spots, 1 mm apart, were positioned in the center of the tumor within one plane at a fixed 
focal length (Table 4.1). The focal spots were positioned at least 1 mm from the tumor margin to 
be able to investigate the transition zone between treated and non-targeted tumor tissue.
 The T-HIFU group was treated as described in chapter 3. Briefly, continuous wave ablation of four 
seconds per focal spot was used, creating temperatures up to >75 °C within the focal volume and 
a lethal dose of at least 240 cumulative equivalent minutes at 43 °C (CEM43) (27). The acoustic 
output power was 35-37 W (acoustic dose of approximately 140 J) per sonication (Table 4.1). Due 
to thermal diffusion a slightly larger area was damaged per sonication. Therefore 12 to 15 sonication 
spots were used, 1.5 mm apart and a cooling time of 40 s was used, creating an estimated total 
lesion size comparable to BH.
MR	imaging
 MR imaging was performed on a 7 T wide bore (20 cm) small animal MR system (ClinScan, Bruk-
er, Biospin, Ettlingen, Germany) with an additional Tx body coil insert (free bore size of 154 mm) 
and a homebuilt Rx surface coil (diameter 42 mm). T1w localizers and T2w images were acquired 
before treatment for calibration of the transducer coordinates with the MR system, tumor localiza-
tion and therapy planning (Fig. 4.2, Table 4.2) (chapter 3).
 A real-time T1w echo planar imaging (T1w-EPI) sequence (Siemens, Erlangen, Germany) was 
used for MR thermometry measurements, based on a proton resonance frequency shift method, as 
treatment monitoring (Table 4.2)(19). With this sequence three and six coronal slices perpendicular 
to the US beam and one sagittal slice in plane with the US beam were imaged each 1.8 s and 3.8 s 
during respectively T-HIFU or BH. These images could directly be visualized with the treatment soft-
ware (Thermoguide, IGT, Pessac, France) and used for real time MR thermometry measurement 
(Table 4.2; chapter 3). The body temperature, measured with the rectal thermometer, was used 
as a reference to determine the absolute temperature. Based on this real time monitoring with 
temperature map overlay, the focal spot position can be evaluated and manually adapted during 
treatment. During BH, additional T2w images were made after 8-10 and 16-20 sonications.
 Since T2w and (Ce-) T1 weighted imaging are often used for T-HIFU evaluation (17,23,24), these 
imaging methods were used for evaluation of the ablated lesion after treatment. As the tissue is 
liquefied during BH, an increase of signal on T2w imaging is expected. Since the blood vessels will 
be damaged during treatment, (Ce-)T1w-3D-VIBE (volume metric interpolated breath-hold ex-
amination) was chosen to determine the non-perfused 3D volume. Additional (CE-)PDw images 
were used to receive high contrast images of the tumor in order to detect possible hemorrhages. 
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MR imaging (T2w, PDw and T1w-3D-VIBE) was performed immediately after T-HIFU (n=8), BH 
(n=8) and for controls (n=7), as well as two and four days post-treatment (n=4 for T-HIFU and BH, 
n=3 for controls) for treatment evaluation (Table 4.2, Fig. 4.2). Four mice of each group received 
in addition a T1w-DCE scan immediately after treatment to further evaluate perfusion, possible 
hemorrhages and/ or edema after treatment. After about five T1w images (2.4 s per image) 0.2 ml 
Gadovist (0.04 mmol/ml) was manually injected (<2 s) in the tail vein of the mouse. Immediately 
after MR imaging, the tumors of these mice were removed for histopathological evaluation (within 
one hour after treatment). The remaining mice (n=4 for T-HIFU and BH, n=3 for control) received 
additional T1w-DCE imaging on day four after treatment, after which the tumor was removed for 
histopathological evaluation. Each DCE scan was followed by an extra set of contrast enhanced 
T1w-3D-VIBE, T2w and PDw MR scans (Table 4.2, Fig. 4.2). All figures presented (MR and histo-
pathological) were made in the coronal plane and zoomed in at the tumor with an ablated lesion 
visible inside (Fig. 4.3).
Table 4.2 MR parameters
SE: spin echo, GRE: gradient echo, VIBE: volumetric interpolated breath hold examination, FLASH: fast low angle 
shot, EPI: echo planar imaging, FOV: field of view, TR: repetition time, TE: echo time, FA: flip angle   
     
Sequence Se-
quence 
Type 
Slice Thick-
ness (mm)/ 
No. of slices 
FOV 
(mm) 
Matrix TR/	TE	(ms) FA 
(de-
gree) 
Band-
width 
(Hz/Px) 
Total acqui-
sition time 
(min:sec) 
T1w  
localizer 
axial 
GRE 1.50/ 30 130x 130 256x 256 236.0/ 4.00 25 260 1:02
T1w  
localizer 
coronal 
GRE 1.00/ 50 100x 100 128x 128 517.0/ 4.00 25 260 0:50
PDw  
coronal  
TSE 1.00/ 16 45x 45 256x 256 2500.0/ 
14.00
180 130 1:35
T2w  
coronal + 
sagital 
TSE 1.00/ 16 45x 45 256x 256 2500.0/ 
41.00
180 130 1:35
T1w 3D Flash 3D 
VIBE
0.26 50x 50x 
50
192x 192x 
192
10.0/ 1.57 25 490 2:39
T1w DCE Turbo 
FLASH
1.00/ 6 50x 50 128x 128 400.0/ 1.58 15 810 12:00 (2.4 s/
image)
T1w- EPI 
(T-HIFU)
GRE-EPI 1.00/ 4 35x 35 64x 60 20.91/ 4.50 15 501 1.80 s/image
T1 -EPI 
(BH)
GRE-EPI 1.00/ 7 35x 35 64x 60 20.91/ 4.50 15 501 3.10 s/image
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Figure 4.3  Real time T1w EPI imaging and T2w imaging for BH. (A, B) Real time T1w EPI imaging (after 4 
(A) and 25 (B) sonication spots) revealed a slightly hyper-intense lesion with hypo-intense rim. 
(C–F) images after 0 (C), 10 (D), 20 (E) and 25 (F) sonications. A clear hyper-intense lesion is 
seen corresponding to the planned treatment.
Histopathology
 The tumors were inked for visual orientation and fixated in formaldehyde immediately after 
surgical resection of the tumor. The tumors were embedded in paraffin after which 4 µm thick 
tissue sections were cut parallel to the coronal MR imaging (perpendicular to the US beam). For 
the histopathological evaluation of the treatment, hematoxylin and eosin (H&E) stained sections of 
the tumor at multiple levels were made. Special attention was given to the quality and quantity of 
the ablation area and the transition zone between vital and non-vital tissue: type of necrosis, the 
amount of fragmentation, the presence of hemorrhages and the size of the transition zone.
 Additional immunohistochemical stainings were performed on representative tissue sections. Ap-
optosis and cell proliferation were evaluated using caspase-3 (Rabbit-anti-active, 1:1000 in 1% PBS/
BSA, BD Pharmingen) and Ki67 (Rat-anti-mouse, 1:50 in 1% PBS/BSA, TEC-3 DAKO) antibodies, 
respectively. The presence of vessels within the lesion and remaining tumor was evaluated with the 
endothelial cell marker CD34 (Rat-anti-mouse, 1:10 in 1% PBS/BSA, Hycult).
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Correlation	of	MR	imaging	with	histopathology
 To evaluate whether MR imaging can be used to determine the lesion size after BH, the cor-
relation between the dimensions of the lesion on MR images and H&E stained sections was de-
termined. Lesion diameters were measured on both histopathological slides and MR images. The 
correspondence between these diameters was determined by calculation of the coefficient of 
determination (R2) to the line of identity (y=x). The correlation was analyzed using a Bland-Alt-
man plot performed in SPSS (IBM SPSS Statistics for Windows, version 20, SPSS, Chicago, Ill). One 
mouse of the BH group (n=8) was excluded from these measurements because of a clear mis-
match between the angle of the MR images and the histopathological slides of the tumor.
 
Figure 4.4  MRI and histology after BH or T-HIFU. Upper row, T-HIFU; lower row, BH. (A, E) PDw imaging; 
(B, F) CE-PDw, 15 min after contrast injection. (C)The H&E stained section corresponding to A, 
B, (D) Zoom (scale bar 100 μm) of rectangle in C with additional zoom (scale bar 20 μm) of 
the different layers of the transition zone: 1, vital tumor; 2,apoptotic compressed rim; 3, edema; 
4, coagulated, compact cells. (H, I, J) zoom (scale bar 100 μm) of rectangles shown in G with 
additional zoom (scale bar 20 μm). (H) Fragmentized lesion with chromatin fragments (purple 
dots); small nuclei remaining (arrow). (I) Sharp transition zone (<200 μm) between non-treated 
and treated tissue. (J) Small hemorrhages (delineated area).
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Figure 4.5  DCE imaging immediately after treatment; contrast is injected after five T1w images (i.e. after 
8—10 s. (A, B) T1w-DCE after BH: (A) before contrast injection and (B) 3.5 min after contrast 
injection. (C, D) T1w-DCE after T-HIFU: (C) before contrast injection and (D) 3.5 min after con-
trast injection. Graphs E and F are T1w intensity measurements of the T1w-DCE images. ROI’s 
are determined based on contrast enhanced PDw images: red = tumor, green, = edge of lesion, 
blue = lesion, purple = hemorrhage.
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Results
Mouse treatment evaluation
 Initial ex vivo studies and an in vivo pilot study revealed that complete fragmentation of the tis-
sue by BH of mouse tumors, with our system, occurred with 150 pulses of 5 ms (duty factor 0.005) 
and an acoustic output power of 154 W. We determined that the focal length should be <40 mm 
to prevent elongation of the focal volume, and that the focal spot needed to be positioned at a 
depth of at least 1-2 mm within the tissue to prevent skin damage. Therefore these settings were 
used for BH of the mouse tumors in this study (Fig. 4.1, Table 4.1). One millimeter spacing was 
used between the multiple sonication spots (22 to 25) that were positioned within one plane. The 
average focal length was 35.2 mm (range 34.2-37.5 mm). 
 All mice were treated with BH without major complications. In the days following treatment 
with BH (n=8) or T-HIFU (n=8) only minor redness of the skin was detected. After BH treatment, 
no damage was detected in surrounding tissues such as the leg muscle or bone, while after T-HIFU 
minor complications occurred in two animals (i.e. difficulty in using the tumor bearing leg, n=1, and 
a wound of the skin, n=1).
 During T-HIFU the temperature within the focal region increased to 79 °C (±18 °C, range 46.9-
100 °C) within four seconds. The lethal dose of tissue (CEM43≥240min) was reached within an 
area of 29.7 mm2 (±12.6 mm2, range 8.1-45 mm2). During BH the temperature increased to only 
43 °C (±3.5 °C, range 34,5-50.7 °C) within 20 s, after which it stabilized around this temperature. 
The thermal dose CEM43 within the focal region was only 0.06 (±0.38, range 0-4.9), indicating that 
thermal damage during BH is negligible.
MR	imaging
 During BH the real-time generated magnitude images (T1w-EPI) revealed a slight signal drop 
within the focal zone. After multiple sonications, a hyper-intense region became visible with a clear 
hypo-intense rim (Fig. 4.3A,B). During T-HIFU, the intensity dropped within the focal spot, but the 
intensity returned as soon as the HIFU pulse stopped. These intensity drops were probably the 
result of cavitation or boiling effects.
 Immediately after BH and in between sonications, T2w images revealed a clear hyper-intense 
area (average intensity increase of 26%, ±13 with a hypo-intense rim (average intensity decrease 
of 26% ±10 (Fig. 4.3C-F and Fig. 4.4E). The size and shape of the ablation zone correlated with the 
planned treatment area. DCE measurements revealed a normal inflow of contrast in the remaining 
tumor and an absence of contrast uptake into the ablated area. This indicates that there was no 
perfusion after BH (Fig. 4.5B,E). However, on CE-PDw imaging some small hyper-intense areas 
were detected at the borders of the ablation zone (Fig. 4.4F), which correlated to a constant linear 
increase of the contrast agent revealed by the DCE measurements (Fig. 4.5A,B,E). 
 Immediately after T-HIFU, limited signal changes were visible on T1w, T2w, PDw images (Fig. 4.4A). 
Only after contrast injection a well-defined lesion became visible (Fig. 4.4B). The DCE measure-
ments revealed a normal contrast uptake within the well-perfused tumor and no contrast uptake 
within the ablated area, indicating that there was no perfusion after ablation (Fig. 4.5D,F). Only 
within the transition zone a linear increase of the contrast agent was detected (Fig. 4.5C,D,F). Here-
by on CE-PDw images a clear hypo-intense region with a hyper-intense rim was detected which 
corresponded with the treated area (Fig. 4.4B).
Promotieboekje-Binnenwerk-v3.indd   84 08-05-17   17:44
85 |  CHAPTER 4
 The T1w-3D-VIBE images had a low SNR making different tissue structures difficult to detect, 
including the transition zone between vital and non-vital tissue after BH. However, after T-HIFU the 
contrast enhanced T1w-3D-VIBE images did reveal a lesion due to the presence of a hyper-intense rim. 
Figure 4.6  T2w intensity after boiling histotripsy. The lesion and transition zone T2w intensities as a fraction 
of the tumor T2w intensity. All values are relative to the non-treated tumor tissue.
Figure 4.7  MRI and histology 4 days after treatment. Upper row, T-HIFU; lower row, BH. (A, F) T2w 
imaging (B, G) CE-T2w imaging, 12 minutes after contrast injection. (C,H) H&E stained tissue 
sections. (D,E) zoom (scale bar 50 μm) of rectangle in C. (D) Necrotic tissue within the ablated 
area with and without visual nuclei remaining (circle, 2x zoom of D). Cell structures are still 
visible. (E) Sharp border between necrotic and vital tumor tissue. (I, J) Zoom (scale bar 50 μm) 
of rectangles shown in H. (I) Outer rim of the lesion. (J) Droplets of chromatine agglomeration 
(arrows). Within the square the influx of granulocytes within the lesion is shown (extra zoom 
with scale bar 20 μm).
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Figure 4.8  Dynamic contrast enhanced imaging 4 days after treatment. (A, B, C) T1w -DCE after BH: (A) 
before contrast injection, (B) 3.5 min and (C) 10.5 min after contrast injection. (E, F, G) T2w 
-DCE after T-HIFU: (E) before contrast injection; (F) 3.5 min and (G) 10.5 min after contrast 
injection. Graphs D and H are T1w intensity measurements of the T1w-DCE images. ROI’s are 
determined based on contrast enhanced PDw images: red = tumor, green = edge of lesion, blue 
= lesion.
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 Four days after BH the ablated region was more difficult to detect on the T2w MR images (Fig. 
4.6 and 4.7F,G). Compared to the situation immediately after treatment, the ablated region became 
less visible due to absence of the hypo-intense rim and decrease of the intensity (two out of four 
tumors) and homogeneity of the ablated area (Fig. 4.6 and 4.7F). However after contrast injection 
the contrast between non-vital and vital tumor tissue returned on Ce-T2w and Ce-PDw images 
(Fig. 4.7G). The T1w-DCE images revealed a rapid normal contrast inflow within the tumor and 
minor leakage of the contrast agent into the center of the non-perfused lesion (Fig. 4.8A-D).
 Four days after T-HIFU, the treated region could not be distinguished from the vital tumor tissue 
on standard T1w-3D-VIBE, T2w and PDw images. Similar to immediately after treatment, a non-per-
fused area was detected within the hyper-intense perfused untreated tumor after contrast injection 
(Fig. 4.8E-H). Almost no contrast uptake was seen within the ablated area and a slightly more 
intense rim was detected on Ce-T1w-3D-VIBE, Ce-T2w and Ce-PDw images (Fig. 4.7B). However 
this was not as clear as immediately after T-HIFU treatment. 
 Overall these data imply that T2w imaging was most useful for visualizing the ablated region after 
BH treatment. For T-HIFU a contrast agent was required to visualize the non-perfused, damaged 
area.
Tumor appearance
 Upon histopathology examination, all control tumors (n=7) exhibited a highly cellular tumor with 
marked mitotic/proliferative activity as well as multiple, dispersed apoptotic cells.
 One hour after BH, in H&E stained sections a sharply delineated lesion was seen within the highly 
cellular tumor corresponding to the ablated area (Fig. 4.4G). In this lesion the tumor cells were 
(almost) completely disintegrated with small particles of basophilic debris (consistent with frag-
mented chromatin) remaining in a background of smudgy eosinophilic material (Fig. 4.4H). Blood 
vessels were not recognizable in this area anymore. The transition zone varied between extremely 
sharp (only one cell wide) to a somewhat broader zone, still <200 µm, consisting of a mixture of 
disintegrated and apoptotic (caspase-3 positive) cells (Fig. 4.4I). Proliferating cells (Ki67 positive) 
were absent in the treated region, but the surrounding vital tissue revealed normal high cellular 
proliferation with dispersed apoptosis (supplementary Fig. 4.1). Surrounding the ablated area, some 
dilated vessels were seen (supplementary Fig. 4.1D), as well as some micro-hemorrhages (Fig. 4.4J).
 One hour after T-HIFU, the H&E stained sections revealed an ablation zone with concentric layers 
(Fig. 4.4C). In the periphery, vital tumor tissue was present (Fig. 4.4D1), inside of which a sharply 
demarcated rim of 100 - 200 µm with a high number of pyknotic nuclei and apoptotic (caspase-3 
positive) cells (Fig. 4.4D2 and supplementary Fig. 4.1E,F). Further inward a zone with increased 
space in between cells with pyknotic nuclei and apoptotic and fragmented cells was found, consist-
ent with edema (Fig. 4.4D3). The center of the lesion contained many cells with pyknotic nuclei and 
dispersed apoptotic cells (Fig. 4.4D4), and local spots with complete disintegration of the tissue, 
comparable to the effects resulting from BH, were seen (Fig. 4.4C-arrow-). Furthermore, almost 
all tumor cells in the different zones of the tumor were positive for the proliferation marker Ki67. 
Vessels were still present within the ablated area after T-HIFU. Large dilated vessels, as seen after 
BH, were not found. Only within one out of four tumors, a small area with micro-hemorrhage was 
detected.
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 The H&E sections of the lesions four days after BH revealed an influx of a variable and in some 
places very high number of neutrophilic granulocytes in the center of the lesion and dispersed 
presence of confluent, basophilic material (Fig. 4.7H-J). The amount of apoptotic cells within the 
transition zone between vital and non-vital tumor tissue was limited (supplementary Fig. 4.2A,D). 
However, within two tumors some areas surrounding the lesion revealed an increased number of 
apoptotic cells compared to control tumors (supplementary Fig. 4.2B). Both the hemorrhages and 
dilated vessels, seen one hour after treatment, were no longer visible four days after BH.
 Four days after T-HIFU, a sharp transition between a central area with coagulated, necrotic tissue 
and peripheral, vital tumor tissue was present (Fig. 4.7C,E). In the central area, pyknotic nuclei and 
‘ghost cells’ were still visible to a variable extent, but apoptotic and proliferating cells were not 
present (Fig. 4.7D, supplementary Fig. 4.2). The surrounding, vital tumor tissue, revealed normal high 
proliferation with dispersed apoptotic cells.
 These data indicate that both treatments were able to successfully ablate the entire planned area, 
but that the ‘dynamics’ of tissue destruction were distinct. 
Correlation	of	MR	imaging	with	histopathology
 The high intensity lesion and the surrounding dark rim seen on T2w images after BH correspond-
ed with the central area with disintegrated tissue and the surrounding zone containing pyknotic 
nuclei and apoptotic cells, respectively (Fig. 4.4E,G,I). Four days after treatment the amount of py-
knotic nuclei and apoptotic cells decreased, which correlated with the decrease or absence of the 
hypo-intense rim seen on T2w images. The small hyper-intense foci seen on CE-PDw images at this 
rim correspond to the microhemorrhages seen in H&E stained slides one hour after BH treatment 
(Fig. 4.4F,G,J). 
 While T2w images were suitable to differentiate between vital and non-vital tissue after BH, con-
trast injection was required for detection of the ablated area after T-HIFU. The non-perfused region 
seen with DCE measurements immediately after as well as four days after treatment (Fig. 4.5F and 
8H) correspond with the lack of vessels observed with histopathology after T-HIFU (supplementary 
Fig. 4.1H).
 To quantify the correlation between lesion sizes as seen by MR and by histopathology, their 
diameters were measured on MR images and on H&E stained slides (Fig. 4.9). T2w images before 
contrast injection were most suitable for detection of the lesion after BH and CE-PDw images after 
T-HIFU. The R2 of the measured diameters to the line of identity for T-HIFU and BH was respective-
ly 0.54 and 0.79. The lesion size measured on MR images thus corresponds better with pathology 
for BH than for T-HIFU. The good correlation of the lesion size measured by MR and histopathology 
also follows from a Bland-Altman plot (Fig. 4.9). The average discrepancy between the diameter 
measured on MR and histopathology is -0.14 and 0.28 for respectively the T-HIFU and BH group. 
The limits of agreement after T-HIFU (1.96 sd. = 1.89/-2.18) is slightly larger than after BH (1.96 sd. 
= 1.38/-0.83). This good correlation between the lesion detected with MR and the damaged tissue 
seen at histopathology slides shows that MR imaging is an excellent evaluation method for BH.
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Figure 4.9   Comparison between MR and pathology lesion size. (A) H&E slice and (D) T2w image after 
BH. (C, E) BH; (D, F) T-HIFU; (C, D) Scatter plot of measured diameter of the lesion measured 
on pathology H&E slices and MR images, both immediately after treatment and four days after 
treatment. The coefficient of determination R2 of the data is calculated to the line of identity 
(y = x, dotted line); (E, F) Corresponding Bland—Altman plot.
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Discussion
 Mouse tumor areas were safely ablated in vivo with the use of a BH method, using MR thermom-
etry for treatment monitoring and MR imaging for treatment evaluation. Importantly, this treatment 
did not evoke side effects, and all mice recovered completely with full use of the leg involved in 
the days after BH. T2w imaging was the most suitable MR imaging method for planning and eval-
uation of BH. The treatment was successful as the treated area was completely fragmentized into 
submicron fragments. Moreover, a lesion with a very sharp border (<200 µm) between non-vital, 
disintegrated and vital tumor tissue was created and could easily be visualized with T2w imaging. 
 A high level of agreement was found between the lesion measured on T2w imaging and on 
histopathology slides. The immediate and thorough fragmentation of the tissue by BH results in a 
liquefied area without cell structures, connective tissue or vessels that is visible as a homogenous 
hyper-intense area on T2w images. Thus T2w images were able to provide guidance on the disin-
tegration of the area of interest. The measurements of the lesion size on MR images revealed a 
slightly larger lesion size (on average 0.28 mm) than on histopathology. This can at least partly be 
explained by tumor shrinkage during the process of formalin fixation and paraffin embedding, the 
lower spatial resolution of the MRI (28), and/or a small deviation of the orientation of the tissue 
sections. In contrast to BH, after T-HIFU the morphological changes of cells take some time, so that 
MR contrast (T1, T2 or PD) changes are minimal or absent. A contrast agent was required to dis-
tinguish damaged, non-perfused tissue in the center of the lesion from perfused vital tumor tissue 
in the periphery. As the contrast agent (T1/PD sensitive) only enters perfused tissue, the perfused 
vital tumor becomes bright and non-perfused non vital tissue remains dark on DCE, Ce-T1w and 
Ce-PDw images. However, this then concerns an indirect measurement of the treated area instead 
of visualization of the damaged tissue directly.
 The morphological changes in the ablated region after T-HIFU were also more difficult to recog-
nize on H&E stained sections. Due to heat fixation, the cells in the center of the treated area still 
maintained their cytological and nuclear staining characteristics to a variable extent (29). Therefore, 
one hour after treatment it appeared in H&E and Ki67 stained sections that most cells within the 
lesion were still alive and proliferating, while four days after treatment all cells were dead or dying 
within that area. In contrast to BH, four days after T-HIFU cell contours were still visible in the center 
of the ablated area and clotted remnants of the nuclei were found. As also suggested by others (16), 
most likely after T-HIFU the cells in the center of the lesion were heat-fixated, while cells near the 
periphery went into an apoptotic state. 
 The hypo-intense rim surrounding the lesion created by BH on T2w images immediately after 
treatment can be explained by the closely packed dead and apoptotic cells, containing many pyk-
notic nuclei and less cytoplasm as seen on histopathology sections. This hypo-intense rim on T2w 
images slowly disappeared within the following days after treatment (day two and four) as an effect 
of the decrease in dead and apoptotic cells. These data also suggest that a limited amount of cells 
present at the treatment border experienced thermal denaturation, which is in line with the ex vivo 
work of Khokhlova et al (8). 
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 The absence of contrast influx within the lesion during DCE measurements immediately after 
BH treatment is indicative for the lack of perfusion within the ablated area. This is further substan-
tiated by the absence of immunohistochemical staining for the vessel marker CD34. These findings 
correlate with earlier studies, reporting that very small vessels (<100 µm) were destroyed by CH 
(30). In comparison, after T-HIFU the capillaries were still visible within the ablation zone itself in 
CD34 stained sections. However, as observed with the DCE measurements, there was no perfusion 
of these vessels. After BH only few micro-hemorrhages were detected on histopathology section 
in the transition zone of the lesion. These regions correlated to the small hyper-intense regions on 
CE-PDw imaging in this border zone, which were measured as linear diffusion of the contrast agent 
by DCE measurements.
 Four days after both BH and T-HIFU no perfusion was measured within the lesion. An increased 
amount of linear contrast leakage was, however, detected within the BH ablated zone after four 
days. This suggests an increase in permeability of the vessels resulting in leakage of the contrast 
agent into the tumor or lesion. Preliminary data suggest an influx of granulocytes and macrophages 
four days after BH. After T-HIFU, influx of these cells was mainly detected at the edges of the coag-
ulated tissue. It would be interesting to study immune effects in more detail to distinguish between 
normal wound healing processes and tumor specific immune responses.
 A limitation of the current ablation method is the relatively long treatment time, since 22-25 focal 
spots were targeted subsequently and each focal spot required 150 pulses with only one pulse per 
second, i.e. total treatment time of 55-62.5 min. To ablate the same volume with T-HIFU, 12-15 focal 
spots were required each of only four seconds and a cooling time of 40 seconds i.e. total treatment 
time of 8.8-11 min. Future studies therefore should aim at decreasing the treatment time. Possible 
solutions might be to reduce the amount of pulses or to ablate multiple spots at the same time 
instead of subsequent sonication of the focal spots (31). 
 It is shown that real-time T1w-EPI images can be used to visualize the focal volume and for 
MR thermometry during BH. However, during BH tissue will be fragmentized, which causes signal 
changes for the ablation zone during treatment. These signal changes could result in phase chang-
es, which might influence the accuracy of the temperature measurements via MR thermometry. 
However these changes offers opportunities for other imaging techniques and as guidance for BH. 
The boiling bubble and cavitation effects that occur during BH could cause intra-voxel incoherent 
motion (IVIM) effects. These effects can be detected by strong gradient echo motion sensitive 
sequences (32). Another possibility is to use acoustic radiation force imaging (28,33). Hereby the 
cavitation effects or displacement of the tissue during BH can be visualized and this might be used 
as an alternative for MR image guidance of BH.
 T-HIFU is currently applied clinically, while BH is still in a preclinical phase. Nevertheless, several 
aspects of mechanical HIFU as exemplified by BH may represent a major advantage in selected clin-
ical HIFU treatments, including ablation of tumors (5). Tissue fragmented into submicron particles 
without major hemorrhages as occurs after BH, can easily be removed by natural wound healing 
responses thus resulting in removal of the tumor mass (34). T-HIFU results in coagulated necrosis 
further evolving into scar tissue, leaving a fibrotic mass. This makes BH an interesting method for 
the treatment of, for example, benign prostatic hyperplasia or brain tumors in which removal of 
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the tissue mass is preferable. Another major advantage of BH in comparison to T-HIFU is that there 
is no heat sink effect as well as the absence of thermal diffusion to surrounding tissue, resulting 
in a very sharp transition zone between treated and non-treated tissue. Further studies aimed at 
understanding the physiological effects and applicability of different HIFU treatments are important 
to develop personalized HIFU treatments for distinct disease settings.
 In conclusion, we demonstrate that subcutaneous mouse tumors can be treated by an MR 
guided BH method. This method causes complete fragmentation of tissue of the target area with a 
sharp border between vital and non-vital tissue. The created lesion can easily be identified by T2w 
imaging, both immediately after treatment and during the follow-up in the next days. The hyper-in-
tense area seen on T2w imaging correlates very well with the lesion as detected in H&E stained 
sections. This setup will enable more detailed investigation of the in vivo effects of BH.
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Suppl. Figure 4.1  Caspase-3 (apoptosis), Ki67 (proliferation) and CD34 (vessel) staining one hour after 
treatment. Top row: after BH. Bottom row: after T-HIFU. Caspase-3, apoptosis (cytoplas-
mic and nuclear) staining (A, E) with corresponding zoom in of the transition zone of the 
lesion (B,F). After BH a small amount of apoptotic cells were detected in the transition 
zone with occasionally some spreading in the surrounding tissue (A, arrow). After T-HIFU 
a clear border is detected with a high amount of apoptotic (caspase-3 positive) cells (F). 
Vessels are stained by CD34 staining (D,H, arrows) and can be seen after zoom in at 
the position shown with a square in A and E respectively. Some dilated vessels are seen 
surrounding the non-vital tissue after BH (D). Ki67 proliferation staining of the nuclei 
(C,G) reveals a high proliferating tumor after both BH and T-HIFU, while the zoom (scale 
bar 20 μm) reveals no proliferating cells within the ablated lesion after BH (C) and still 
positive marked cells within the ablated region after T-HIFU (G). 
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Suppl. Figure 4.2  Caspase-3 (apoptosis) and Ki67 (proliferation) four days after treatment. Top row: four 
days after treatment BH. Bottom row: four days after T-HIFU. Caspase-3, apoptosis 
staining (A, E) with corresponding zoom (B,D,F,H). Ki67, proliferation staining (C,G). Four 
days after BH the transition zone of the lesion revealed a limited amount of apoptotic 
cells(B) and a limited influx of proliferating cells within the lesion (C), remaining vital tis-
sue is comparable as normal tumor tissue with high proliferating cell density and disperse 
apoptotic cells. Four days after T-HIFU the staining for apoptotic (E,F) and proliferating 
cells (G) was negative in the central area. Although in the central area, patchy (non-spe-
cific) staining for caspase-3 was (still) present (H).
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Abstract
 Interest in mechanical high intensity focused ultrasound (HIFU) ablation procedures is rapidly 
growing. Boiling histotripsy (BH) is applied for mechanical disintegration of soft tissue into submi-
cron fragments with limited temperature increase using the shock wave and cavitation effects of 
HIFU. Research on BH has been largely limited to ex vivo experiments. As a consequence, the in 
vivo pathology after BH treatment and the relation to preexistent tissue characteristics are not 
well understood. This study reports on in vivo MR guided BH treatment, either with 100 or 200 
pulses per focal spot, in three different subcutaneous mouse tumor models: a soft-tissue melanoma 
(B16OVA), a compact growing thymoma (EL4), and a highly vascularized neuroblastoma (9464D). 
Extensive treatment evaluation was performed using MR imaging followed by histopathology 2 
hours after treatment. 
 T2 weighted MRI allowed direct in vivo visualization of the BH lesions in all tumor models. The 
100 pulse treated area in the B16OVA tumors was larger compared to the predicted treatment 
volume (500±10%). For the more compact growing EL4 and 9464D tumors this was 95±13% and 
55±33%, respectively. Histopathology after the 100-pulse treatment revealed completely disinte-
grated lesions in the treated area with sharp borders in the compact EL4 and 9464D tumors, while 
for B16OVA tumors the lesion contained a mixture of discohesive (partly viable) clusters of cells, 
micro-vessel remaining, and tumor cell debris. The treatment of B16OVA with 200 pulses increased 
the disintegration of the tumor cells. In all tumor types only micro-hemorrhages were detected 
after ablation (slightly higher after 200-pulse treatment for the highly vascularized 9464D tumors). 
Collagen staining (AZAN) revealed that the collagen fibers were to a greater or lesser extent still 
intact and partly clotted together near the lesion border in all tumor models.
 In conclusion, this study reveals effective mechanical fragmentation of different tumor types us-
ing BH without major hemorrhages. However, treatment settings may need to be adjusted to the 
tissue characteristics for optimal tissue fragmentation.
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Introduction
 Over the last decade, local treatments such as laser, cryo, or focused ultrasound ablation have be-
come promising modalities for treatment of solid tumors. High intensity focused ultrasound (HIFU) 
is the only non-invasive treatment modality with a large range of applications (1). Thermal HIFU 
ablation is already used in a clinical setting for the treatment of benign and malignant tumors. With 
a continuous exposure duration of seconds the tissue is heated to over 60 °C, resulting in thermal 
coagulation of the tissue (2-4). Next to this ablation using thermal effects, the interest in mechanical 
destruction by HIFU is growing. Cavitation cloud histotripsy (CH) and boiling histotripsy (BH) are 
two new focused ultrasound ablation methods able to mechanically disintegrate soft tissue into 
submicron fragments (5,6).
 Thermal damage is created using the absorbing effect of continuous ultrasound waves with 
relatively “low” intensities of ~102 W/cm2 within the focal spot. CH and BH, however, are using 
the shock wave and cavitation effect of ultrasound to mechanically disintegrate the tissue, using 
microsecond and millisecond pulses with intensities of at least 10 kW/cm2 within the focal spot. A 
low duty cycle (<2%) is used to limit thermal damage (5,6). So far, both mechanical HIFU methods 
have primarily been used in pre-clinical settings (chapter 2). Compared to reports on CH, only 
little has been published about the in vivo effects of BH (7-11). Both methods result in submicron 
fragmentation of tissue that has major advantages compared to thermal ablation techniques. For 
instance, the border between treated and non-treated tissue is (generally) extremely sharp since 
there is no thermal diffusion (7,chapter 4). Furthermore, a liquefied lesion is created that can be 
resolved via natural drainage or absorbed by natural wound healing responses, while the necrotic 
mass resulting from thermal ablation evolves into a fibrotic mass (10,13). 
 For clinical applications, BH has several advantages over CH. In CH, microsecond pulses with high 
peak acoustic power are used to initiate a cloud of micrometer sized bubbles. However, the time 
to initiate this cloud is not always predictable, and the cavitation activity can stop unexpectedly in 
the course of the treatment (14). While CH has this stochastic character, BH is more predictable 
and controllable. In milliseconds a millimeter sized boiling bubble is created, and the combination of 
this tissue-vapor interface with incoming HIFU shock waves results in fragmentation of the tissue 
(15). The time to create this bubble is known as the time-to-boil and can be determined based on 
tissue characteristics (15). Furthermore, CH requires a relatively large transducer and an amplifier 
generating extremely high acoustic power, while a BH system has fewer restrictions with respect to 
transducer size and acoustic power. Therefore, BH can be more readily implemented with clinically 
available HIFU systems. Cardiac and respiratory motion is another major limitation for accurate 
treatment with CH. For BH a low pulse repetition frequency and long duration between pulses is 
used (1-2 pulses per second), which makes it more suitable for cardiac or respiratory triggering and 
thus less sensitive for motion artifacts (6,16). 
 In our previous study we showed the first results of in vivo BH in mice bearing subcutaneous 
(s.c.) thymoma (EL4) (chapter 4). However, for CH it is known that the optimal settings of tissue 
fragmentation depend on the targeted tissue type (17,18). Tissues with a firm consistency, e.g. be-
cause of higher amount of collagen and higher cell density, are less sensitive to CH treatment than 
softer tissues, i.e. low tissue consistency. Most likely, the amount of pulses or higher treatment dose 
should be applied with increased tissue consistency to generate complete fragmentation of the 
tissue (8,13). Although, very soft tissues, such as the bladder wall, also have been shown to be less 
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sensitive to the treatment (17). Much less is known regarding the effects of BH ablation settings, 
treatment duration, and target tissue characteristics on the effectiveness of BH in vivo (7,19,20).
 Previously, we showed that mice bearing subcutaneous (s.c) thymoma (EL4) can be treated safely 
and reproducibly with BH (chapter 4). In our current study we compare in vivo BH treatment in 
three tumor models having distinct tumor tissue characteristics at the same s.c. location. In addi-
tion to the EL4 thymoma, we treated soft-tissue melanomas with loosely packed cells (B16OVA; 
containing little collagen), and highly vascularized, slow growing neuroblastomas (9464D; with a 
higher density of collagen). We tested the feasibility of BH treatment (100 versus 200 pulses) and 
evaluated the impact on tissue pathology by MRI and histopathology in relation to tumor tissue 
characteristics.
 
Materials and Methods
Animal preparation
 Female C57Bl/6NCrl mice (9-11 weeks old, Charles River Wiga, Sulzfeld, Germany) were used 
for the experiments. The mice were maintained under pathogen-free conditions in the Central 
Animal Laboratory and the experiments were performed according to the guidelines of the animal 
care of the Radboud University Medical Center (Radboudumc, Nijmegen, The Netherlands). 
 Tumor cells were cultured at 5% CO2 concentration. The EL4 thymoma cells were cultured 
in Iscove’s Modified Dulbecco’s Medium (IMDM, Gibco) with 10% fetal calf serum (FCS) and 
1% antibiotic/antimycotic (Gibco). B16OVA melanoma cells were cultured in Minimal Essential 
Medium (MEM) with 5% FCS, 2% sodium-bicarbonate, 1.5% MEM vitamins, 1% sodium-pyruvate, 
1% non-essential amino acids, 1% antibiotic/antimycotic (all Gibco), 0.1% β-mercapthoethanol, 1 
mg/ml G418 and 60 ug/ml hygromycin. 9464D neuroblastoma cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM, Gibco), with Glutamax supplement, 10% FCS, 1% L-glutamine, 
1% antibiotic/antimycotic and 0.1% β-mercapthoethanol. Cells were harvested when they reached 
70% confluence and were suspended in PBS (for 9464D) or suspended in a 2:1 mixture of PBS 
and Matrigel Matrix (Corning) for EL4 and B16OVA.
 The mice were divided over the different tumor groups and received a subcutaneous injection 
on the right hind leg of 1 x 106 cells of 9464D (n=10) or 5 x 105 cells of B16OVA (n=10) or EL4 
(n=6). Tumor growth was evaluated daily with calipers. When the largest tumor diameter reached 
7 mm (after 9-17 days for B16OVA and EL4, and after 37-53 days for 9464D) the mouse was 
selected to undergo treatment (Fig. 5.1).
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Figure 5.1   Flow chart of treatment. Tumors resection for histopathologic evaluation was about 2 hours after 
treatment: 1h post-imaging and 1h period after imaging to evaluate the usage of the tumor 
bearing leg.
Treatment setup and protocol 
 The treatment and imaging setup used is extensively described in chapter 3 and 4 of this thesis. 
Briefly, the mice were anesthetized by 3% isoflurane gas inhalation and maintained by 1-2% isoflu-
rane during treatment to keep the breathing frequency between 30-60 per minute. A heated air-
flow device was coupled to a rectal thermometer to monitor and maintain the body temperature 
of the mouse during treatment. For acoustic coupling, the tumor area was shaved and remaining 
hair was removed with standard hair removal cream. The mouse was positioned in a right lateral 
position with the tumor inside a degassed water bath on top of the MR compatible animal HIFU 
system (Image Guided Therapy –IGT–, Pessac, France). A 3 MHz HIFU transducer (16 channels 
annular array cylindrical transducer, diameter 48 mm) with a full-width-half-maximum focal spot of 
0.5 x 0.5 x 2.0 mm was used for treatment. Trajectory planning software (Thermoguide, IGT) was 
used for treatment planning and guidance.
 Per tumor model the mice were divided into non-treated controls (n=3), 100 pulse treated 
mice (n=3), or 200 pulse treated mice (n=4). The BH method used for treatment of the tumors 
is similar as described in chapter 4. 16 or 25 focal spots, depending on the tumor size, with 1 mm 
spacing were positioned in one plane within the center of the tumor at a fixed focal length of 33.2 
mm (±2.7). The thickness of the lesion was considered as 2 mm, i.e. equal to the focal spot size, 
making the predicted treatment volume either 4 x 4 x 2 mm or 5 x 5 x 2 mm, for respectively 16 
or 25 focal spots. A custom ablation trajectory was designed to limit local temperature rise: each 
focal spot received one pulse (5 ms with an acoustic output power of 155-160 W), with a pause 
of 495 ms before moving to the next spot. After each spot received one pulse, the trajectory was 
repeated for a total of 100 or 200 pulses per focal spot. Total treatment time was 1250 or 2500 
seconds, respectively.
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MR	imaging
 MR imaging was performed with a 7 T small animal MR scanner (20 cm bore size, ClinScan, 
Bruker Biospin, Ettlingen, Germany) with a transmit body coil insert (free bore diameter 154 mm) 
and a custom receive-only surface coil (diameter 42 mm). Before and immediately after treatment, 
a series of T2 weighted (T2w, turbo spin echo sequence, TR: 2500 ms, TE: 41, 0.176 x 0.176 x 1.000 
mm) MR images were acquired, in three planes, for treatment planning and evaluation (Fig. 5.1). 
Detailed parameters of the MR sequences have been described previously (12). For real-time MR 
thermometry guidance a T1 weighted echo planar imaging (T1w-EPI) sequence (0.58 x 0.55 x 1.00 
mm, TR: 30.91 ms, TE: 7 ms, FA: 15°, Siemens, Erlangen, Germany) based on a proton resonance fre-
quency shift method was used. Seven coronal images were made each 4.6 seconds. After treatment 
a series of dynamic contrast enhanced (DCE) MR images were made using a T1w turbo-FLASH 
sequence (TR: 400, TE: 1.58, FA: 5, 0.391 x 0.391 x 1.000 mm) (12). After five T1w images (2.4 
seconds per image) 0.2 ml Gadovist (0.04 M) was intravenously injected in the tail vein. 
Histopathology
 After treatment, and post-MR imaging, the mice were allowed to recover from anesthesia to 
assess active use of the tumor bearing leg. After about one hour (i.e. 2h after treatment) the mice 
were sacrificed by cervical dislocation and the tumor was removed for histopathological evaluation 
(Fig. 5.1). The tumors were marked with black and blue dye for visual orientation and fixated in 
formaldehyde. The tumors were embedded in paraffin, oriented parallel to the coronal MR images 
(perpendicular to the ultrasound beam). Four µm thick tissue sections were cut every 300 µm and 
stained with hematoxylin and eosin (H&E). The slides were evaluated for type of necrosis, quality 
and quantity of the transition zone between vital and non-vital tissue, the amount of fragmentation 
and the presence of hemorrhage. An AZAN trichrome staining method was used for assessment 
of connective tissue (nuclei are colored dark red, cytoplasm becomes orange and collagen fibers 
stain blue using solutions of phosphotungastic acid; 1:20, Boom bv, Meppel, The Netherlands, and 
Orange G 1:200 and aniline blue 1:50, Klinipath, Duiven, The Netherlands). Additional immuno-
histochemical stainings were performed on sections of the tumor with the largest lesion volume. 
For this, the paraffin-embedded sections were first deparaffinized, followed by antigen retrieval by 
citrate (10 mM) for 10 minutes in a microwave. To block non-specific antibody binding, the sections 
were incubated with normal goat serum. Subsequently, the tissue sections were incubated with 
antibodies against the endothelial marker CD34 (Rat-anti-mouse, 1:10 in 1% PBS/BSA, Hycult), the 
proliferation marker Ki67 (Rat-anti-mouse, 1:50 in 1% PBS/BSA, TEC-3 DAKO) and the apoptosis 
marker caspase-3 (Rabbit-anti-active, 1:1000 in 1% PBS/BSA, BD Pharmingen). Subsequent staining 
was performed using biotin-labeled secondary antibodies, followed by ABC-horseradish peroxi-
dase and the 3,3’-diaminobenzidine (DAB) reaction. Sections were counterstained with hematoxylin.
 All mean parameter values reported for this study are given with standard deviation (±SD).
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Figure 5.2  T2w imaging immediately after treatment. Sagittal T2 weighted MR imaging of control tumors 
(A,B,C) and tumors immediately after 100-pulse (D,E,F) or 200-pulse (H,I) treatment. The 
length of the lesion is measured in longitudinal direction to the ultrasound beam. (G) The lesion 
size is presented as a percentage of the planned treatment volume, either 100- or 200-pulse 
BH, determined based on T2w images.
 
Results
Mouse treatment evaluation 
 Except for one mouse, all mice completely recovered after BH treatment with full usage of the 
tumor bearing leg. Two B16OVA melanoma bearing mice were excluded from further evaluation 
because accurate BH was not guaranteed: one mouse was excluded due to technical problems of 
the HIFU system during treatment, and in a second mouse the treatment was stopped after 126 
pulses because of an ulceration wound. 
 Analysis of the temperature within the ablation area during treatment revealed that the temper-
ature slowly increased after which it stabilized around 42±1.0, 42.3±1.4 and 45.1± 2.5 °C for EL4, 
B16OVA and 9464D tumors, respectively. Of note, the elevated core temperature observed in 
mice bearing the well-vascularized 9464D tumor was compensated by adjusting the air flow heater 
to ensure the core temperature would not exceed 38 °C.
 Prior to treatment, the real time T1w-EPI images showed hypo-intense areas inside the B16OVA 
melanoma, correlating to preexistent necrosis due to fast tumor growth (see tumor appearance 
section). These regions became more hyper-intense during treatment after more than 10 pulses 
per focal spot. While proceeding with the treatment, a lesion became visible in all tumors with 
slightly more hypo-intense borders. Upon treatment completion, a hyper-intense lesion with a 
hypo-intense border was seen on the T2w images of all treated mice, irrespective of tumor type, 
although these borders were less clear for treated B16OVA tumors (Fig. 5.2). The hyper-intense 
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lesion corresponded with the fragmented tumor debris and absence of cells as well as some edema 
effects. The increase in apoptotic cells, the slight increase in red blood cells and the compression of 
cells at the borders of the treated area as observed by pathological analysis corresponds with the 
hypo-intense rim on T2w images. 
 A significant increase in lesion size, as determined on T2w images, was found in the B16OVA 
tumors specifically in the longitudinal length of the lesion, i.e. along the US beam (Fig. 5.2). The lesion 
size after 100 pulses was in the longitudinal direction 7.5±0.1 mm in the B16OVA tumors, rela-
tive to the EL4 (2.7±0.3 mm) and 9464D tumors (1.8±0.4 mm). The lesion size in the 100-pulse 
treated mice appeared to be larger for B16OVA melanomas (500±10%) compared to the planned 
treatment volume (Fig. 5.2G). The lesion in the EL4 and more compact 9464D tumors were re-
spectively 95±13% and 55±33% of the planned treatment volume.
 The T1w DCE images were used to evaluate the vascularity and hemorrhage after treatment. 
These DCE images revealed normal contrast uptake within the untreated control tumors. After 
ablation, minimal to no contrast uptake was seen within the ablated areas of all treated tumor types, 
indicating the absence of perfused vessels. Of note, in the highly vascularized 9464D tumor a more 
diffuse linear contrast uptake was measured within the lesion. This linear contrast uptake could 
indicate an increased amount of hemorrhage or permeability of the vessels in the remaining tumor 
tissue (data not shown). 
Figure 5.3  Histopathology of non-treated and 2 hours after 100-pulse treatment. A, B and C shows the 
untreated thymoma, EL4 (A), neuroblastoma, 9464D (B) and melanoma, B16OVA (C), scale 
bar 500 μm. The melanoma reveals preexistent necrosis (C, asterisk). Additional zooms, higher 
magnification images (scale bar 20 μm) of immunohistochemical staining 1: CD34, vessel; 2: 
caspase-3, apoptosis; 3: H&E; 4: AZAN, collagen staining blue and 5: Ki67, proliferation. D, E and 
F show tumors after 100 pulse BH treatment. Note the sharp border between liquefied area 
and intact tumor cells in the thymoma (D) and neuroblastoma (E) on the additional magnifica-
tion (1: H&E) and intact collagen fibers (2: AZAN staining) as well as the amount of apoptosis 
in this transition zone (3: caspase-3 staining). The lesion within the melanoma (F) revealed 
mixture of debris and discohesive cells (magnification 1: H&E) partly apoptotic (2: caspase-3) 
and viable (3: Ki67).
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Tumor appearance
 The morphology of all three tumor types was analyzed based on standard H&E staining. All 
untreated tumors appeared as relatively homogeneous tumors (Fig. 5.3A-C). As expected, CD34 
staining revealed a significantly higher vascularity in 9464D neuroblastomas (Fig. 5.3B1) compared 
to EL4 or B16OVA tumors (Fig. 5.3A1, C1). AZAN staining revealed that 9464D neuroblastoma 
contained by far the most collagen fibers, with long fibers running throughout the entire tumor. 
EL4 thymoma exhibited an intermediate amount of collagen fibers whereas B16OVA melanoma 
contained very little collagen, consistent with its soft consistency (Fig. 5.3A4,B4,C4). B16OVA tum-
ors had a slightly lower cell density relative to the other tumors. Due to the soft tissue and loosely 
packed structure of B16OVA melanoma, some deformation may have occurred during resection 
and fixation of especially these tumors. Therefore the correlation between histopathology slides 
and MR images for B16OVA tumors was less apparent as for the other tumor types. 
 Proliferation (as indicated by Ki67 positive (tumor cell) nuclei) was abundant in all tumor types, 
although it was slightly less pronounced in the 9464D tumors (Fig. 5.3B5). The number of apoptotic 
cells (caspase-3 positive), interspersed throughout the tumor, was slightly higher for 9464D tumors 
compared to EL4 or B16OVA (Fig. 5.3A2,B2,C2). Only in the untreated B16OVA tumor a homo-
geneously appearing preexistent necrotic area with sharp edges was observed (Fig. 5.3C, asterisk).
 Following BH treatment with 100 pulses per focal spot a clear demarcated fragmentized lesion 
was visible on H&E stained sections for both EL4 thymoma and 9464D neuroblastoma. Cells (in-
cluding apoptotic cells) were no longer recognizable within the lesion in these tumor types (Fig. 
5.3D,E). Additionally, the transition zone consisted of a sharp border of only a few cells wide (Fig. 
5.3D1, E1). A high amount of apoptotic cells was seen within this transition zone in the EL4 tumors, 
which was much less pronounced in the 9464D treated tumors (Fig. 5.3D3,E3). 
 In contrast, the damaged area in B16OVA melanoma was larger than the planned treatment 
volume, similar as observed with MRI. The lesion was less well demarcated and contained a mixture 
of disintegrated tumor material, islets of discohesive cells, and dilated vessels (Fig. 5.3F). The cells 
present in the treated area included apoptotic cells, but viable cells were readily detected as well 
(Fig. 5.3F2,3). Strikingly, for B16OVA tumors the transition zone between treated and non-treated 
tumor tissue was frayed and much less clear in comparison to the transition zone in the EL4 and 
9464D treated tumors. This frayed transition zone did not contain apoptotic cells. The histological 
data, in combination with the increased lesion volume in contrast to the planned treatment volume, 
derived from all B16OVA tumors are consistent with the interpretation that viable parts of tumor 
tissue originating from the treatment borders are drifting into the fragmented ‘soup’ of tumor de-
bris. 
 To investigate the effect of more intense BH treatment and whether the efficacy of BH treat-
ment can be improved for tumors with soft consistency (like B16OVA), we extended BH treat-
ment to 200 pulses per focal spot for 9464D and B16OVA. The 200 pulse treatment of the B16O-
VA revealed a lesion size (measured on T2w images) of 233±70% of the planned volume, with a 
longitudinal length of 3.7±0.6 mm (Fig. 5.2G,I). The variation in lesion volume and length for 100 or 
200 pulse treated B16OVA tumors can be explained by the variety in tumor shape and thickness 
(in longitudinal direction) of the tumor. Histopathology of the 200 pulse treated B16OVA revealed 
a more homogeneously liquefied lesion, with only a negligible amount of recognizable single cells 
within the ablation area remaining. The 200 pulse treated B16OVA tumor region now appeared in 
many aspects similar to EL4 or 9464D tumors treated with the 100-pulse regimen. However, even 
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after 200 pulses the transition zone in B16OVA remained more frayed as compared to the tumors 
with a more firm consistency (Fig. 5.4A,B). We hypothesize that this data implies that the surround-
ing cells, which were drifted into the ablation area after 100-pulse treatment, are also fragmentized 
with extension to 200-pulse treatment. 
 Continuation of the treatment to 200 pulses increased the lesion size of the 9464D tumors to 
98±8% of the planned treatment volume as measured on T2w images (Fig. 5.2G). With histopatho-
logical evaluation, no clear difference in amount of fragmentation, size of the transition zone, or 
amount of apoptosis was detected between 100 and 200 pulse treated 9464D tumors (Fig. 5.3E 
and 5.5). The amount of micro-hemorrhage was slightly increased for the 200 pulse treated 9464D 
tumors, especially in the transition zone and the direct surroundings of the ablation area (Fig. 5.5A-
C). Interestingly, 9464D treated tumors contained various dilated vessels outside of the ablation 
area with intraluminal fragmented debris (Fig. 5.5F,G). No increase in hemorrhage was seen for 
B16OVA melanoma after extended treatment. The surrounding B16OVA melanoma tissue con-
tained an increased amount of dilated vessels (Fig. 5.4C), as well as an increased amount of edema 
in the 200 pulse-treated tumor (Fig. 5.4A, asterisk). 
 AZAN staining revealed that in all tumor models, either 100 or 200 pulse treatment, collagen 
fibers were to variable extent still visible after ablation. These collagen fibers were seen either as 
loose strings within the ablated area, or clotted together (appearing similar as amianthoid fibers 
(22); Fig. 5.3E2 and 5.5E). These remaining collagen fibers in the lesion were often located near the 
border of the lesion (Fig. 5.4D and 5.5D).
Figure 5.4  Histopathology of the melanoma (B16OVA) 2 hours after 200 pulse treatment. A: H&E 
overview, scale bar 500 μm. Asterisk shows edema, arrow shows drainage of the tumor 
debris. Additional zooms shows a frayed border of the ablated area (B: H&E) with dilated 
vessels (C: CD34) and remaining collagen fibers within the ablated area (D: collagen stained 
blue with AZAN, scale bar 20 μm).
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Discussion
 MR guided boiling histotripsy (BH) is feasible in different mouse tumor models. Even treatment of 
a highly vascularized tumor (9464D) resulted in only limited micro-hemorrhages, and all of the mice 
completely recovered. However, the pathological effects of this treatment may differ substantially 
depending on the tissue characteristics of the tumor, indicating that the acoustical parameters used 
for BH ablation should be adapted to such characteristics to obtain the optimal treatment effect.
 The density and structure of the tumor has an impact on especially the lesion size created by BH. 
As determined on T2w images, in 100-pulse treated EL4 thymomas, 95% of the planned targeted 
volume was damaged, compared to 55% of the more compact growing 9464D neuroblastoma 
tumors. Nevertheless, both the EL4 and 9464D treated tumors revealed completely fragmented 
tumor debris without any distinguishable cells within the clearly delineated lesion that showed a 
sharp transition zone with the surrounding intact tumor cells. In contrast, the 100 pulse treatment 
of B16OVA tumors revealed a five times larger lesion size on T2w imaging compared to the 
planned ablation area, and histopathological evaluation of these tumors presented a mixture of 
clusters of discohesive (partly viable) cells and micro-vessels within the fragmented tumor debris. 
The combination with the frayed and unclear transition zone between treated and vital tumor 
tissue suggests that in this situation viable tumor tissue, originating from the treatment borders, 
drifted into the ablation area during or after treatment. Which might occur due to acoustic stream-
ing effects created inside the liquefied area . Intensifying the treatment to 200 pulses resulted in 
fragmentation of these cells as well, revealing a homogenous liquefied lesion similar as seen in 
treatment of EL4 or 9464D tumors. 
 The amount of collagen appears to influence the effectiveness of the treatment in two ways. 
First, as suggested by others, firm (tumor) tissue, with high amount of collagen, results in a reduced 
bubble size created during BH. Thus a smaller lesion size per focal spot is created (18,20,23). These 
effects were also seen in our study, as the lesion size created by BH was larger or smaller than 
the planned treatment area in respectively the B16OVA (low amount of collagen) and the 9464D 
(high amount of collagen) tumors. These collagen fibers may also prevent that cells present at the 
border of the ablation area are flowing into the ablation area as seen in the B16OVA tumors after 
treatment. Secondly, some studies suggested that collagen fibers are less sensitive to the mechanical 
effects of BH (5,11,17). Our study reinforces this observation as in all tumor types, especially in the 
9464D tumor model, within the liquefied tumor debris at least some collagen fibers were still intact 
and detected. Often these collagen fibers seemed to be pressed towards the borders of the lesion, 
possibly due to the radiation force of the boiling bubbles created with BH, and occasionally clotted 
together appearing similar as so called amianthoid fibers (22). These findings imply that collagen 
fibers might indeed be more resistant to BH treatment. However, more research is required to 
quantify the effect of the amount of collagen in the tissue to the treatment.
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Figure 5.5  Histopathology of neuroblastoma (9464D) 2 hours after 200 pulse treatment. A: H&E over-
view, scale bar 500 μm with additional magnification of hemorrhages on the H&E sections 
(B,C; scale bar 20 μm) and intact collagen fibers (D,E; AZAN, scale bar 50 μm). E,F and G 
are from the same tumor, but at a different pathological level. E: clotted collagen fibers/material 
(AZAN staining, scale bar 50 μm). F: Fragmented nuclear debris within the intraluminal space 
of the vessels, H&E, scale bar 100 μm with additional zoom (G, scale bar 20 μm).
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 During treatment, the core temperature of 9464D tumor bearing mice increased as well as the 
local temperature within the ablation area. The temperature within the ablation area during treat-
ment was 45 °C in the 9464D and 42 °C in both the EL4 and B16OVA tumors. This indicates an 
increased release of energy, which is transferred into heat, in the well vascularized 9464D tumor 
model. This slight temperature increase might be explained by the higher tissue consistency of the 
9464D tumor. The firm consistency of the tissue due to the high amount of collagen and vessels 
could result in an increased nonlinear effect and a higher absorption rate of the ultrasound energy 
(24-26). Another explanation might be the increased vaporization and micro-bubble formation 
within the blood (27-29). Hereby more cavitation effects occur and a higher amount of energy 
is released. These two mechanisms could indicate that the time-to-boil is shorter for the 9464D 
neuroblastoma (2,20). As the time-to-boil is shorter, the pulse duration during treatment could be 
shortened to create a similar fragmentized lesion, but with less temperature increase (15,20).
 The increased local temperature could induce thermal stress to the cells in the transition zone 
of the ablated area (30,31). These cells could go into an apoptotic state as seen in the EL4 treat-
ed tumors. The 9464D treated tumors however did not show an apoptotic rim, but revealed a 
slightly higher amount of apoptotic cells in the remaining untreated 9464D tumor tissue. This ef-
fect could be explained by thermal heat sink effects because of the high amount of vessels in the 
tumor. Although these differences are small, it should be noted that the increased temperature to 
45 °C is in the range to create hyperthermia effects in the tissue. These effects should be taken into 
account when mechanisms of immunologic responses after BH are examined (30,32). Therefore, 
new studies with long-term follow up are required to investigate these effects in more detail.
 The small vessels within the ablation area were destroyed, as also described by others (28,33), 
although this did not result in major hemorrhages (including the highly vascularized 9464D neuro-
blastoma model). The hemorrhages found were only minimal and slightly higher after 200 pulses 
compared to 100 pulse treated tumors. Interestingly, in these tumors various dilated vessels were 
detected outside the ablation area containing intraluminal fragmented (tumor) debris. These effects 
can be explained by the acoustic streaming effect of HIFU (34). Blood and fragmented tumor 
debris is pushed into the vessels away from the treatment site as an result of the acoustic force 
within the focal spot. Beside this, small vessels are occluded due to the radiation force generated 
at the focus which limits the amount of hemorrhages (35). 
 It is shown that tissue characteristics such as cell density or the amount of blood vessels and 
collagen are of influence to the local treatment effect of BH. Further research is required to 
correlate these characteristics with the optimal treatment settings to mechanically disintegrate the 
tissue with BH, as well as quantification of the tissue characteristics prior to treatment via different 
imaging modalities. MR or US acoustic radiation force imaging, for example, are modalities able to 
determine tissue density and might be used to quantify the measure of disintegration of the tissue 
(36,37). Photoacoustic tomography or US Doppler imaging are modalities to provide metabolic, 
hemodynamic or vascular information of the tissue which could be of influence to the treatment 
(38).
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 In conclusion, our study, involving an intensive histopathological evaluation of BH treatment of 
tumor models with variable density, structure and vascularity, showed that BH in these tumors is 
feasible. However treatment settings need to be adjusted to the tissue characteristics of the tumor. 
Collagen appears to be less sensitive for BH. Incomplete treatment of tumors with more loosely 
packed cells, containing less collagen, could result in floating of the dislodged surrounding cells into 
the liquefied ablation site, resulting in a mixture of tumor debris and clusters of dicohesive cells. 
An increase of the amount of pulses results in a more homogeneous and complete disintegration 
of these cells. BH of solid tumors is a promising therapeutic approach. Further research with long-
term follow-up is required to investigate the long term physiological responses in different types of 
tumor to BH.
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Summary
 Over the last decades image guided local (thermal) therapies, such as laser, cryo- or radiofre-
quency ablation (RFA), are upcoming alternatives for radical approaches (surgery and external 
beam radiation) for the treatment of solid tumors (1). High intensity focused ultrasound (HIFU) 
is an emerging technique and currently the only non-invasive focal ablation therapy (2). Thermal 
HIFU (T-HIFU) ablation is widely known and already clinically used for both benign and malignant 
solid tumors. Next to T-HIFU, the interest in mechanical destruction of tissue with HIFU is growing. 
In chapter 2 of this thesis an intensive investigation of different mechanisms of mechanical HIFU 
treatments is described. While there are many different methods of mechanical HIFU ablation, 
cavitation cloud histotripsy (CH) and boiling histotripsy (BH) are the only pure mechanical HIFU 
ablation methods able to mechanically fragmentize soft tissue into submicron fragments. However, 
little is known about the in vivo effects of these treatment modalities. To understand the in vivo 
physiological, pathological and immunological effects, large cohort animal studies are required. Mice 
are most accessible for large cohort studies and there are many disease models available in mice. 
However, most commercially available HIFU systems with a focal volume small enough for mice 
treatments do not have sufficient power for CH or BH. The aim of this thesis was to develop a 
setup for mechanical HIFU treatment of murine tumors using MRI for treatment guidance and 
evaluation. This setup was used for optimization of the treatment settings of mechanical treatment 
using a BH method, as well as extensive in vivo histopathological and physiological evaluation of the 
treatment.
 An MRI guided HIFU setup is developed for the treatment of subcutaneous tumors in a mouse. 
In chapters 3 and 4 this setup is described and it is shown that mice bearing a subcutaneous tumor 
can accurately be treated with different HIFU ablation methods using MRI for treatment guidance 
and evaluation. These studies reveal that real time T1w MRI and MR thermometry can be used for 
both T-HIFU and BH treatment guidance. T2w imaging was most suitable for the detection of the 
ablated area after BH treatment, but contrast enhanced imaging was required for detection of the 
lesion after T-HIFU. 
 In T-HIFU a continuous wave ablation strategy of a couple of seconds per focal spot is used. The 
absorption of the US energy by the tissue is converted into heat, inducing irreversible damage and 
coagulation of the tissue. Thermal diffusion induces a relatively large transition zone between com-
pletely damaged and intact tumor tissue (chapter 4). Thermal diffusion of one focal ablation spot 
influences temperature build-up in the connected focal spots as the ablation progresses, resulting in 
overtreatment and damage of surrounding tissue (3). Therefore, a cooling time of almost a minute 
is required between each focal ablation spot to limit overtreatment of the tissue. Thus, thermal 
diffusion has major influences to the ablation trajectory (treatment planning) and treatment time 
as well as damage to surrounding tissue.
 Boiling histotripsy appeared to be most sufficient with 5 ms pulses, a duty cycle of <5% and an 
acoustic power of 155-160 W in the thymoma tumor model. Mechanical fragmentation of the tis-
sue is created by the mechanical force and shock wave effects of the US wave. The transition zone 
between the fragmented lesion and intact tissue is only a couple of cells wide to a maximum of 
200 µm. The damaged area created per focal spot is limited to the dimensions of the focal volume 
and the influence of the neighboring focal spots is negligible (4,5). The combination of this sharp 
transition zone and known focal volume size makes treatment planning of the treatment volume 
accurate and predictable (chapter 4). 
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 As described in chapter 2, there is some evidence that tissue characteristics are of influence 
to the effectiveness of BH treatment. Therefore a new study was done in which different type of 
tumors were treated with BH. Chapter 5 of this thesis revealed that tumors with different tissue 
characteristics, such as vascular density and stiffness (i.e. amount of connective tissue), respond 
different to BH treatment. Both the treated area as well as the degree of fragmentation depends 
on the treatment settings (power, pulse duration, amount of pulses) and tissue characteristics. It 
appeared that collagen fibers are less sensitive to BH treatment and more pulses were required to 
fragmentize these fibers. It is also noted that the compactness of the tissue is of influence on the 
damaged volume by BH treatment.
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Discussion
 Subcutaneous mouse tumors can accurately be treated with both BH and T-HIFU with the MR 
guided HIFU setup created in this PhD project. MR imaging can be used in both methods for treat-
ment guidance and evaluation. However, the effectiveness of BH treatment also depends on the 
tissue characteristics. In this section some issues regarding BH treatment, treatment time and de-
pendency of the tissue characteristics to the treatment, as well as the treatment imaging, guidance 
and evaluation, will be discussed.
Boiling histotripsy in a mouse model
 BH treatment time applied in the studies described in this thesis were long (>60 min ablation 
time) due to the low pulse repetition frequency of 1 pulse per second, the high amount of required 
pulses per focal spot (>100), and the small focal volume (0.5 x 0.5 x 2.0 mm FWHM). For large 
cohort mice studies within a reasonable amount of time, the treatment time for larger volumes 
need to be decreased significantly.
 There are several options to decrease the treatment time for BH. First of all, it can significantly 
be reduced by using a transducer with a lower operating frequency (1-2 MHz) instead of the 3 
MHz transducer that was used in the studies described in this thesis. A decrease of the operating 
frequency to 1-2 MHz will result in a significantly larger focal volume (1 x 1.5 cm) and thus a larger 
area of ablation. Consequently less focal spots are required to ablate a larger volume, thus decreas-
ing the treatment time. This aspect could be used for treatment of large animal models or clinical 
implementation, but is less sufficient in mice. A larger focal volume result in a higher possibility to 
damage the surrounding tissue in the small mice. It should be noted that a longer pulse duration or 
higher acoustic power is required to generate BH with a lower operating frequency (4).
 We significantly decreased the treatment time by a reduction in the amount of pulses and ab-
lation of multiple focal spots simultaneously (chapter 5). When using a point by point treatment 
strategy, a treatment time of 62.5 minutes was required to create a 5 x 5 x 3 mm lesion with 150 
pulses per focal spot (chapter 4). The treatment time was decreased to 21 minutes by decreasing 
the amount of pulses to 100 per focal spot and an optimized sonication trajectory (chapter 5). 
During the off-period for one treatment spot (i.e. in between pulses), the transducer is mechanical-
ly displaced to the next spots, until each spot received one pulse. The trajectory was repeated for a 
total of 100 pulses per spot. In this way multiple locations are sonicated in one duty cycle. The use 
of this trajectory and a reduction of the amount of pulses did not result in a significant difference in 
histopathological effect in a EL4 thymoma model. However, the tissue characteristics of the tumor 
determine whether the amount of pulses and thus treatment time can be decreased even more, 
as seen in chapter 5 and described by others (5-8).
 Tissue characteristics appear to be of major influence to the effectiveness of BH treatment. The 
treatment of a less compact tumor, such as the B16 melanoma, suggested that a larger volume 
is affected per focal ablation in contrast to a well dense and compact tumor such as the 9464D 
neuroblastoma model (chapter 5). However after 100 pulses still islands of cells were detected 
within melanoma treated tumors. Schade et al. (8) evaluated BH treatment in ex vivo kidneys 
and revealed that only 15-30 pulses per focus were required for fragmentation of the cortex and 
90-120 pulses per focus to fragmentize the collecting system. It is suggest that the amount of con-
nective tissue or collagen inside the tissue plays a major role to the sensitivity of the tissue to BH 
treatment. At first the collagen fibers might be more resistance to the radiation force generated by 
the cavitation effects which occur during BH. Secondly, a high amount of connective fibers result in 
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a reduced bubble size formation of the cavitation bubbles, as suggested by others (5). Thus a smaller 
volume will be destroyed. Thirdly, the fibers prevent that cells at the border of the ablation area are 
flowing into the treatment area as was suggested in the B16OVA tumors (chapter 5). This suggest 
that the sensitivity of the tissue to BH decreases with an increase of the amount of collagen within 
the tissue. However, this has to be investigated in more detail. The vascularity of the tissue might 
be of influence as well. As shown in chapter 5 the temperature during treatment slightly increased 
in a more vascular tumor model (neuroblastoma) comparison to the less vascularized melanoma 
or thymoma tumor models. This becomes of interest when investigating the specific mechanism 
behind the immunologic effect to the treatment.
 In conclusion, the treatment setup created can be used for accurate BH treatment of subcuta-
neous mouse tumors. However, the treatment time and optimal treatment settings for complete 
liquefaction of the tissue depend on the characteristics of the tissue. More research is therefore 
required to investigate which tissue characteristics are responsible for the sensitivity of the tissue 
to BH. Starting with investigation of the influence of tissue density and the amount of collagen in 
the tissue. This information could be used to determine the optimal BH treatment settings of the 
targeted tissue.
Image guidance and treatment evaluation
 Optimal imaging for either treatment planning, guidance or evaluation, via US or MRI, is an im-
portant aspect required for accurate non-invasive treatment in both T-HIFU and BH methods. HIFU 
treatment is not possible without good visualization of the tumor margins and treatment effects. In 
the studies described in this thesis a 7 T small animal MR scanner was used for treatment planning, 
guidance and evaluation. T2w imaging was sufficient for detection of the subcutaneous tumor mar-
gins and to determine the treatment volume for the studies performed in this thesis. T2w imaging 
might not be sufficient for detection of tumors located within an organ. Further optimization of 
tumor detection for treatment planning using other MRI approaches is required. 
 MR thermometry is most commonly used as guidance for T-HIFU treatment and was therefore 
used to guide both T-HIFU and BH in the studies described in this thesis. During both treatments 
MR thermometry could be used for localization of the focal spot and to check the temperature 
within the ablation area plus surrounding tissue. However, while MR thermometry is very useful 
for real-time T-HIFU treatment evaluation, this method is less valuable for BH treatment evalua-
tion. The temperature increase during T-HIFU within ablation area could easily be visualized with 
a temperature and thermal dose map. Based on these maps, the damaged volume (lethal dose) 
could be determined. The temperature change during BH is very small as the tissue is mechani-
cally fragmentized. Therefore, the lethal dose could not be determined based on the temperature. 
Furthermore, the tissue changes and cavitation effects due to the treatment might also affect the 
MR signal and thus the accuracy of the temperature measurements. Thus, while MR thermometry 
can be used for real time guidance of BH, it cannot be used to determine the lethal dose and is 
suboptimal for BH treatment evaluation.
 Besides temperature effects, other tissue changes might be visualized using MR-techniques that 
can be used for (real-time) treatment evaluation of BH. In chapter 4 it was already noted that dur-
ing BH treatment at first a signal drop was detected in the real-time T1w images due to cavitation 
effects, after which a slightly more hyper-intense region occurs due to liquefaction of the tissue; 
however, treatment margins were difficult to distinguish on these images. In addition, it was not 
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known whether the tissue was already completely liquefied, i.e. reached a lethal dose, or whether 
the treatment had to be continued. The cavitation effects that occur during treatment can cause 
intra-voxel incoherent motion, which could be visualized using strong gradient echo motion sen-
sitive sequences (9). MR Acoustic radiation force imaging (MR-ARFI) might be an opportunity for 
real-time evaluation of BH. This technique is already used to verify the position of the focal spot be-
fore (thermal) HIFU treatments. With this technique a short (low power) HIFU pulse is given which 
results in a small displacement of the tissue, which can be visualized using MR gradients (10,11). This 
technique might also be used to determine the tissue stiffness by measuring the displacement of 
the tissue. It is to be expected that the stiffness of the tissue decreases when the tissue becomes 
more liquefied, thus the displacement of the tissue increases. Hereby the displacement could cor-
relate with the amount of fragmentation and might be an indication of the mechanical lethal dose 
of the tissue during BH. In the future it might even be possible to combine MR thermometry with 
MR-ARFI to determine both temperature and displacement of the tissue during treatment and use 
these for real time guidance and to determine the lethal dose of BH (12,13).
 Although real-time MR treatment guidance by MR thermometry is suboptimal for BH, the treat-
ed area can immediately be visualized with non-contrast MR. The liquefaction of the tissue leads to 
a hyper-intense region on T2w imaging with hypo-intense borders. These images are very useful to 
determine the size of the liquefied lesion and based on these images, one can decide to continue 
the treatment if necessary. However, it should be noted that the intensity changes were less visible 
with the melanoma tumors compared to the more compact tumors such as the neuroblastoma 
or thymoma as described in chapter 5. Histopathological evaluation, however, revealed that the 
ablated area in these melanoma tumors still contained clusters of cells. Thus, it might be possible 
that the quantitative T2 value correlate to the amount of liquefaction of the tissue. Consequently, 
T2w imaging is useful to determine the lesion size, but not yet to determine the level of fragmen-
tation. Further research is therefore required to investigate the actual quantitative T2 values after 
treatment, as these might correlate to the level of fragmentation of the tissue. Another opportunity 
which might be able to determine the level of fragmentation could be apparent diffusion coeffi-
cient (ADC) mapping. The ADC values are sensitive to cellular densities and structure of the tissue. 
Changes of the cellular density and tissue structure, due to BH, would change the ADC values 
(14-16). Further research on different imaging methods will be required for accurate evaluation and 
guidance of BH treatments with MRI. 
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Future perspective
 To date, thermal ablation with HIFU is used in a clinical setting, where MRI, MR thermometry 
and thermal dose mapping are used for accurate treatment planning, guidance and evaluation. The 
results with T-HIFU as a treatment modality are good, however the interest in the mechanical treat-
ment effects is increasing. Although some technical challenges (such as the prolonged treatment 
time, finding the correct treatment settings and lack of good real time image guidance) which have 
been discussed extensively above, have to be overcome. BH can have several major advantages: 
in particular in relation to antitumor immune treatment and for other clinical treatments next to 
T-HIFU and CH. In the following section a future perspective will be given regarding these two 
issues.
Immunomodulation by HIFU
 Although HIFU is a local treatment option, it may also induce systemic effects. The ablation results 
in large volumes of tumor debris in situ, which will gradually be reabsorbed as part of a physiological 
healing response. Possibly, the tumor debris could be used to create an in situ cancer vaccine able 
to stimulate systemic immune responses, which is not (or less), pronounced after surgical resection. 
However, how our body will handle the ablated tumor is still unclear and will be in part dependent 
on the treatment method (thermal or mechanical), the characteristics of the tumor debris and 
the interactions with the different immune cells. As a result of the ablation, tumor antigens as well 
as multiple bioactive molecules including damage-associated molecular patterns (DAMPs), will be 
released. Combined with general inflammation and immune-regulatory processes of the wound 
healing response following ablation, this will result in different innate and adaptive immune effects.
 HIFU ablation, either thermal coagulation (T-HIFU) or mechanical fragmentation (BH), results in 
a depot of tumor material which will remain in situ, and contains tumor antigens, including mutated 
neoantigens, in a (partially) denatured or non-denatured state, depending on the temperature 
reached in the focal zone. Tumor antigens present in this depot can be captured by tissue-resident 
phagocytic cells, such as dendritic cells (DCs), that subsequently migrate toward the tumor draining 
lymph node (LN). Alternatively, tumor antigens may passively enter the circulation or lymphatics 
and be transported to LNs where they can be taken up by LN-resident DCs.
  For other ablation methods, such as cryo or RFA, it has been shown that the presence of tumor 
debris is necessary to evoke a tumor specific antitumor immune response and that ablation is ef-
fective in obtaining antigen-loaded DCs in tumor draining LNs (17-19). Similar effects are expected 
after HIFU. But, so far only a limited number of studies have investigated the presence of tumor 
antigens in HIFU ablated tumor debris. It can be expected that there will be a difference between 
T-HIFU or BH. As after thermal ablation a lesion of coagulative necrosis is formed with denaturation 
of the proteins and tumor antigens, as well as a transition zone of cells undergoing apoptosis at a 
slower rate due to heat stress (20,21). While BH leads to cellular fragmentation with only a minimal 
temperature increase (22,23). It should be noted that it is difficult to determine the degree in which 
antibodies can recognize (partially) denaturated or fragmented tumor antigens. More research is 
needed to elucidate the nature of tumor antigens present in the debris after T-HIFU or BH and the 
kinetics of their release into the circulation.
 Next to tumor antigens, HIFU ablation results in the release of a mixture of signals, including both 
immune stimulatory and inhibitory signals. So far only the release of immune stimulatory signals 
following HIFU ablation have been investigated. HIFU treatment, thermal or mechanical, of MC-38 
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colon adenocarcinoma cells in vitro resulted in a rapid release of endogenous DAMPs, such as HSP-
60 and ATP, from the damaged tumor cells (24), from which the latter can act as chemoattractant 
for DCs (25). Subsequently, in vitro incubation of DCs or macrophages with this supernatant re-
sulted in an upregulation of co-stimulatory molecules on their surface (CD80 and CD86), as well 
as an increased secretion of IL-12 by DCs and an elevated secretion of TNF-α by macrophages. 
The stimulatory effect was more pronounced by mechanical HIFU treatment compared to T-HIFU 
treatment (24). In addition it was shown that HIFU could induce HSP expression in vitro (26,27), as 
well as in vivo (27-30), which could stimulate further immune effects. However, most studies looking 
for HIFU-induced DAMP release have focused on immune stimulatory signals such as HSPs. Future 
investigations should include a broader range of DAMPs, including immune inhibitory signals, and 
the need to define the impact of these factors on the immunological outcome. 
 In conclusion, tumor ablation could lead to formation of an in situ antigen depot containing 
all types of (tumor) antigens, which can be processed and presented by antigen presenting cells 
(APCs), such as DCs and macrophages. Furthermore, ablation could lead to the release of DAMPs 
that potentially could activate cells from the innate immune system, such as DCs. However, the 
kinetics of release of tumor antigens and DAMPs, both stimulatory and inhibitory, from the depot 
after T-HIFU or BH requires further investigation.
 Studies investigating the anti-tumor immune response in vivo after thermal or mechanical HIFU 
are limited. Additionally, comparison of data from different HIFU studies is complicated by the lack 
of detail in the treatment description, as well as classification of the acoustic field generated and 
the temperature reached within the lesion, as also described in chapter 2. Nonetheless, increasing 
evidence indicates that HIFU-induced tumor ablation can modulate antitumor immunity and might 
be more potent in mechanical HIFU treatment compared to thermal HIFU treatments. Zhang and 
colleagues investigated thermal HIFU treatment of H22 hepatocellular carcinoma (HCC) in mice 
and observed an increased maturation of DCs in thermal HIFU-treated tumors (31,32). Complete 
tumor eradication by thermal HIFU-treatment was shown to significantly reduce tumor growth of 
rechallenged tumors in a neuroblastoma model (33). Furthermore, thermal HIFU ablation of H22 
hepatocellular tumors resulted in increased cytotoxicity of cytotoxic T lymphocytes (CTLs), com-
pared to untreated controls (34). Additionally, an increase in the number of tumor-specific CTLs 
in the HIFU-treated cohort was seen. Adoptive transfer of these HIFU-activated CTLs was shown 
to evoke potent antitumor immune responses in tumor-bearing mice in terms of survival bene-
fit and tumor regression (34). Similar results regarding CTL activation were obtained from mice 
bearing B16F10 melanomas and MC-38 colon adenocarcinomas (35,36). Interestingly, mechanical 
HIFU ablation of B16F10 tumors was slightly more potent in activating CTLs compared to ther-
mal HIFU ablation (36). Furthermore, HIFU treatment, thermal and mechanical, of MC-38 colon 
adenocarcinomas resulted in enhanced infiltration of DCs (CD11c+) into tumors and subsequent 
migration to tumor draining LNs, which was more pronounced in mechanical HIFU treated mice 
(35). Although these data suggest that HIFU (thermal or mechanical) significantly influence the 
immune system, no potent tumor-specific immunity has yet been convincingly demonstrated. The 
tumor-specific immune response due to the diverse treatment options, thermal and mechanical, has 
to be investigated in more detail. 
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 The differences in immune treatment response between thermal or mechanical HIFU ablation 
could be explained by the temperatures reached in the focal zone during treatment and the tumor 
debris which is created. In chapter 4 it was described that temperatures above 65 °C were reached 
during thermal ablation. This leads to instant coagulation of the cells and denaturation of proteins 
as well as tumor antigens and danger signals. Additional, non published, immunohistochemical gran-
ulocyte staining (GR-1) of the treated tumors in chapter 4 revealed that granulocytes were slightly 
infiltrated in the transition zone between treated and non-treated tissue, and were not able to 
infiltrate into the compact coagulated mass (Fig. 6.1). As reported in chapter 4, the transition zone 
reaches temperatures between 40 and 50 °C due to heat diffusion (37,38). Cells in this transition 
zone suffer from thermal stress and undergo apoptosis. Cells exposed to hyperthermia were re-
ported to be responsible for release of inflammatory cytokines and HSPs, which can attract APCs 
and activates DCs (29,38-40). For T-HIFU, a treatment regime where each thermal focal spot does 
not overlap with its neighbors has been recommended, as it has been shown that DCs accumulate 
mostly in the periphery of a lesion, where tumor cells are exposed to temperatures of <55 °C 
(41). This observation implies that sparse-scan thermal treatment regime could be more potent in 
stimulating immune effects, indicating the importance of optimization of the T-HIFU scan strategy 
for optimal tumor ablation and stronger immune effects.
 While a dense coagulated mass is created after thermal ablation, the cells are fragmented into 
a liquefied debris of submicron particles with BH. Denaturation of proteins is limited as the tem-
perature during treatment remains low (<55 °C). Mechanical disruption of cells could potentially 
release a large amount of non-denaturized tumor specific antigen fragments, as well as DAMPs in 
the form of ATP and HSPs. Although it should be noted that also immune inhibitors could be re-
leased. The liquefied debris remains in situ and may function as an unbiased source available to the 
immune system and could possibly be used as an in situ cancer vaccine (6,42,43). Initial granulocyte 
immunohistochemical staining (GR-1) of the BH treated tumors described in chapter 4, revealed a 
large influx of granulocytes, and neutrophils, into the fragmented debris four days after treatment 
(Fig. 6.1). This influx appeared to be much larger compared to thermal ablation in which the influx 
was only seen in the transition zone of the ablated region. These results indicate that mechanical 
HIFU treatment, such as BH, have a clear impact on the innate immune system but more research 
is required to investigate its impact on adaptive immune responses. It has been shown that provid-
ing external immune stimuli, following different ablation technologies, is crucial to generate potent 
ablation-induced adaptive immune effects. For cryoablation, it is known that in vivo proximity of 
tumor antigen and immune stimulus (in these studies; TLR-9 agonist CpG-ODN) in place and time 
is crucial for optimal activation of the adaptive immune system. Indeed, efficacy of cancer immuno-
therapy was strongly increased only when CpG-ODN was administered peritumoral immediately 
after cryoablation (44,45). In the B16 model, RFA and cryoablation have also been combined 
with a checkpoint blockade antibody directed against CTLA-4, resulting in increased numbers of 
tumor-specific T cells with increased IFN-γ secretion potential, and protection against outgrowth of 
tumor rechallenges (17). Later these results were confirmed in a spontaneous mouse tumor model 
of prostate cancer (46).
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Figure 6.1  Additional, non published, immunohistochemical staining of the tumors described in chapter 
4. Top row: 4 days after T-HIFU; Bottom row: 4 days after BH. Left column shows an H&E 
staining of the entire tumor. Right column shows a correlating zoom with GR-1 granulocyte 
staining.
 In conclusion, based on literature and the results described in this thesis indicate that the effects 
of tumor ablation with HIFU, either thermal or mechanical, are multifold: 1) the destruction of tu-
mor mass, lowering tumor burden, and 2) the release of tumor antigens, making them available for 
uptake by APCs. The treatment itself will lead to 3) the release of DAMPs and 4) the induction of 
a physiological wound healing response. Ablation will lead to creation of an in situ antigen depot 
containing all types of tumor proteins. Ablation of tumors at temperatures above 65 °C leads to 
denaturation of proteins. This can affect immune responses in opposing ways as high temperatures 
denature immune activating signals, such as danger signals like HSPs, as well as immune suppres-
sive signals such as TGF-β or IL-10. Depending on the tumor microenvironment, it may be more 
important to remove immune suppressive signals or maintain danger signals using, respectively, 
thermal ablation or mechanical ablation. Furthermore, availability of tumor antigens from the tu-
mor debris may be different between thermal and mechanical HIFU. The state of blood vessels in/
near the treated area should be considered as well, since the majority of immune cells will reach 
the induced lesion via the circulation. More experiments looking closely at the optimal treatment 
regime for a given cancer patient are needed to achieve this. In current literature, however, the 
treatment description, as well as classification of the acoustic field generated, is often lacking details 
(see also chapter 2). Furthermore, it is important to know the temperatures reached and whether 
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a more sparse- or dense scan treatment is used. Some murine studies and our preliminary results 
suggest that BH-like treatment has a stronger impact on the immune system than T-HIFU (35,36). 
However, studies describing mechanical HIFU, such as BH, are limited, underscoring the need for 
further investigation. The setup created and described in this thesis can be used for representative 
and adequate research to investigate the adaptive and innate immune effects of both mechanical 
and thermal HIFU ablation techniques.
Clinical application of boiling histotripsy in comparison to T-HIFU or cavitation 
cloud histotripsy
 Boiling histotripsy is still in the beginning of development. As discussed, there are some issues 
which has to be investigated before clinical implementation is feasible. Such as: Finding the correct 
treatment settings and the correlation with tissue characteristics; Optimization of image treatment 
guidance and evaluation; and long term follow up in mice or large animal models as until now only 
immediate to short term in vivo effects are investigated. However, BH offers some interesting op-
portunities for clinical implementation and has some major advantages in comparison to thermal 
HIFU ablation or other mechanical HIFU ablation techniques such as cavitation cloud histotripsy.
 Heat-sink effect is a major challenge in T-HIFU treatment especially in well vascularized tissue 
such as the liver or kidneys. Therefore, extensive treatment time is required to ablate this type of 
tissue to prevent inconsistent ablation, especially near large vessels. As a result, surrounding tissue 
could be damaged due to heat diffusion. Extended continuous ablation could result in heating of 
tissue in the ultrasound beam path such as the ribs or skin as well (47,48). Heat-sink effects or 
heating of tissue in the ultrasound path are negligible with BH treatment due to the low duty cycle 
and short millisecond pulses which are used. Hereby collateral damage to surrounding tissue will 
be negligible. This makes this technique more suitable for liver and kidney treatments.
 With T-HIFU important structures, such as larger vessels or nerves, within the ablation area can 
get damaged, which can result in major complications after the treatment. These structures might 
remain intact using the correct settings of BH. In chapter 5 and by others (6-8) it is shown that 
the efficiency of BH correlate to the tissue characteristics. It appears that tissue containing a higher 
amount of connective tissue, i.e. collagen, is less sensitive to the treatment (8). While this makes 
treatment planning a bit more challenging, these tissue characteristics can also be used to limit 
adverse effect in the treatment of liver tumors, renal cancer or benign prostatic hyperplasia (BPH). 
Adaption of the ablation parameters for BH, i.e. decreasing the amount of pulses or operating 
power, could spare import structures such as larger vessels, nerves or collective tissue within the 
ablation area. For example, major complications in T-HIFU treatment of prostate cancer are urinary 
retention, incontinence, and erectile dysfunction due to damage of the urethra or neurovascular 
bundles. These structures, containing a higher amount of connective tissue, could be spared by using 
the correct BH treatment settings (a lower amount of power or decreased amount of pulses). In 
the liver larger vessels, containing a high amount of collagen, will be less sensitive to BH. By de-
creasing the intensity or amount of pulses of BH it might be possible to spare these vessels while 
destroying the affected tumor tissue. Similarly, tumor in the kidney can be fragmented without 
damaging the collective system (8,49,50). Thus although planning of the treatment becomes more 
difficult due to the dependency of the tissue characteristics, these aspects can also be used for 
better BH treatment.
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 A major disadvantage of T-HIFU is the fact that after treatment a large coagulated mass will 
remain which eventually will be replaced by scar tissue. However in many cases, such as BPH or 
brain tumors, fast removal of the tumor or tissue mass is the most important reason to treat the 
patient. For example, BPH often results in urinary difficulties or even incontinence. Removal of the 
tissue mass is the main reason of treatment. Thermal HIFU ablation of the prostate has already been 
widely investigated. Although initial results were encouraging, the long-term effects were less prom-
ising. Madersbacher et al. revealed that 44% of the patients treated for BPH with transrectal T-HIFU 
had to undergo additional salvage trans-urethral resection of the remaining coagulated or healthy 
prostate tissue (51). BH, however, offers the opportunity to mechanically fragment the tissue. Con-
sequently the liquefied lesion could be removed by gradual reabsorption as a normal process of 
healing response or flushed out via the lymphatic system or blood vessels (52-54). This will result in 
rapid debulking of the tissue mass and leaving a minimal amount of scar tissue (54). Some studies 
even suggest that the liquefied tissue will be replaced by regenerated healthy tissue. For example 
Vlaisavljevich et al. revealed that the liquefied lesion created in a liver by a CH treatment was almost 
completely replaced by regenerated liver parenchyma within 28 days (55).
 In vivo CH treatment in porcine models already revealed that mechanical fragmentation is an ef-
fective method for the treatment of BPH, kidneys and liver (56,57) and the first clinical trials for the 
treatment of BPH are currently in progress. However, it will be easier to implement BH in clinical 
practice compared to CH. A major limitation for clinical implementation of HIFU, is the fact that for 
different organs a different device is required for accurate treatment. For CH a special HIFU system 
is required, containing large ultrasound transducers and amplifiers able to generate high amounts of 
acoustic power, has to be purchased by the clinicians. BH, however, requires significantly less power 
and can be achieved with smaller transducers and is already feasible with current clinical available 
HIFU systems (53). Since no additional device has to be purchased, both T-HIFU and BH can often 
be done with one device, the transition to daily clinical practice will be easier and more interesting 
for clinicians.
 Another disadvantage of CH is that deep located organs are challenging to treat. The large pen-
etration dept, i.e. more attenuation, makes it difficult to get enough energy within the focal spot 
for accurate CH treatment. BH can be achieved with a smaller transducer such as a transrectal or 
even smaller endoscopic transducer as shown by Li et al. (58). This aspect in combination with the 
lower energy required for BH, will make it possible to treat deeper located organs. Beside these 
opportunities, respiratory or cardiac motion has been a technical barrier in the treatment of organs 
such as the liver or kidneys with T-HIFU or CH (48). The low duty cycle (1-2 pulses per second) 
used for BH treatment offers possibilities for respiratory or cardiac motion triggering. Although CH 
and BH result in relatively similar pathological effects, as described in chapter 2, BH might be less 
complicated to put in clinical practice and offers new opportunities. 
 This thesis showed that boiling histotripsy is a promising ablation method, but some large barriers 
have to be taken before clinical implementation is feasible. To accomplish this goal a broad range of 
knowledge has to be achieved about the optimal technical treatment settings and correlation with 
the characteristics of the targeted tissue of interest. Beside this, good visualization of the target and 
evaluation of the treatment effects, with the use of MRI, is required. Therefore, a close collaboration 
between different disciplines (technicians, interventional radiologist, surgeons and immunologists) 
will be key to make this technique a success and ready for clinical implementation.
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 Beeld geleid locale (thermische) therapieën, zoals laser, cryo of radiofrequente ablatie, zijn sterk 
opkomende alternatieven naast radicale behandelingen (zoals chirurgie en bestraling) voor de be-
handeling van solide tumoren. Ablatie met behulp van gefocusseerd ultrasound, ook wel bekend als 
HIFU (high intensity focused ultrasound), is een opkomende techniek en op dit moment de enige 
niet-invasieve focale ablatie therapie die er is. Thermisch HIFU (T-HIFU) ablatie is een bekende 
techniek die al in een klinische settings wordt gebruikt voor behandeling van zowel goedaardige als 
kwaadaardige solide tumoren. Maar naast thermische ablatie groeit ook de interesse van mecha-
nische ablatie met HIFU. In hoofdstuk 2 is uitgebreid onderzoek beschreven naar de verschillende 
mechanismen van mechanisch HIFU behandeling. Hoewel er vele verschillende methoden zijn 
van mechanisch HIFU ablatie, zijn cavitatie histotripsy (CH) en boiling histotripy (BH) de enige 
pure mechanische HIFU ablatie methode waarmee zacht weefsel gefragmenteerd kan worden in 
submicron grootte fragmenten. Echter, er is nog weinig bekend over de in vivo effecten van deze 
technieken. Om beter inzicht te krijgen in de in vivo fysiologische, pathologische en immunologische 
effecten, zijn dierstudies in grootte cohorten noodzakelijk. Muizen zijn het meest toegankelijk voor 
dit soort grootte cohort studies. Daarnaast zijn er veel verschillende ziekte modellen beschik-
baar in muizen. De meeste commercieel beschikbare HIFU systemen, met een focus klein genoeg 
voor muizen, kunnen echter niet voldoende akoestische power genereren voor CH of BH-achtige 
ablatie methoden. Het doel van dit proefschrift was om een opstelling te ontwikkelen waarmee 
mechanische HIFU behandelingen kunnen worden uitgevoerd in muis tumoren, met daarbij MRI 
(beeldvorming met magnetische resonantie) voor het begeleiden en evalueren van de behandeling. 
Deze opstelling werd vervolgens gebruikt voor het optimaliseren van de juiste instellingen voor 
mechanisch HIFU ablatie met een BH methode, met daarbij uitgebreide in vivo histopathologische 
en fysiologische evaluatie van de behandeling.
 Een MRI geleide HIFU opstelling is ontwikkeld voor de behandeling van subcutane tumoren in 
muizen. In de hoofdstukken 3 en 4 wordt deze opstelling beschreven en is te zien dat muizen met 
een subcutane tumor accuraat behandelt kunnen worden met verschillende HIFU ablatie metho-
den. Hierbij wordt MRI gebruikt voor begeleiding en evaluatie van de behandeling. Deze studies 
tonen aan dat real-time T1 gewogen MR beelden en MR thermometrie gebruikt kunnen worden 
voor het controleren van zowel T-HIFU als BH behandeling. T2 gewogen MRI-beelden waren het 
beste bruikbaar voor detectie van het geableerde gebied na BH behandeling, maar contrast ver-
sterkende beeldvorming was nodig voor detectie van het geableerde gebied na T-HIFU.
 Voor T-HIFU wordt een ablatie strategie gebruikt waarbij er een continue ultrasound (US) golf 
wordt gefocusseerd gedurende een aantal seconden. De US energie wordt geabsorbeerd door het 
weefsel en omgezet in hitte, wat zorgt voor onherstelbare schade en coagulatie van het weefsel. 
Thermische diffusie zorgt ervoor dat er een relatief grote transitie zone is tussen het geableerde en 
intacte (niet behandelde) tumorweefsel (hoofdstuk 4). Thermische diffusie van het ene focuspunt 
beïnvloedt hiermee de temperatuur in de gebieden van de aanliggende focuspunten wanneer de 
ablatie wordt voortgezet. Dit zorgt voor overbehandeling en schade aan het omliggende weefsel. 
Om overbehandeling te minimaliseren is daarom een koelingtijd nodig van meer dan 1 minuut tus-
sen de verschillende ablatiepunten. Thermische diffusie zorgt dus voor schade aan het omliggende 
weefsel en heeft ook grote invloed op het behandeltraject (planning) en de behandeltijd.
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 Boiling histotripsy bleek het meest effectief met een pulsduur van 5 ms, een duty cycle van 
<5%, en een akoestische power van 155-160 W in een thymoom tumormodel. Het mechanisch 
fragmenteren van het weefsel wordt veroorzaakt door de mechanische kracht en shock wave 
effect van de US golf. De transitiezone tussen het gefragmenteerde weefsel en intact onbehandeld 
weefsel is slechts een aantal cellen breed tot een maximum van 200 µm. De schade die veroor-
zaakt word per focuspunt blijft beperkt tot de dimensies van het focusvolume en de invloed op 
aangrenzende focuspunten is verwaarloosbaar. De combinatie van deze scherpe transitie zone en 
het bekende volume van het focus, maakt planning van de behandeling en het behandelgebied 
nauwkeurig en voorspelbaar (hoofdstuk 4).
 Zoals in hoofdstuk 2 beschreven, zijn er aanwijzingen dat weefseleigenschappen van invloed zijn 
op de effectiviteit van de BH behandeling. Daarom is er een studie opgezet waarbij verschillende 
type tumoren behandeld worden met BH. Hoofdstuk 5 van dit proefschrift geeft weer dat tumo-
ren met verschillende weefseleigenschappen, zoals vaatdichtheid en stevigheid (i.e. hoeveelheid 
bindweefsel), anders reageren op BH behandeling. Zowel het behandelvolume als ook de mate 
van fragmentatie hangt af van de behandelparameters (zoals power, pulsduur en aantal pulsen) 
en weefseleigenschappen. Het blijkt dat met name collageenvezels minder sensitief zijn voor BH 
behandeling en dat meer pulsen nodig zijn voor het fragmenteren van deze vezels. Daarbij is ook 
de dichtheid van het weefsel van invloed op het beschadigde volume door BH-behandeling
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